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CHAPTER 1. 
FOOD BY-PRODUCTS 
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A by-product is a secondary product derived from food industries that does not represent the 
primary service produced. In other words, a by-product is the "output of a process that has a minor 
quantity and/or a net realizable value when compared to the main products". A by-product can be 
useful and marketable or it can be considered waste. 
 
1.1. Food by-products: current production and uses 
 
The food processing industry, despite the great articulation of its productive sectors, is 
characterized by a significant production of by-products (Federalimentare, 2006). Because of 
complexity of the food system, estimating sizes and impacts of these streams is very difficult. 
However, some estimates can be derived from literature. Wirsenius (2008) estimated the amounts of 
by-products (used for feed) and wastes of food processing in terms of energetic values (i.e. J which 
is expressed as energetic value per 100 energetic units food produced). In particular, in Western 
Europe per 100J food, 56J ends in by-products, while 20J is lost from the food system. According 
to a survey performed by Awarenet (2004), the European Food processing activities produce about 
250 million tonnes per year of by-products and waste along with relevant amounts of high COD 
effluents. Also in Italy the economic dimension of the management of by-products from food 
processing industries is significant. The 2-3% of the dry volumes and the 7-10% of the moist 
volumes produced are by-products. The estimated sale value is around 300 million euro per year 
(Federalimentare, 2006). 
Such waste streams are only partially valorised at different value-added levels (spread on 
land, animal feed, composting), whereas the main volumes of them are managed as waste of 
environmental concern, with relevant negative effects on the overall sustainability of the European 
food processing industry. With increasing disposal costs, alternative uses of co-products are 
increasingly being sought. The economic value of each product comes from its intrinsic nutritional 
or applicability value. Moreover for a company the utilization of a by-product can give some 
benefits from the economical point of view. The erroneous classification of such products as 
"waste" is doubly negative: from one side, the producers are forced to manage the disposal of the 
materials even if they are still susceptible to use, from the other side, the potential users are forced 
to search expensive alternative sources of supply (Federalimentare, 2006).  
More serious consequences are reflected on the ecosystem. In fact, disposed by-products 
would finish in the landfill or through the drains, water courses, creating in this way serious 
environmental problems (Smith, 1998).  
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Due to the current promotion of sustainability in the production and consumption of food by 
governments and international institutions, and, at the same time, considering that food systems 
must satisfy increasing needs in quantitative and qualitative terms, because of the increment of the 
world population (Mancini et al., 2011), it is clear that the exploitation and the use of food by-
products must be increasingly enhanced. 
Although in the industrialized society various former by-products have been upgraded to the 
food domain (for example whey protein isolates) and feed domain, still vast streams of by-product 
exist that have potential for the food domain. With an eye on potential handling and application 
purposes, primary and secondary by-products are distinguished. 
Primary by-products (e.g. farming by-products such as straw and residues from land 
management) are traditionally largely used for caring and feeding animals. With an eye on their 
composition further enhancement of nutrient utilization efficiency for feed (FAO, 2012) and 
utilization for renewable materials and energy are the most relevant development directions.  
Also secondary by-products (processing residues) are largely used for feeding purposes. 
With (historical) industrialisation and scaling up of food processing, the distance between the place 
of generation and utilisation of the by-products has increased. Consequently, specialized by-
products trading companies have developed, who still mainly aim at feed markets. In general wet 
by-products are transported directly from place of origin to the farmer, whereas parts of the dry by-
products are processed to feed concentrates. 
Some examples food by-products are reported in table 1. Their reutilization can cover the 
production of: animal and pet food (with sugar beet pulp, corn gluten, cereals used for the 
production of beer, whey, by-products of the meat processing), pharmaceutical and cosmetic 
compounds (collagen, gelatin), bio-fertilizer, food ingredients (gluten, germ and fiber), bio-fuels. 
The chemo-physical properties, the shelf life, the availability and transportability of the by-products 
are crucial to establish their possible use. 
The sugar industry by-products are the easiest to be found and utilized (Smith, 1998). For 
example the molasses has a sugar content close to the 50% and nowadays it is widely used for the 
antibiotics, organic acids and bakers' yeast productions (Smith, 1998). Over 20 million tons of 
animal by-products emerge annually from EU from slaughterhouses, plants producing food for 
human consumption, dairies and as fallen stock from farms 
(http://ec.europa.eu/food/food/biosafety/animalbyproducts/index_en.print.htm). 
In large-scale food industry sectors, with voluminous homogeneous protein-rich by-product 
streams (like dairy and meat processing), development of application in higher-value domains been 
very successful in last decades. Some example are summarized in table 2. A number of new and 
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more sophisticated possible exploitation of food processing by-products and waste have been 
foreseen, tested and sometimes also scaled up (Kosseva, 2009; Galanakis, 2012).    
 
1.2. Industrial examples of uses of food by-products 
Notwithstanding the complexity of introducing new foods (or ingredients) based on by-
products, various examples of innovations in this field have been successfully introduced in 
practice. 
Current societal focus (and stimulating governmental arrangements) on bio-energy, bio-fuels 
and other renewable bio-based solutions has resulted in a large number of practical in those areas, 
which has overwhelmed applications in the food domain. Except for industrial uses of dietary fibres 
from food by-products (Elleuch et al., 2011), the number of practical examples on innovative use of 
the by-products presented in scientific literature lately is very limited. Yet, various appealing 
examples exits. Below a brief summary of some of these successful practical examples in the sector 
of animal and vegetable by-products and waste is reported; for each example key success factors 
and obstacles are also briefly outlined.  
 
1.2.1. Vegetable by-products 
1.2.1.1. Starch production by-product 
The processing of crops like potato, wheat, rice and corn results in considerable side stream 
which contain notably potentially valuable proteins. Most prominent example is the food-grade 
isolation potato protein.  
Previously the protein was separated from the potato juice by thermal and acid denaturation, 
which resulted in an insoluble aggregates with lost functionality, only suited for feed. Recently the 
Solanic company (AVEBE, Netherlands) has developed a plant that successfully extracts native 
potato proteins from potato juice (by-product from potato starch production), and the product is 
marketed to food industries (e.g. bakery, meat, sport supplements). The key success factor is the 
development of the isolation process combined with the high quality of the derived proteins 
(solubility, emulsification, foaming and gelling quality, high nutritional value, low allergenicity) 
compared to other commercial ones of different animal or vegetal origin.  
Some other attempts to extract highly functional proteins from other crops are less 
successful (e.g. extracting gluten from wheat and β
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1.2.1.2. By-products from vegetables canning 
Vegetable canning results in considerable amounts of by-products (peels, rejects, etc.). 
These are traditionally traded as cattle feed or composted. Value for bio-energy production is 
limited because of the high water content and limited energetic value. Therefore, interest in 
application for human food is getting more attention. Recently the company Provalor has developed 
a process for vegetable juice (natural colorant in food) and fibres extraction from the by-products. 
The main key success factor for this process is represented by the development of an adequate 
extraction process with highly appreciable yields. Moreover, also the increasing interest in ‘clean 
labels’ (the natural colorant can replace synthetic colorants in food products) and Societal call for 
sustainable valorisation of by-products have acted as external factors promoting the success of this 
process. 
 
1.2.1.3. By-products from legume 
Grain legumes, also known as pulses, are plants belonging to the family Leguminacae, 
which are grown primarily for edible grains or seeds. India is the fifth largest legume produced in 
the world. Among the legumes, the soybean, also classed as an oilseed, is pre-eminent for its high 
(38-45%) protein. By-products of legume include: hulls, husk, seeds etc. Microcore Research 
Laboratories (India Pvt Ltd.) has developed a process and patented the technology for the 
converting husk of Bengal gram to insoluble dietary fibers and micro-crystalline dietary cellulose 
which can be used in daily diet to control obesity. The main success factors are represented by the 
development of the adequate technology to obtain the insoluble fiber and the high demand for such 
a functional component which has strongly increased worldwide. 
 
1.2.2. Animal by-products 
Traditionally the major parts of an animal are used as food, feed or materials. As such real 
waste products from animal slaughter hardly exist. However, there is a continuous technical 
innovation to maximize the value the refinement and splitting of streams. Stringent regulation 
change with regard to BSE has been a game changer in these industries for the application of by-
products for food and feed. 
 
1.2.2.1. Alternative sourcing of gelatin 
Confidence in traditional sources of gelatin (amongst others bovine hides and bones) was 
seriously damaged by BSE breakout. Increase of gelatin prices has been a trailblazer for alternative 
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production processes. A successful example is the Dutch company Ten Kate Vetten that developed 
a production process primarily aiming at extracting fats from pig slaughter by-products. Such a 
process was innovated so that high-quality gelatin can be isolated from their processing water. The 
(mild) fat extraction process furthermore enabled valorisation of other protein products in pet feed.  
 
1.2.2.2. Beef collagen fibre 
In leather production substantial amounts of animal material occur are cut off and wasted. 
Hulsh of Protein Technologies in the Netherlands has innovated their process such that these cut 
offs are kept in food-grade quality and processed to native collage fibres with superior water 
binding and structuring properties compared to common thermally denatured collagen (due to mild 
drying and grinding procedures that leave the collagen fibres in their native triple helix structure). 
The collagen product is Halal certified.  
 
1.2.2.3 Other successful examples on animal by-products 
• Insuline from pancreas: pharmaceutical hormone for diabetic patients. 
• Mucine from pig bowels: ingredient for synthetic saliva. 
• Blood proteins processing and valorisation 
• Cholesterol from Lanoline (sheep wool fat).   
• Cholesterol as building block for the pharmaceutical industry, cosmetics 
industry and crucial feed additive for shrimps. 
Each of these examples was driven by internal factors: costs of wastage and/or value of the 
product.  
 
Table 1. By-products that could be exploited as substrates for biotechonological processes 
(Smith, 1998) 
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Table 2. Summary of common and potential uses of by-products in various agro-food sectors. 
 
Sector (by-product) Historical or 
common use 
State-of-the-art use (and potentials) in food and 
other high-value applications 
Vegetable processing 
(peels, reject, etc.) 
Dairy feed  Food-functional properties of various compounds 
are broadly recognized.  
Practical implementation is limited because of 
technological and/or economic reasons. In a 
limited number of practical situations, food 
ingredients are produced out of the by-products 
(e.g. food-grade trimmings for processed foods, 
vegetable juices from food-grade peels and 
rejects). 
Vegetable wastes such as sugar beet leaves, 
cauliflower leaves and gram plant with empty 
pods can serve as a good source of essential 
vitamins and antioxidants and serve as an organic 
source of minerals. 
Oil seeds (cake) Protein-rich animal 
feed 
Deriving attractive protein-rich ingredients for 
food applications will require major changes in 
oil extraction processes.  
Fruits (seed, peel 
pomace, kernel, 
wastes) 
Feed for livestock; 
components are used 
for cosmetics and 
paints. 
Fruit peels have relatively high contents of 
functional food compounds. For example, apple 
pomace is a rich source of polyphenols, minerals 
and dietary fibre (Sudha et al., 2007), and banana 
peels have high contents of pectins (including 
glucose, galactose and xylose).  
Beyond the food domain, a product like banana 
peel can be used for biomethanation. 
Furthermore, it can be used as a sorbent that 
removes heavy metals from waste water.  
Cereals(bran, husks) Feed for livestock Because of high contents of dietary fibres, bran is 
traditionally used in amongst others bakery and 
products and breakfast cereals.  
Part of the rice bran is used for rice bran oil; 75% 
of this oil is used in the food domain, whereas 
25% is used for soap manufacturing. Rice bran 
wax is an important by product of rice bran oil 
industry. Rice bran wax can be used in the 
preparation candles, polishes, cosmetics, 
emulsifiers and other industrial preparations. 
Relatively new is the application in minced meat, 
contributing to water binding capacity. 
Wheat bran could be utilized in solid state, liquid 
state fermentations and animal feeds. 
Dairy by-products 
(whey, skim milk, 
butter-milk, etc) 
Protein-rich animal 
feed 
Value of whey (powder) as high-value protein 
product in food is very high. 
Whey obtained as a by-product of cheese industry 
has long been utilized in the production of 
fermented beverages, both alcoholic and non-
alcoholic (acidic). 
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Skim milk is a by-product obtained during the 
manufacture of cream. It is rich in solids-not-fat 
content and has high nutritional value. It is 
regarded as a by-product only when it is either 
not economically utilized or utilized for derived 
by-products like casein and related products, co-
precipitates, protein hydrolysates etc. E.g.: From 
by-product of skim milk cultured butter milk and 
Bulgarian butter milk has been prepared. 
Sugar processing by-
products (sugarcane 
bagasse) 
Generation of steam 
and power required to 
operate the sugar 
factory 
Amongst the alternative valorisation options are 
use of fibres for paper and boards and bio-
ethanol.  
Meat processing 
(bone meal , poultry 
by-products meal & 
other animal by-
products) 
Feed for livestock,  
pets and aquaculture 
(rich of essential 
amino acids, fatty 
acids, vitamins and 
minerals) 
Because of danger of Bovine spongiform 
encephalopathy (BSE), stringent limitations have 
been formulated by governments on use of animal 
by-products in feeds. 
Next to feed applications, currently food, 
pharmacy, pet food, compound feed, fertilisers 
and technical applications are produced out of 
meat by-products. 
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CHAPTER 2.  
PEPTIDES AND FOOD 
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Peptides are short polymers of amino acids present in humans, animals, and plants, and 
represent an important component of the innate immunity, as they may also participate in the 
antioxidant, antimicrobial and signalling functions. They can be synthesized ex novo (like carnosine 
or gluthatione), or they can be produced after proteolysis. In the first case, the new molecules are 
synthesized to complete predetermined functions; in the second case, instead, they can follow 
different pathways, such as the metabolic pathways of amino acids, or remain in a latent state within 
the protein sequence. The peptides released from proteolytic processes during food processing are 
related to the functional, nutritional and sensorial properties of the final product. 
The desire for functional foods and the need to reduce chemical preservatives are connected 
with the ever increasing health and nutrition concerns of the consumers (Mills et al., 2011) . 
The concept that proteins can be tailored and their fragments modelled to achieve a 
particular function, is now of great interest. In general, peptides generated from food proteins 
present the great advantage to derive from harmless sources and therefore are considered safe. 
Moreover, the production of peptides obtained from these sources could bring additional value to 
food by-products, representing a breakthrough area for the industry of the future (Pellegrini, 2003) . 
 
2.1 Properties of peptides 
  
2.1.1 Structure and functional properties 
Peptides are polymers of at least two amino acids linked together by covalent bonds, 
between the carboxyl group of one molecule and the amino group of the other molecule. All the 
polymers containing more than 50 amino acids are considered proteins, whereas peptides are those 
containing less than 50 units. Indeed, the complexity of the structure and the degree of activity are 
supplementary methods to discriminate proteins from peptides (Van De Weert and Randolfh, 2012)  
The length and the amino acid composition of these molecules will determine their 
physicochemical properties. Each peptide presents a free amino group in the N-terminal region and 
a free carboxylic group in the C-terminal with equalised magnetic charges. The elements 
responsible for the final charge of the peptide, which can be ionized, belong to the inner amino acid 
side chains. These side chains are very important in the food industry. Also the Maillard reaction, 
generating colour and flavour compounds during the baking process, relies on the presence of these 
amino acids side chains. At the same time, the inclusion of a peptide or their in situ production, can 
improve the texture of the food product. For example the development of the texture in the Cheddar 
cheese during ripening has been thought to depend upon the extent of proteolysis. Because more 
peptide bonds are broken and more new charged groups (NH3 +/COO−) are available to compete 
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for water, the “free” water content of maturing Cheddar cheese curd is reduced (O’Mahony et al., 
2005). The foaming capacity is another peptide-dependant property, which has been widely applied 
in the alcoholic beverages industries (such as beer and sparkling wine) (Sharpe et al., 1981). The 
liberation of hydrophobic sequences during hydrolysis can lead also to peptides with emulsifying 
properties (Shimizu et al., 1984). Finally, peptides with antifreezing properties have been reported; 
they have been obtained or isolated from Antarctic and Arctic fish and they were mainly alanine- 
and cystine-rich (Wohrmann, 1996). Some others, such as alcalase hydrolizates of bovine gelatine, 
ranging from 600 to 2700 Da, are also able to inhibit recrystallization of ice in frozen ice cream mix 
as well as in frozen sucrose solutions (Wang and Damodaron, 2009) 
 
2.2 Sensory properties  
Peptides can contribute considerably to the final taste of food, in particular cheese and meat 
products (Hansen-Møller et al., 1997) and they may cover the entire range of taste modalities: 
sweet, bitter, umami, sour and salty (Temussi, 2012; Seki et al., 1990). Compounds with acidic-rich 
residues have a sour taste, whereas those rich in hydrophobic residues have a bitter taste, and those 
with a more balanced composition display little or no taste.  
Sequence and conformation can also play an important role in flavour. Nowadays, 
aspartame (L-aspartyl- phenylalanine methyl ester) is the most extensively used peptide to 
substitute sugar in beverages. This peptide has the same calories of sucrose, but it is 200 times 
sweeter; hence, aspartame can be used in a lower concentration, and it can be supplied to diabetics. 
However, some disadvantages have been detected, such as: low stability at high temperature, low 
solubility at neutral pH, and high sensitivity to proteolytic reactions. Moreover, phenylalanine, one 
of its breakdown products, must be avoided by people suffering of phenylketonuria (PKU) 
(Temussi, 2012). Mazur et al (1969) demonstrated that the molecule providing the sweetness to this 
peptide is from one side the Asp residue, but also a very precise steric structure (H-L-Asp-L-Phe-
OMe). All the other possible chiral isomers, i.e. D-L, L-D and D-D H-Asp-Phe-OMe, are bitter.  
As mentioned above, hydrophobic peptides possess bitter taste. Bitter peptides are prevalent 
in a wide variety of aged or fermented foodstuffs, because enzymatic hydrolysis frequently 
generates bitterness; the development of bitter taste in cheese during maturation is a well-studied 
example (Temussi, 2012). Otagiri et al. (1985) reported that a strong bitter taste is observed when 
arginine is contiguous to proline). Finally, although the umami (taste enhancer) depends mainly to 
the glutamate, novel "umami petides" have been studied and isolated. Yamasaki and Maekawa 
(1987) isolated the "delicious peptide” from a beef soup (H-Lys-Gly-Asp-Glu- Glu-Ser-Leu-Ala-
OH), which produces a taste similar to that food product. However, there is no significant evidence 
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to consider the small umami peptides as an independent class; it is possible that their taste is a 
consequence of the presence of Asp or Glu. In this way, it is clear that the chemical nature of 
peptides, particularly their incredible conformational versatility, plays a relevant role in determining 
many structure–activity relationships, including those connected to food acceptance (Temussi, 
2012). 
 
2.3 Peptides bioactivities 
The study of functional and bioactive peptides has been extensively promoted (Perez Espitia 
et al., 2012). A peptide is considered bioactive if it can support health through a positive impact on 
the functions or conditions of living beings (Korhonen and Pihlanto, 2006). The beneficial effects of 
peptides depend on their antimicrobial (Reddy et al., 2004; Rajanbabu and Chen, 2011), antioxidant 
(Sarmadi and Ismail, 2010), antithrombotic (Wang and Ng, 1999), anti-hypertensive (Erdmann et 
al., 2008), opioid and immunomodulatory behaviour (St Georgiev, 1990; Gauthier et al., 2006). The 
main peptides bioactivities are reported in figure 1. 
 
                          
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Bioactive properties of food protein-derived peptides. 
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2.3.1. Anti-hypertensive peptides  
Many of the physiological functions in an organism are mediated by peptides; for 
instance, blood pressure can be regulated by peptides, like angiotensin-II or bradykinin. The 
antihypertensive effect is defined by measuring the capability of a putative peptide to inhibit the 
angiotensin-I-converting enzyme (ACE, EC 3.4.15.1). ACE is a constituent enzyme of the renin-
angiotensin system that plays a crucial role in blood pressure regulation and fluid and electrolyte 
balance (Martínez-Maqueda et al., 2012) These processes are catalysed by two mechanisms: 
either by the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, or by the 
degradation of bradykinin, a potent vasodilator, and other vasoactive peptides. Some anti-
hypertensive peptides are reported in table 3. 
Most bioactive peptides generated from milk proteins have demonstrated ACE-I activity. 
They can be released from two different pathways: milk protein hydrolysis or milk fermentation. 
A number of peptides with antihypertensive properties have been identified from casein and 
whey proteins with gastric and pancreatic enzymes. 
One of the peptides with proven antihypertensive effect is a αs1-casein-derived peptide, 
with sequence FFVAPFPGVFGK. The casein hydrolyzate containing this peptide has been 
patented and commercialized as an antihypertensive product named Peptide C12®. Moreover αs1-
casein represents a source of bioactive peptides since two other sequences that reduce systolic 
blood pressure (SBP) have also been identified (RYLGY and AYFYPEL) (Contreras et al., 
2009). The use of food-grade enzymes, derived from microorganisms, to release bioactive 
peptides has also become a common strategy. In nature, the proteolytic activity of lactic acid 
bacteria during fermentation of dairy products gives off peptides and amino acids, which are used 
as nitrogen sources necessary for bacterial growth (Martínez-Maqueda et al., 2012). However, 
some of these peptides, produced by Lactobacillus helveticus in combination with 
Saccharomyces cerevisiae during milk fermentation, revealed blood pressure lowering properties 
(i. e. VPP and IPP). Other strains responsible for the liberation of antihypertensive peptides are 
Lactobacillus helveticus CPN4, Lactobacillus bulgaricus and Streptococcus thermophilus 
(Nakamura et al., 1995) 
Eggs are another important source of antihypertensive peptides. Ovokinin (FRADHPFL), 
resulting from the pepsin hydrolysation, is one of them. These properties can be enhanced by 
emulsification with egg yolk, because phospholipids promote its absorption and protect the 
peptide from intestinal peptidases (Fujita et al., 1995).  An intriguing discovery about the 
bioactive egg peptides is that even if they show ACE-I activity in vivo, many of them may not 
work in vitro, demonstrating only partial correspondence between in vitro and in vivo effects. 
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Due to their optimal extracting conditions, collagen and gelatin are considered as good 
sources of bioctive peptides. They are obtained mainly from porcine skin and bovine hide, as well 
as bones, tendons and cartilages. Moreover, studies considering novel sources, such as meat, 
poultry or fish and marine by-products and waste are already being developed (Martínez-
Maqueda et al., 2012).  Some previously reported antihypertensive meat peptides are MNPPK 
and ITTNP, which were released in the thermolysin hydrolysis of porcine muscle myosin. Other 
peptides were found to be particularly active, such as AVF and VF, from an insect protein 
digestion, YYRA from chicken bone hydrolysate and KRVIQY from porcine myosin 
hydrolysate. 
Antihypertensive peptides inhibitory to ACE can also be derived from vegetable proteins, 
such as gluten, zein and hordein (Gobbetti et al., 1997). Indeed, hydrolysed or fermented soybean 
proteins produced several sequences responsible for the in vitro antihypertensive activity (Tab. 
3). 
A daily consumption of a moderate amount of antihypertensive peptides from natural 
sources could elicit a blood pressure reduction not far from that of synthetic drugs, because the 
majority of patent drugs available in the market contain similar bioactive peptides to those found 
in the above mentioned food products (Martínez-Maqueda et al., 2012). 
 
2.3.2. Antithrombotic peptides 
Cardiovascular diseases (CVDs) lead to the development of thrombosis, due to the 
alterations in the coagulation mechanisms. Increased occurrence of thrombosis has been linked to 
platelet hyperreactivity, high levels of haemostatic proteins (e.g., fibrinogen), defective 
fibrinolysis and hyperviscosity of the blood (Erdmann et al., 2008). Therefore, antithrombotic 
drugs are commonly used to reduce platelet aggregation and enhance fibrinolysis. Similarities 
between the mechanisms of milk clotting, defined by the interaction of κ-casein with chymosin, 
and blood clotting, defined by the interaction of fibrinogen with thrombin, have been reported. To 
date, food derived peptides with antithrombotic properties are mainly the result of enzymatic 
hydrolysis of κ-casein (Erdmann et al., 2008) (tab. 3). The dodecapeptide of fibrinogen and the 
106-116 sequence of κ-casein show functional homologies. Another peptide, with 
MAIPPKKNQDK sequence, functions mainly because of the presence of three amino acid 
residues (Ile108, Lys112, Asp115). It inhibits both the aggregation of ADP activated platelets as 
well as the binding of human fibrinogen γ-chain to its receptor region on the platelet surface 
(Smacchi and Gobbetti, 2000). 
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Table 3. Examples of anti-hypertensive and antithrombotic peptides deriving from different food 
sources. 
sequence source reference
Anti-hypertensive FFVAP α-CN f23-27 Maruyama et al., 1985
AVPYPQR β-CN f177-183 Maruyama et al., 1986
YGLF α-LA f50-53 Mullally et al., 1996
ALPMHIR β-LG f142.148 Mullally et al., 1997
KVLPVPQ β-CN f169-174 Maeno et al., 1996
LVYPFPGPIPNSLPQNIPP β-CN f58-76 Miguel et al., 2006  
LHLPLP β-CN f133138 Miguel et al., 2007
YP α-CN f146-147 Maeno et al., 1996
FFVAPFPGVFGK α-CN f23-34 Keshmirian and Nogrady 1988  
RYLGY α-CN f90-95 Contreras et al., 2009
AYFYPEL α-CN f90-96 Contreras et al., 2009
VPP β-CN f(84–86) Nakamura et al., 1995
IPP β-CN f(74–76) Nakamura et al., 1995
YRGGLEPINF Egg white Miguel et al., 2007
ESIINF Egg white Miguel et al., 2008
YAEERYPIL Egg white Miguel et al., 2005
RADHPFL Egg white Miguel et al., 2006
IVF Egg white Miguel et al., 2007
Hydrolysate Egg white Miguel et al., 2008
FRADHPFL Ovalbumin Fujita et al., 1995
QVSLNSGYY D-hordein Gobbetti et al., 1997
SAYPGQITSN α-zein Gobbetti et al., 1998
FNQ α-zein Yano et al., 1996
LAY α-zein Yano et al., 1997
LLP α-zein Yano et al., 1998
LNPA α-zein Yano et al., 1999
LQQ α-zein Yano et al., 2000
AY α-zein Yano et al., 2001
NWGPLV Soy (glycinin) Kodera and Nio, 2006
IAP Wheat (gliadin) Motoi and Kodama, 2003  
Wheat protein hydrolysate Kodera and Nio, 2006
GA(Hyp)GL(Hyp)GP Chicken leg collagen hydrolysate Saiga et al., 2008 
GF(Hyp)GP Porcine skin collagen hydrolysate Ichimura et al., 2009 
LKP Meat (chicken muscle) Fujita et al., 2000
IKW Meat (chicken muscle) Fujita et al., 2001
LAP Meat (chicken muscle) Fujita et al., 2002
ITTNP Meat (porcine muscle) Nakashima et al., 2002
MNPPK Meat (porcine muscle) Nakashima et al., 2003
YYRA Chicken bone extract hydrolysate Nakade et al., 2008 
KRVIQY porcine myosin hydrolysate Muguruma et al., 2009 
DLTDY Oyster protein hydrolysate Shiozaki et al., 2010  
DY Oyster protein hydrolysate Shiozaki et al., 2011
Hydrolysate Oyster protein hydrolysate Shiozaki et al., 2012
Hydrolysate Salmon muscle protein hydrolysate Ono et al., 2003 
Hydrolysate Squid skin collagen hydrolysate Lin et al., 2012 
VF Insects hydrolysis Vercruysse et al., 2010 
AVF Insects hydrolysis Vercruysse et al., 2011
Antithrombotic MAIPPKKNQDK k-CN f106-116 Jolles et al., 1986
KDQDK k-CN f112-116 Qian et al., 1994
KRDS Lactotransferrin f39-42 Qian et al., 1995   
k-CN f106-112 Battazzi, 1996 
k-CN f106-116 Battazzi, 1996 
k-CN f112-116 Battazzi, 1996
k-CN f113-116 Battazzi, 1996
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2.3.3. Hypocholesterolemic and hypotriglyceridemic peptides 
A destabilised blood lipids profile (hypercholesterolemia and/or hypertriglyceridemia) is 
another risk factor for CVDs. It has been reported that dietary proteins with low ratios of 
methionine/glycine and lysine/arginine, such as soy and fish protein, favour a 
hypocholesterolemic effect, whereas bovine and casein, having higher amino acid ratios, tend to 
elevate cholesterol levels (Erdmann et al., 2008). The most studied hypocholesterolemic peptides 
derive from soy proteins (tab. 4). Peptides produced from this source revealed that a hydrophobic 
region is required for biological activity. Moreover, a proline residue seems to be a key 
component. Hypotriglyceridemic activities have been also detected in different animal species 
when hydrolyzed globin has been provided. This effect may depend on the capability of the 
peptides to decrease intestinal fat absorption and to enhance the lipolysis of triglycerides 
(Erdmann et al., 2008). 
 
 
Table 4. Examples of antioxidant, hypocholesterolemic and opioid peptides deriving from 
different food sources. 
 
sequence source reference
Antioxidant MY Fish (sardine muscle) Erdmann et al., 2006
LLPHH Soy (β-conglycinin) Chen et a., 1995
YFYPEL Milk (casein) Suetsuna et al., 2000
MHIRL Milk (β-lactoglobulin) Hernandez-Ledesma et al., 2005 
YVEEL Milk (β-lactoglobulin) Hernandez-Ledesma et al., 2006
WYSLAMAASDI Milk (β-lactoglobulin) Hernandez-Ledesma et al., 2007
YAEERYPIL Egg (egg white) Davalos et al., 2004
β-CN f98-105 Rival et al., 2001  
β-CN f177-183 Rival et al., 2002
β-CN f169-176 Rival et al., 2003
β-CN f170-176 Rival et al., 2004
k-CN f96-106 Kudoh et al., 2001    
Hypocholesterolemic LPYPR Soy (glycinin) Yoshikawa et al., 2000 
IAVPGEVA Soy (glycinin) Pak et al., 2005
Opioid RYLGYLE α-CN f90-96 Loukas et al., 1983
YIPIQYVLSR k-CN f25-34 Chiba et al., 1989
β-CN f60-63 Meisel, 1997
β-CN f60-70 Fiat et al., 1993    
GYYPT gluten Fukudome and Yoshikawa, 1992 
GYYP Fukudome and Yoshikawa, 1993
YGGTL Fukudome et al., 1997 
YGGT
YPISL
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2.3.4. Antioxidant peptides 
The use of antioxidants as preservatives has been systematically applied in the food 
industry. Recently, the use as health products of food-derived peptides has also attracted interest, 
because they can supplement endogenous antioxidants against oxidative stress (Fang et al., 
2002). Recent studies have shown that peptides with antioxidant properties can be released from 
food sources such as milk casein, whey protein, egg and soy protein and food by-products 
(Erdmann et al., 2008; Bougatef et al., 2010). Some examples of bioactive peptides derived from 
different protein sources are listed in table 4. 
Some suggested mechanisms influencing the antioxidant properties of peptides have been: 
metal ion chelation, scavenging or quenching of reactive oxygen species (ROS), inhibition of 
enzymatic (lipoxygenase- mediated) and nonenzymatic peroxidation of lipids and essential fatty 
acids (Udenigwe and Aluko, 2012). The antioxidant activity has been attributed to certain amino 
acid sequences, in particular histidine, proline, cysteine, methionine, and aromatic amino acids. 
Chen and co-workers reported that histidine residues of peptides are able to chelate metal ion, 
quench active oxygen, and scavenge OH (Chen et al., 1998) through its imidazole group, which can 
participate in hydrogen atom transfer and single electron transfer reactions (Chan and Decker 1994). 
This activity can be increased adding hydrophobic amino acids (such as proline and leucine) to the 
N-terminus of a dipeptide His-His. This hydrophobic part is important because it can lead the 
antioxidant peptides to interact with hydrophobic cellular targets (Chen et al., 1998). Although 
selected information about the specific activities of single peptides has been reported, it is not clear 
how protein hydrolysates contribute in these processes. Li et al. (2008) noticed that there is a dose-
dependent relationship between hydrolysate concentration and antioxidant activity. The highest 
antioxidant activity was found in peptides between 500–1500 Da.  
 
2.3.5. Opioid peptides  
Opioid peptides are small molecules naturally produced in the central nervous system 
(CNS) and in various glands throughout the body. They contribute to some behaviours, such as 
motivation, emotion, and attachment, the control of food intake and the response to stress and 
pain. They work in the same way of classic alkaloid opiates (such as morphine and heroin) 
(Froehlich, 1997). Exorphins, a class of peptides with opioid activity, were found in pepsin 
hydrolysates of wheat gluten and soy -protein (Fanciulli et al., 2003; Zioudrou et al. 1979) 
(tab. 4) and others, called cytochrophins and hemorphins, have been produced from 
enzymatically treated bovine blood (Brantl et al., 1986). 
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2.3.6. Immunomodulatory peptides 
Immunomodulatory peptides are able to enhance the functions of immune system, 
including regulation of cytokine expression, antibody production, and ROS-induced immune 
functions (Hartmann and Meisel 2007; Yang et al., 2009). It has been reported that a tryptic 
digest of rice protein can promote phagocytosis and increase superoxide anion production in 
human leukocytes (Takahashi et al., 1994). In addition, egg-derived peptides are used during 
cancer immunotherapy to increase immune functions (Mine and Kovacs-Nolan, 2006). 
(Udenigwe, 2012) Chicken meat proteins, especially myosin, tropomyosin and collagen, contain 
bioactive peptide fragments with immune-stimulating properties which, theoretically, could be 
released through the activity of proteinase K (Dziuba et al., 1996). 
 
2.3.7. Anticancer peptides 
A number of studies on anticancer peptides have been focused on soy peptides, in 
particular in Lunasin (Hernandez-Ledesma et al., 2009). The anticancer property of lunasin is 
predominantly against chemical and viral oncogene-induced cancers, and based on the 
modulation of histone acetylation and deacetylation pathways specifically. The final effects are 
repression of cell cycle and promotion of apoptosis in cancer cells (Hernandez-Ledesma et al., 
2009). Recently, 2 large peptides (Leu-Pro-His-Val-Leu-Thr-Pro-Glu-Ala-Gly-Ala-Thr and Pro-
Thr-Ala-Glu-Gly-Gly-Val-Tyr-Met-Val-Thr) from tuna dark muscle by-product hydrolyzed with 
papain and protease XXII were isolated by Hsu and co-workers (2011). These peptides exhibited 
dose-dependent antiproliferative activities against cultured breast cancer (MCF-7) (Hsu et al., 
2011). This result demonstrates the potential of meat products and meat by-products as valuable 
sources of bioactive peptides for incorporation into functional foods (Ryan et al., 2011). 
 
2.3.8. Antimicrobial peptides  
One of the first lines of defence against infections used by animals, plants and insects is 
the production of antimicrobial peptides. According to data already reported, antimicrobial 
peptides should be relatively short (12 to 100 amino acids), positively charged (to interact with 
lipids) and amphiphilic (to enter into the cell membrane). Despite their similar properties, 
antimicrobial peptides have very limited sequence homologies with a wide range of secondary 
structures. To date, hundreds of such peptides have been identified and their different 
mechanisms of action have been elucidated (Jenssen et al., 2006). There are at least four major 
groups (Mackintosh et al., 1998): 
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1) Linear helical peptides without cysteine, such as the cecropins from insects and pigs 
(Boman, 1995);  
2) Peptides with an antiparallel β-sheet structure stabilized by two or three intramolecular 
disulfide bonds, such as defensins (Ganz, 2003); 
3) Peptides with one intramolecular disulfide bond, such as bactenecin (Romeo et al., 
1988); 
4) Linear peptides containing high proportions of one or more amino acids, in particular 
tryptophan-, arginine- and proline-rich peptides, like drosocin (Bulet and Stöcklin, 2005). 
Jennesen et al. (2006) reported that the antimicrobial action in peptides is given by 
permeabilization through the microbial cells. In such case, a model has been proposed to describe 
the mode of action (fig. 2): first, in the “aggregate” model (A), there is a reorientation of the 
peptides spanning the membrane and forming an aggregate; then, on the “toroidal pore” model 
(B), peptides form pores; in the “barrel-stave” model (C), peptides are inserted in a perpendicular 
orientation to the plane of the bilayer, form the “staves” in a “barrel”-shaped cluster, and in the 
“carpet” model (D), peptides aggregate in parallel to the lipid bilayer, showing a detergent-like 
activity. Peptides that do not act by permeabilising the membrane can work at different levels: 
inhibiting DNA and RNA synthesis (E), decreasing protein synthesis (F), reducing the enzymatic 
activity (G), modifying aminoglycosides (H), or forming structural components (I) that can 
disturb the normal bacterial growth. Bacteria antimicrobial peptides (bacteriocins) are among the 
first ones to be isolated and characterized. They are produced as defence from other bacteria that 
might compete in the same environment. One of the main studied bacteriocins is nisin, a 
lanthionine containing a peptide, used for nearly 50 years as a food preservative (Jenssen et al., 
2006). 
Even though it has not been as well-studied as the antioxidant capacity of food peptides, 
the hydrolysis of food proteins can generate new and potent antimicrobial peptides (tab. 5). The 
most investigated food-derived antimicrobial peptide is lactoferricin, the fragment 17-41 of the 
iron-binding glycoprotein lactoferrin. This peptide has antimicrobial activity against Gram-
negative bacteria and Candida albicans (Farnaud and Evans, 2003). 
Peptides released from milk proteins are the richest source of antimicrobial peptides 
(AMPs). Peptides obtained from bovine αs1-casein and produced by Lactobacillus acidophilus 
DPC6026, are active against both Gram-positive and Gram-negative bacteria; these have been 
proposed as bioprotective compounds if supplied in milk food products (Hayes et al., 2006)  
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Figure 2. Mechanisms of action of antibacterial peptides proposed by Jenssen et al., 2006. 
 
Muscle foods as source of antimicrobial peptides are less documented. A peptide obtained 
from bovine meat (GLSDGEWQ) inhibited the growth of both Gram-positive and Gram-negative 
pathogens. It was also reported that GFHI and FHG inhibited the growth of the pathogen P. 
aeruginosa (Ryan et al., 2011). Moreover, a cysteine rich antimicrobial peptide was produced 
from the digestion of oyster muscle, using a combination of alcalase and bromelin (Liu et al., 
2008). This peptide also resulted active inhibiting the growth of the fungi Botrytis cinerea and 
Penicillium expansum (Ryan et al., 2011) 
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Table 5. Examples of antimicrobial peptides deriving from different food sources. 
 
sequence source reference
Antimicrobial YQEPVLGPVRGPFPIIV colostrum Birkemo et al., 2009
YQEPVLGPVRGPFPI colostrum Birkemo et al., 2010
RPKHPIKHQGLPQEVLNENLLRF colostrum Birkemo et al., 2011
IKHQGLPQE casein Hayes et al., 2004
VLNENLLR casein Hayes et al., 2005
SDIPNPIGSENSEK casein Hayes et al., 2006 
GLSDGEWQ beef sarcoplasmic protein hydrolysate Ryan et al., 2011
GFHI beef sarcoplasmic protein hydrolysate Ryan et al., 2012
FHG beef sarcoplasmic protein hydrolysate Ryan et al., 2013
 
 
2.3.9. Multifunctional peptides 
The functions described above can be detected in different peptides, but sometimes one 
peptide show multiple activities at the same time. In this case it is defined as a multifunctional 
peptide (Udenigwe and Aluko, 2012). A hexapeptide (TTMPLW) derived from αS1-casien (f194–
199), through trypsin-catalyzed digestion, exhibited both ACE-inhibitory and immunomodulatory 
activities (Meisel, 2004); in addition, a β-lactoglobulin-derived β-lactorphin (YLLF) inhibited 
ACE activity and also possessed opioid-like activity (Mullally et al., 1997). Moreover, crude 
chemotryptic α-casein hydrolysates displayed several in vitro bioactivities such as ACE 
inhibition, antioxidant, Zn2+-binding, and antibacterial activities (Srinivas and Prakash, 2010). 
Four peptides (GFHI, DFHING, FHG, and GLSDGEWQ) present in beef sarcoplasmic protein 
hydrolysates have been reported to possess anticancer, antimicrobial, and ACE-inhibitory 
properties (Jang et al., 2008).  
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CHAPTER 3. 
GLYCOPEPTIDES 
 
 
 23 
 
Glycopeptides are molecules present and produced in nature. The study of sugars bounded 
to amino acids has become increasingly interesting, since these structures have been showed to play 
important roles in fertilization, the immune system, brain development, the endocrine system and 
inflammation (http://en.wikipedia.org/wiki/Glycopeptide). Some glycopeptides, isolated from 
microorganisms, are already used as antibiotics (Kahne et al., 2005), while some others instead are 
produced by the insects as the first defence against bacterial infections (Bulet and Stöcklin, 2005). 
The synthesis of novel glycopeptides can be useful to elucidate glycan function in nature, but the 
current major challenge is to uncover their therapeutic and biotechnological applications in food 
(http://en.wikipedia.org/wiki/Glycopeptide). 
 
3.1. Structure  
 
Glycopeptides are short sequences of amino acids (minimum 7-8) bound to one or more 
mono-, di- and oligosaccharides. The function of the sugar group has not been fully elucidated; 
even though the absence of that sugar inside the chain can reduce around 100 times the 
glycopeptide bioactivity (Otvos et al., 2002). In general it could be hypothesized that the presence 
of the sugar determines a chemical and physical rearrangement of the peptide conformation, 
similarly to what occurs in proteins, as described above.  
Different studies that tried to design non-glycosylated analogues of glycopeptides in order to 
explore the role of glycosylation have been published. Kaur et al. (2006), for example, reported that 
it is possible to obtain a functionally equivalent non-glycosylated analogue from a native 
glycosylated peptide just by performing strategic modifications of the sequence. This means that the 
presence of the sugar provides the peptide with a new spatial distribution. At the same time, the 
peptide, and in particular the type of amino acid, can influence the special sugar conformation once 
it is linked (Hindley et al., 2005). 
Some of the most studied glycopeptides belong to insects and they are produced as a 
mechanism of defence against bacterial invasion. These peptides, most of them rich in proline, can 
undergo glycosylation with one, two, or three glycan residues, forming a O-glycosylated 
substitution with a conserved threonine residue (Gobbo et al., 2002). The first characterized 
glycopeptide was Drosocin, a O-glycosylated peptide, consisting of 19 amino acid residues (of 
which nearly one third are proline), and three characteristic Pro-Arg-Pro motifs. Drosocin is 
glycosylated on Thr 11 by either a monosaccharide (such as N-acetyl-galactosamine) or a 
disaccharide. The presence of the disaccharide in the middle of the molecule may open the turn 
comprising residues 10-13 to a more extended conformation, thus helping drosocin to assume the 
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most suitable orientation to bind to its putative intracellular target. In many cases the integrity of the 
carbohydrate side chain is also necessary for the maximum activity of the glycopeptides (such as 
formaecin and diptericin); however, it has also been reported that unglycosylated peptides, like 
pyrrhocoricin, appear to be more potent than the native glycosylated form. To date, it has not been 
possible to define a specific structure for "the" glycopeptide, and in particular many studies are still 
in progress (Gobbo et al., 2002). 
A well-studied glycopeptide, already patented as a potent drug is Vancomycin. It was first 
isolated in 1953 from a soil sample and it is produced by the bacteria Amycolatopsis orientalis. It is 
a 1449.3 Da molecule and from its structure several novel compounds were isolated, produced and 
designed. The common structure in all, called "vancomycin-related", contains a homologous 
heptapeptide scaffold. Five out of the seven residues in vancomycin are aromatic, and the remaining 
two residues are modified tyrosines, with chlorine at the meta position of the aromatic ring, and an 
OH substitute at the benzylic carbon of the side chain. The electron-rich side chains of these 
aromatic amino acid residues facilitate the oxidative crosslinking, leading to a rigid architecture of 
the heptapeptide scaffolds. Finally, the peptide framework is glycosylated, by a mono- or 
disaccharide on residue 4 (Kahne et al., 2005). Another glycopeptide with bioactive properties was 
isolated by Yang et al. (2009) from a fermentation broth of Penicillium sp. M03. This molecule is a 
1017 Da and contains five aminoacids (Ala, Glu, Gly, Asp and Ile) plus two monosaccharides 
(glucose and xylose). PGY is also a low molecular-weight glycopeptide; it was isolated by Wu and 
Wang (2009) from the fruit Ganoderma lucidumwas. This molecule possess a peptide part with a 
Ser-Arg-[(Ala)2(Gly)2] sequence, and a carbohydrate part, coupled by O-linkage via Ser, 
constituted of  a backbone of (1 → 3)-β-glucan with (1 → 6)-linked Araf branches. The 
carbohydrate moiety, especially the side chains of terminal α-L-Araf residues, is essential for the 
preservation of the activity of this class of glycopeptides. 
 
3.2. Antifreezing activity 
 
It is already well known that many O-glycan-rich glycoproteins, especially isolated from 
artic fish, act as in vivo “antifreezer”, preventing nucleation of ice and allowing them to survive at 
temperatures of -2 °C (Gamblin et al., 2009). In fact, antifreeze glycopeptides (AFGP) and peptides 
have been isolated from 37 species of Antarctic fish. The glycopeptides are made up of a tripeptide 
repeat (alanine-alanine-threonine), with a disaccharide moiety attached to the threonyl residues 
(Wohrmann, 1996). Their molecular weights range from 2600 Da to 34000 Da (Wohrmann, 1996). 
These compounds kinetically depress the temperature at which ice grows, in a non-colligative 
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manner, and hence exhibit thermal hysteresis, i.e. a positive difference between the equilibrium 
melting point and the ice growth temperature (the temperature at which seed ice crystals will grow 
in the solution) (Harding et al., 2003) 
 
3.3. Sensory properties 
 
Certain glycopeptides and peptides provide an improved taste function, in particular for the 
kokumi taste function. These molecules could be used in a wide range of industrial applications and 
enhance the basic tastes, as well as impart thickness, spread, continuity, and unity of the final 
product (https://usgene.sequencebase.com/patents/US20060083847). 
 
3.4. Glycopetides bioactivities 
 
Just like peptides, the glycopeptides have revealed different properties and bioactivities. The 
main studied property is the antimicrobial one. Nevertheless, their additional properties have been 
reported to a lesser extent.  
 
3.4.1. Antioxidant activity 
Wu and Wang (2009) isolated from the fruiting bodies of G. lucidum a new water-soluble 
glycopeptide (PGY) with higher levels of antioxidant properties against superoxide radicals, 
compared with a selected antioxidant (BHT). This activity strictly depends on the carbohydrate 
moiety, while the peptide moiety appears to be nonessential for their antioxidant activity. 
Furthermore, they demonstrated that PGY provides higher levels of antioxidant characteristics 
against superoxide radicals, in comparison with that of a selected antioxidant (BHT). 
 
3.4.2. Antitumor activity 
Natural ecosystems play an important role as a source of new antitumor compounds. The 
antitumor bleomycin (BLM) was first isolated from Streptomyces verticillus; it provided the name 
to a class of natural antitumor glycoconjugates, made of complex polypeptide aglycones with a 
variety of mono-, di-, and tetra-saccharides attached. The BLM, clinically known as Blenoxane 
(Bristol-Myers Squibb), treats several types of tumours, such as testicular cancer (90% efficiency), 
Hodgkin’s lymphoma, and carcinomas of the skin, head and neck. However, the cytotoxic 
therapeutic efficacy of BLM is limited, due to induction of lung fibrosis. The mechanism of action 
of BLM depends on a metal-dependent oxidative cleavage of DNA and RNA, which leads to cell 
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death. Three functional domains can be recognized inside the structure of BLM: the N-terminal 
domain, represented by pyrimidoblamic acid (PBA) along with β-hydroxy-histidine, is the metal-
binding domain and enables the activation of molecular oxygen; the C-terminus is the DNA-binding 
domain, and it is formed from a bisthiazole moiety with a cationic tail; and the hydroxyl group of b-
OH-His, which that participates in cell recognition and uptake and in metal ion coordination. 
NC0604 is a BLS analogue isolated from Streptomyces verticillus var. pingyangensis, with 
enhanced antitumor activity and lower pulmonary toxicity (La Ferla et al., 2011). 
Other natural antitumor glycopeptides have been found in macromycetes (macro-fungi). PSP 
and PSK, from the macro-fungus Coriolus versicolor, for example, are well known for their 
immunomodulatory and antitumoral activities. Both glycopeptides stimulate the T-cell activation, 
and induce cytokine production in vitro and in vivo, enhancing ‘‘killer’’ cytotoxic activity against 
tumours; they are considered biological response modifiers. The glycopeptides 220-GP and 120-GP 
obtained from pronase- treated ovomucin (an egg-white glycoprotein) were found to have high 
direct antitumor activity at low concentrations; both glycopeptides have shown to promote complete 
rejection of direct tumours and slight growth inhibition of distant tumours. A number of muramyl 
glycopeptides (fragments of murein, a bacterial peptidoglycan from the cell wall) are known to 
cause growth inhibition and necrosis of experimental tumours. For example, glucosaminylmuramyl 
dipeptide (GMDP) was reported to enhance tumoricidal activity of macrophages, by inducing the 
secretion of TNF-α, one of the key players of macrophage cytotoxicity against tumoural cells. 
GMDP also augmented the cytotoxic effect on tumour cell lines, when combined with TNF-a and 
cisplatin;  in this case, 100% tumour cells were killed (La Ferla et al., 2011). 
 
3.4.3. Antimicrobial activity 
Vancomycin was the first glycopeptide antibiotic to be discovered. Despite its toxicity 
profile, it gained prominent use to face the problem of the emergence of a large-scale resistant S. 
aureus. The mechanism by which vancomycin exerts its action depends on the inhibition of cell 
wall synthesis in Gram-positive bacteria, as opposed to the Gram-negative, because the outer 
membrane in the Gram-negative bacterial membrane keeps the glycopeptides from reaching their 
targets at the periplasmic face of the cytoplasmic membrane (Kahne et al., 2005). The large 
hydrophilic molecule is able to form hydrogen bond interactions with the terminal D-alanyl-D-
alanine moieties of the NAM/NAG-peptides (fig. 3). In this way, it prevents the transglycosylation 
and subsequently affects the transpeptidation, which is essential for bacterial cell wall cross-linking 
(Sujatha and Praharaj, 2012). Several studies attempting to develop new molecules mimicking 
vancomycin have been reported (Chen et al., 2002). Hence, glycopeptides having effect on Gram-
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negative microorganism have been isolated as well. In fact, Drosocin, a glycopeptide isolated from 
insects, works in a low micromolar range of concentration, and it is mainly active towards Gram-
negative bacteria (Bullet and Stocklin, 2005). 
 
 
 
Figure 3. Mechanisms of action of Vancomycin towords sensitive and not sensitive bacteria 
(http://en.wikipedia.org/wiki/Vancomycin). 
 
The relatively slow-killing kinetics of drosocin and the observation that an all-D analogue is 
50 to 150-fold less active than the native isomer suggested that the peptide do not seem to have a 
membrane permeabilization mechanism, which is thus markedly dissimilar to that of lytic peptides 
such as cecropins. 
As already indicated, deglycosylation significantly reduces the antimicrobial activity of 
drosocin. The syntheses of differently glycosylated peptide analogues showed that the antimicrobial 
activity against several Gram-negative bacteria is affected by the type of sugar and the type of 
glycosidic linkage, particularly in the case of E. coli D21 and the K. pneumoniae strains (Gobbo et 
al., 2002). 
The mechanism of action of these proline-rich glycopeptides could depend on the interaction 
with the lipopolysaccharides (LPS) of Gram-negative bacteria and/or with the bacterial 
chaperone/heat shock proteins GroEL and DnaK; such an interaction inhibits protein folding 
(Kragol et al., 2001). The fact that some of these glycopeptides (i.e. pyrrhocoricin analogues) do not 
show selectivity towards Gram-negative or Gram-positive strains, has confirmed that their toxicity 
for bacteria is not strongly related to membrane binding. At the same time, the specificity to certain 
bacterial strains may derive from altered binding to DnaK (Otvos et al., 2000). An additional effect 
of glycopeptides is the protection of host cells from pathogen adhesion. The anti-adhesive capacity 
of the glycopeptides was reported by Yang and co-workers when β-conglycinin hydrolysates were 
produced. These glycopeptides have both a D-mannosyl residue and a hydrophobic region; it was 
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suggested that the presence of the mannose substructure of glycopeptides prevents E. coli and 
Salmonella adhesion to the intestinal epithelium (Yang et al., 2008). Glycopeptides with antibiofilm 
properties have been also reported. In particular, peptides with an amino acid sequence bound to a 
casein or a fragment of casein, comprising at least one glycosylated amino acid, can prevent dental 
caries, gingivitis and periodontitis (http://www.freepatentsonline.com/y2012/0283174.html). 
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CHAPTER 4. 
PROTEASES 
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According to the Enzyme Commission (EC) classification, proteases belong to the hydrolase 
family (group 3), which hydrolyse peptide bonds (sub-group 4). The processing of many food 
products depends on proteolytic activities, because they can enrich the characteristics of the final 
product or generate innovative food and ingredients (Sumantha et al., 2006). Until fairly recently, 
proteases were considered primarily to be protein-degrading enzymes. However, this view 
dramatically changed when their important roles in physiological processes such as generating 
signalling and/or functional molecules was discovered. Consequently, they immediately attracted 
the interest for commercial applications, becoming one of the three largest groups of industrial 
enzymes, and accounting for approximately the 60% of the total worldwide sales of enzymes. 
(http://acd.ufrj.br/proteases/ProteaseApres.htm). In food processing, proteases can be derived from 
the food matrix, generated by microorganisms or supplied as additives. Because of their wide 
applicability, the microbial proteases represent the 40% of the commercial enzymes currently 
present in the market (Rao et al., 1998). 
Proteases can be separated into two major groups based on their ability to cleave peptide 
bonds: when they act at the terminus of polypeptide chains (amino- or carboxy- peptidases), they 
are classified as exopeptidases (EC 3.4.11-19); if they act internally, they are considered 
endopeptidases or proteinases (EC 3.4 21-99). The exopeptidases are used for their debittering 
action and they are becoming increasingly available in the industrial enzyme market (Raksakulthai 
and Haard, 2003). Additionally, proteases can also be classified according to: their optimal pH (as 
acidic, neutral or alkaline); substrate specificity (collagenase, keratinase, elastase, etc.); or their 
homology with well-studied proteins (trypsin-like, pepsin-like, etc.) (Sumantha et al., 2006).  
A more detailed classification is presented in Figure 4. 
 
4.1. Exopeptidases 
 
The exopeptidases act only near the ends of the polypeptide chains at the N or C terminus. 
The aminopeptidases act at on the free N terminus of the polypeptide chain and liberate a single 
amino acid residue, a dipeptide, or a tripeptide; in general, the aminopeptidases are intracellular 
enzymes. The commercial Aminopeptidse I and II have been generated from Escherichia coli and 
Bacillus licheniformis, respectively. In contrast, the exopeptidases act on the free C terminus, to 
liberate a single amino acid or a dipeptide; they have been isolated mainly from Penicillium spp., 
Saccharomyces spp., and Aspergillus spp. Additionally, the omega peptides are enzymes working 
on isopeptide bonds, i.e. an amide bond not present on the main chain of the protein (Rao et al., 
1998). 
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Figure 4. Classification of proteases. Arrows show the sites of action of the enzyme. 
 
 
4.2. Endopeptidases 
 
The endopeptidases work preferentially on the peptide bonds away from the N and C 
termini. The presence of free α-amino or α- carboxyl groups has a negative effect on the activity of 
the enzyme. According to the reactive groups at the active site involved in catalysis, they can also 
be divided into serine- (EC 3.4.21), cysteine- (EC 3.4.22), aspartic-peptidases (EC.3.4.23) and 
metallo-peptidases (EC 3.4 24). Among these, the alkaline proteases are the most industrially 
significant (Sumantha et al., 2006). 
 
4.2.1. Serine proteases 
They are characterized by the presence of a serine group in their active site, and they are the 
most conserved proteases among eukaryotic and prokaryotic organisms. Even if the primary 
structure is different among the members of this class, their general catalytic reaction depends on 
three common amino acids, i.e. serine (nucleophile), aspartate (electrophile), and histidine (base). 
They are active at neutral and alkaline pH (between pH 7 and 11), and they have molecular masses 
between 18 and 35 kDa. Subtilisin is one of the most well-studied serine proteases isolated from 
Bacillus subtilis, although other enzymes have also been discovered in S. cerevisiae (Mizuno and  
Matsuo, 1984) Y. lipolytica (Li et al., 2009), Conidiobolus spp. (Phadatare et al.,1993) and 
Aspergillus spp. (Hajji et al., 2008). Some of these enzymes have already been produced for 
Protease
Aminopeptidase
Carboxypeptidase
Endopeptidase
Dipeptidyl peptidase
Tripeptidyl peptidase
Serine protease
Cysteine protease
Aspartic protease
Metalloprotease
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industrial purposes, such as Alcalase® (from Bacillus licheniformis), Savinase® (from Bacillus 
lentus), Esperase® (Bacillus spp.), etc. (Novozymes, Denmark) (Rao et al., 1998). 
 
4.2.2. Aspartic proteases 
The aspartic proteases owe their name to the presence of aspartic acid residues necessary for 
their catalytic activity. The active-site aspartic acid residue is situated within the motif Asp-X-Gly, 
where X can be Ser or Thr. Because most of the aspartic proteases show a maximal activity at low 
pH (pH 3 to 4), they are also known as acidic proteases; their molecular masses are in the range of 
30 to 45 kDa. Most of the acidic proteases have been studied in fungi and yeasts (Rao et al., 1998). 
A significant property of aspartic proteases is the ability to coagulate milk, as it is evidenced by 
their widespread application in the dairy industry to coagulate casein during the manufacturing of 
cheese (Yegin et al., 2010). 
 
4.2.3. Cysteine proteases 
The activity of cystein proteases depends on the presence of a dyad of Cys and His in the 
catalytic site. These kinds of enzymes occur in both prokaryotes and eukaryotes and have an 
optimal neutral pH. Papain (from Carica papaya), bromelain (from Ananas comorus), ficin (from 
Ficus sp.) are the most studied proteases from food origin; Clostripain and Streptopain are produced 
by Clostridium histolyticum and Streptococcus spp., respectively (Sumantha et al., 2006). 
 
4.2.4. Metalloproteases 
Enzymes belonging to this class are the most heterogeneous proteins according to the 
catalytic site structure. The only common characteristic among them is the requirement for a 
divalent metal ion to perform their activities; thus, they can be endo- or exopeptidases. Collagenase, 
a member of this family, has been discovered in bacteria (Clostridium hystolyticum and 
Achromobacter iophagus), yeasts (Candida albicans, Lima et al., 2009) and fungi, and it is very 
specific for the proteolysis of collagen and gelatine (Rao et al., 1998). 
 
4.3. Functions and Applications  
 
The estimated value of the worldwide sales of industrial enzymes is $1 million a year, with 
proteases accounting for about 60 % the total (Godfrey and West, 1996). Proteases have been 
widely applied, mainly in the detergent and food industries. For example, acidic proteases are used 
in the dairy industry for their ability to coagulate milk protein (casein) to form curds, from which 
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cheeses are prepared (Neelakantan et al., 1999). Alcaline proteases, instead, are useful in baking 
processes (for biscuits, crackers and cookies, for instance), because they can hydrolyse flour 
proteins and thus enhance the texture, flavour, and colour of the final product. Commercial enzymes 
commonly used in the food industry include Alcalase®, Neutrase®, and Novozym®. In addition, 
mixtures of enzymes are available, such as Flavourzyme™ and Kojizyme™. These are fungal 
complexes of exopeptidases and endoproteases derived from the fermentation of soy sauce by 
Aspergillus oryzae. Proteases from Bacillus subtilis have been used to deproteinize crustacean 
waste and obtain chitin (Yang et al., 2000) 
Other fields where proteases have been successfully applied are in pharmaceutical, cosmetic 
and bioremediation processes. Even though applied biotechnological methods have significantly 
improved the production of these enzymes in the past few years, the search for innovative sources 
of enzymes, revolutionary production techniques, and novel applications of such enzymes in 
unexplored fields has continued uninterrupted (Sumantha et al., 2006). 
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CHAPTER 5.  
Yarrowia lipolytica 
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A "non-conventional" yeast is defined as “a microorganism easily distinguished from the 
well-studied and widely used Saccharmyces cerevisae and Schizosaccharomyces pombe”. 
Among the "non-conventional" ones, Yarrowia lipolytica is one of the most studied as a model 
system in physiology, genetics, dimorphism, gene manipulation, protein expression, and lipid 
accumulation research works (Bankar et al., 2009). Since a few amount of sugar is needed for its 
growth, it has been isolated from diverse environments rich in lipids and proteins; its natural 
habitats include oil-polluted environments, rivers and foods such as cheeses, yogurt, kefir, shoyu, 
meat, and poultry products (Bankar et al., 2009). It is considered a non-pathogenic organism and 
it is generally recognized as safe (GRAS) by the Food and Drug Administration (FDA, USA) 
(Cohelo et al., 2010). Isolated for the first time in 1928 by Nannizzi, it just reached industrial 
interest by the late '40s, especially for the dairy industry and later as a producer of citric acid. 
 
5.1. Taxonomy and morphology 
 
Y. lipolytica is a yeast belonging to the Fungi kingdom, division Ascomycota, class 
Saccharomycetes, order Saccharomycetales. The wild form of Y. lipolytica presents different 
morphology ranging from smooth and shiny to wrinkled colonies. These characteristics depend 
on the growth conditions (oxygen, carbon, ammonia availability), but also on the genotype and 
strain (Rodriguez and Domínguez, 1984). It is a dimorphic fungus that can come in the form of 
single cells, pseudo-hyphae, or septate hyphae (Barth and Gaillardin, 1997). The yeast-to-
mycelium transition is associated with unipolar growth, asymmetric division, large polar-located 
vacuoles, and repression of cell separation after division. It is believed that yeast dimorphism is 
related to a defence mechanism against adverse conditions, such as temperature and nutritional 
changes (Cohelo et al., 2010). The name Y. lipolytica was given in 1980 by van der Walt and von 
Arx, but it is still possible to find it with the previous nomenclature, as follows: Mycotorula 
lipolytica (1928), Candida lipolytica (1942), Candida olea (1949), Azymoprocandida lipolytica 
(1961), Candida paralipolytica (1963) Candida pseudolipolytica (1973) (Kurtzman and Fell 
1998). 
 
5.2. Methabolism 
 
Y. lipolytica is a unique, strictly aerobic yeast, with the ability of efficiently degrade 
hydrophobic substrates such as n-alkanes, fatty acids, fats and oils, for which it has specific 
metabolic pathways (Fickers et al., 2005). Even if, from the genome point of view, it is related to 
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Saccharomyces cerevisiae, it has significantly different genetic mechanisms. Particularly, the 
genome displays an expansion of protein families and genes involved in hydrophobic substrate 
utilization (Cohelo, 2010). 
 
5.3. Industrial relevance of Y. lipolytica 
 
There are two reasons for Y. lipolytica to be extensively studied: its secreted metabolites 
and enzymes, and its activities during the cell growth. Without a doubt, the main interesting 
feature about this microorganism is the expression of its extracellular and cell-bonded lipases 
(Ota et al., 1982). Lipases are lipolytic enzymes able to hydrolyze the triglycerides in glycerol 
and fatty acids, and they are also exploitable for several applications in the detergent (substituting 
chemical surfactants), food, and environmental industries. Some of these lipases possess also the 
capability to work under cold conditions (Parfene et al., 2011) and this aspect is progressively 
getting interesting for industrial applications (Joseph et al., 2007). Being capable to consume n-
alkanes, isoprenoids and aromatic hydrocarbons as the group of naphthalenes and the group of 
phenanthrene, Y. lipolytica could be also applied in bioremediation of contaminated environments 
(Bankar et al., 2009) or for the treatment of olive mill wastewaters (Lanciotti et al., 2005). 
Yarrowia lipolytica is recognized as one of the most frequent species associated with milk 
(Lanciotti et al., 2004; Gardini et al., 2006) and meat products (Patrignani et al., 2011 a; 2011b) , 
due to its enzymatic activities, it has been regarded as a good candidate for accelerating ripening 
(Guerzoni et al., 1998; van den Tempetl and Jakobsen, 2000; Lanciotti et al., 2005; Patrignani et 
al., 2007). In fact, thanks to its high proteolytic and lipolytic activities, some yeast species may 
play an important role in the production of aroma precursors from amino acids, fatty acids and 
esters (Suzzi et al., 2001). γ-Decalactone is a peach-like aroma compound, reported in several 
food and beverages, that can be produced biotechnologically, e.g. by Y. lipolytica which is able to 
biotransform ricinoleic acid (12-hydroxy-octadec-9-enoic acid) into the lactone (Cohelo, 2010). 
Another important application of this yeast is the production of citric acid. Currently, the 
conventional procedure depends on the bioconversion of molasses into citric acid by Aspergillus 
niger. This production is estimated to be approximately 1.6 million tons per year (Sauer et al., 
2007) However, the use of Y. lipolytica may bring some more benefits: a larger substrate variety 
(n-paraffin, fatty acids, glucose), a smaller sensitivity to low dissolved oxygen concentrations and 
heavy metals, and higher product yields. One potential disadvantage of this process is the 
secretion of isocitric acid (ICA) as by-product; when it is above 5% of the citric acid 
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concentration can generate problems in the crystallization of CA during the purification process 
(Cohelo, 2010). 
 
5.4. Proteases of Yarrowia lipolytica 
 
The production of proteases by Y. lipolityca and their possible applicability are two 
aspects that need to be studied in depth. Y. lipolytica is a natural secretor of proteins, and it was 
used especially for this property as eukaryotic host for secretion of heterologous proteins. In 
common with many strains of yeast, Y. lipolytica expresses also proteolytic enzymes 
(extracellular and intracellular proteases). In particular, an acidic extracellular protease (AXP) 
and an alkaline extracellular protease (AEP) have been mainly studied (Young et al., 1996). From 
1 to 2% of the total cell proteins belong to AEP; hence, over 1 g of AEP per litre has been 
estimated (Matoba et al., 1988) at high cell densities.  
 
5.4.1. Extracellular proteases 
 
5.4.1.1. Alkaline protease 
The gene xpr2, coding for the AEP, has been cloned and sequenced (Davidow et al., 1987). 
It has a functional promoter region greater than 700 bp, maybe as a result of the complex regulation 
of the gene. The regulatory region, consisting in a TATA box and other two major activation 
sequences, is deeply influenced by the environment (Young et al., 1996). In fact, the gene is 
transcripted during nitrogen or sulphur starvation, lack of carbon sources, and the presence of 
extracellular proteins (Davidow et al., 1987). According to the mRNA sequence, AEP is originally 
synthesized in an immature form, having some pro-regions added (Hernández-Montañez et al., 
2007). Most probably a 55 kDa precursor is synthesized first, and then after different cleavages and 
maturating steps,  52, 44, and 36 kDa polypeptides are generated. In the final step, in which an 
intracellular protease participate, the 32-kDa mature AEP is formed (Matoba et al., 1988). It has 
been also reported that the pro-region is glycosilated (Young et al., 1996). Studies regarding the 
AEP sequence showed a strong homology with the subtilisin family serine proteases. The highest 
homologies belong to the region referring to the active-site of the enzyme (Davidow et al., 1987); in 
particular, a 32% homology with the Bacillus subtilis DY subtilisin (Nedkov et al., 1983), 32% 
homology to Thermoactinomyces vulgaris thermitase (Meloun et al., 1985), and 42.6% homology 
with the Tritirachium album proteinase K (Jany et al., 1986). Once the enzyme is in its mature 
form, it has been reported that the AEP secretion process is rapid.  
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5.4.1.2. Acidic protease 
Initially, three acidic proteases were reported (Yamada and Ogrydziak, 1983), but upon 
additional studies and the development of more sophisticated techniques, it was demonstrated 
that Y. lipolytica produces just one acidic protease under specific growth conditions. The AXP1 
gene encoding the acid protease has been characterized and genetic control of the synthesis has 
been reported (Young et al., 1996; González-López et al., 2002). As the AEP, the AXP is also 
synthesised as a pro-enzyme, having 397 residues and a molecular weight of 42 kDa. The mature 
37 kDa enzyme is produced by cleavage of the precursor between Phe44 and Ala45. In this case no 
glycosylation of the pro region has been reported (Young et al., 1996). According to the final 
primary sequence, AXP shows a 44.94% identity with a 36 amino acid overlap with 
Endothiapepsin, an aspartyl protease from the chestnut blight fungus, Cryphonectria parasitica 
(Razanamparany et al., 1992), and Candidapepsin, the aspartic endopeptidase of Candida 
albicans (Young et al., 1996). 
 
5.4.2. Intracellular proteases 
Although there is scarce evidence, the presence of some intracellular proteases in Y. 
lipolytica has been reported. An aminopeptidase (yylAPE), belonging to the metalloprotease 
group, has been intracellularly detected in a soluble form, whereas a dipeptidyl aminopeptidase 
(yylDAP) activity has been reported both in the soluble and in the membrane fractions. The 
membrane form of yylDAP is a serine protease maybe involved in the maturation process of 
AEP; in contrast, the soluble form yylDAP is a metalloprotease probably involved in the 
dimorphic transition of the yeast. Finally, no specific functions have been described for the 
discovered soluble carboxypeptidase (yylCP) belonging to the serine protease family (Hernández-
Montañez et al., 2007). 
 
5.4.3. Proteases production 
The main element that discriminates the production of AEP or AXP is the environmental 
pH. In general, neutral and high pH values (6-9) lead to AEP production, while low pH (2-6) 
favours AXP (Ogrydziak, 1993).  
Also carbon and sulphur compounds, as well as nitrogen sources (ammonium ions, amino 
acids) can play a role in repressing the protease production. On the other hand, their production 
can be induced if a protein source is present in the growth medium (Nelson, 1986). Moreover, it 
has been reported that an extra carbon source (glucose) reduces AEP production (Akpınar et al., 
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2011). Thus, if the type of synthesized protease is strictly dictated by the environmental pH, both 
proteases are similarly induced at the end of the exponential phase on complex media (González-
López et al., 2002). 
 
5.4.4. Industrial applications 
Due to its lipolytic and proteolytic activities, Y. lipolytica has a high industrial potential. 
In fact, its use as a co-starter for the production of some cheese varieties has already been 
proposed by several Authors (Bintsis and Robinson, 2004; Lanciotti et al., 2005). The 
extracellular proteases have important commercial value and multiple applications can be found 
in various industrial settings. Although there are many microbial sources available for protease 
production, only few are recognized as commercial producers. Since Yarrowia lipolytica is a 
GRAS microorganism it could be used in different industrial processes; however there is missing 
evidence referring to the applicability of Y. lipolytica proteases. One of the first studies by Nelson 
and Young (1986) considered the use of these enzymes in the brewing industry as a chill-
proofing agent for beer. Additional work reported the use of Y .lipolytica enzymes for meat 
tenderisation; hence Krasnowska et al. (2006) showed that yeast preparations had better 
proteolytic (and collagenolytic) activities than pepsin. All enzyme preparations showed different 
activity against beef meat proteins according to the pH. Instead, Patrignani et al. (2007) 
demonstrated that the surface-inoculated Y. lipolytica did not have a deep effect on the immediate 
proteolysis of dried fermented sausage when compared to Debaryomyces hansenii. 
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Microorganisms elaborate a large array of proteases, which are intracellular and/or 
extracellular. Intracellular proteases are important for various cellular and metabolic processes, such 
as sporulation and differentiation, protein turnover, maturation of enzymes and hormones and 
maintenance of the cellular protein pool. Extracellular proteases are important for the hydrolysis of 
proteins in cell-free environments and enable the cell to absorb and utilize hydrolysis products 
(Kalisz, 1988). At the same time, the extracellular proteases have also been widely commercially 
exploited to assist protein degradation in various industrial processes (Kumar and Takagi, 1999; 
Outtrup and Boyce, 1990; Gupta et al.,  2002). 
Commercial protease preparation usually consist of a mixture of various enzymes. They are 
largely utilised in food processing to  
• improve the workability of dough (as backing enzymes particularly for crackers and 
biscuits); 
• optimize and control the aroma formation of cheese and milk products; 
• improve the texture of fish products;  
• tenderize meat; 
• stabilize beer  
 
Due to their large consumption and applications commercial preparations do not have a 
specific action apart from the protease used for the production of hypoallergenic foods. In Europe 
there are about forty commercial protease preparations on the market. Fifteen of these preparation 
are produced with genetically modified Aspergillus and Bacillus spp. Their optimal activity is 
between 35 and 50 °C. 
The resource that I have explored to identify proteases with different promising attitudes has 
been the collection of about 112 strains of Yarrowia lipolytica, isolated from different ecosystems 
(cured meat, Po river alkanes contaminated waters, commercial chilled foods, cheeses, irradiated 
poultry meats or light butter) and characterized during the last 20 years. All the strains belong to the 
DISTAL Alma Mater Studiorum, University of Bologna. Preliminary research on 112 strains 
showed great strain-related differences in the protein breakdown profiles (Badiali, 2004). In 
particular, the cluster analysis of electrophoretic profiles obtained when α- and β-caseins had been 
separately exposed to cell free supernatants of the various strains showed that the profiles of strains 
isolated from the same ecosystem clustered together. On the basis of these results I selected for each 
cluster one strain having the typical proteolytic profile representative of the group. In particular, I 
selected the following strains of Y. lipolytica: 1IIYL4A and 1IIYL8A, both isolated from speck, but 
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characterized by different RAPD-PCR profiles (Badiali, 2004); 16B from irradiated poultry meat; 
PO19 from Po river water; CLCD from salami; Y16 from commercial chilled food.  
 
The main objectives of my research on these strains have been to: 
 
1) evaluate the suitability of proteases released by Y. lipolytica to hydrolyse proteins of 
different origins available as industrial food by-products. In particular I have taken into 
consideration gluten, gelatin, milk and meat proteins;  
 
2) identify proteases with "cold attitude", i.e. proteolytic activity at temperature ≤ 10 °C, in 
order to save energy consumption during industrial processes. In fact, the main technological 
criterium to assess the suitability of a biological process to exploit by-products regards the energy 
consumption during all the phases. Therefore the enzyme to be selected for the biotransformation 
should be active within a temperature range between 4 and 20°C; 
 
3) obtain and characterize peptides having specific biological activity (namely antioxidant, 
anti-hypertensive, antimicrobial, cytotoxic)  
 
4) improve the bioactivity of the peptides through a novel process based on their 
glycation/glycosylation. 
 
The sequence of the activities performed on the selected strains can be summarized in the 
following scheme: 
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7.1. Yarrowia lipolytica strains and culture conditions 
 
The strains of Yarrowia lipolytica used in this Ph.D. thesis belong to the Department of 
Agri-Food Science and Technologies (DISTAL) - Alma Mater Studiourum, University of Bologna. 
The strains selected have different isolation habitats: salami (CLCD), speck (1IIYL4A, 
1IIYL8A), irradiated poultry meat (16B), commercial chilled foods (Y10, Y16) and superficial 
waters of Po river (PO19). The strains were cultivated in Sabouraud broth (Oxoid, Basingstoke, 
England) at 27°C for 72-96 h. 
 
7.2. Protein matrices 
 
The proteolytic activity of Y. lipolytica was evaluated on proteins of different origin also 
available as industrial food by-products, and namely gelatin, meat protein, dairy proteins (skim-
milk, α- and β-caseins), and gluten from wheat. 
In particular, α- and β-caseins were purchased from Sigma-Aldrich, skim-milk from a local 
dairy processing plant, gelatin and meat proteins were extracted from meat by-products used for the 
production of salami. 
 
7.2.1. Total meat protein extraction 
Total proteins were extracted from 2 g of sample (i.e. meat by-products) with 40 ml of 1.1 
M potassium iodide, 0.1 M sodium phosphate, pH 7.4 buffer (Cordoba, 1994). The sample was 
homogenized for 3 minutes and then centrifuged (Beckman Coulter Avanti J-10, Fullertn, CA, 
USA) at 8000 x g for 15 min at 4°C. The supernatant was filtered with 0.22 µm filter and then used 
for the enzymatic activity assay (paragraph 7.4.4.).  
 
7.3. List of chemicals used 
 
 Alcalase (Alc, EC 3.4.21.14, from Bacillus licheniformis) and Flavourzyme (Flv, from 
Aspergillus oryzae), Glycine-Glutamine (Gly-Gln), Glucosamine hydrochloride (GlcN), 2,2-
diphenyl-1-picrylhydrazyl (DPPH), Transglutaminase (TGase) from guinea pig liver, Hanks’ 
Balanced Salt Solution (HBSS) were purchased from Sigma-Aldrich (St. Louise, MO). All 
chemicals used in SDS-PAGE electrophoresis, Size Exclusion Chromatography (SEC), LC-MS/MS 
and MALDI-TOF were of HPLC grade supplied by Sigma-Aldrich (St. Louise, MO), whereas other 
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chemicals were of analytical grade. Fetal bovine serum (FBS) was purchased from Atlanta 
Biologicals (Lawrenceville, GA). 
 
7.4. Proteolytic activity of Y. lipolytica 
 
7.4.1. Extracellular proteases recovery and characterization 
For the production and the recovery of extracellular proteases, the protocol used by Vannini 
et al. (2001) was followed with some modifications. The strains of Y. lipolytica were pre-cultured 
for 72 h at 27°C in Sabouraud Broth under agitation (200 rpm). After centrifugation at 8000 x g 
(Beckman Coulter Avanti J-10, Fullerton, CA, USA) at 4°C for 15 min the supernatants were 
collected and were used as the source of the protease enzymes and thus referred to the 
“supernatants”. 
A preliminary characterization of the extracellular proteases released by the various strains 
was made by analyzing the cell-free supernatants with the technique of substrate-incorporated 
polyacrylamide gel electrophoresis (zymography). Such a technique was used to separate and 
characterize the enzymes produced by cultures of Y. lipolytica and to evaluate their activity on 
substrates (i.e. gelatine and casein) incorporated into the gel.  
 
7.4.2. Characterization of proteases by Zymography 
The characterization of the extracellular proteases was performed by the technique of 
substrate-incorporated polyacrylamide gel electrophoresis (Zymography). In particular two different 
precast Zymogram gels, containing gelatin or caseins as substrate incorporated into the gels (Bio 
Rad), were used to see if proteases showed a different specificity for the substrates. 50 µL of the 
cell-free supernatants of the various strains of Y. lipolytica were mixed with an equal volume of 
Zymogram sample buffer 2X (Bio Rad) and let to rest for 10 min at room temperature. 35 µL of 
each sample was loaded on the gels. A 10 µL aliquot of Precision Plus Protein Standard All Blue 
(Bio Rad) was used as standard. Gels were run in a Mini Protean Cell System with a Tris-Glycine 
SDS Running Buffer at 100 V for the first 10 min and at 120 V for 1 h. After running, the gel was 
soaked into the Zymogram Renaturing Buffer (Bio Rad) and incubated with a gentle agitation for 
40 minutes at room temperature. Subsequently, the Zymogram Renaturing Buffer was washed 
before (30 min) and then replaced with the Zymogram Developing Buffer (Bio Rad). The gel was  
incubated in this buffer overnight at 37°C to allow enzymatic digestion of the protein. 
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Gel was stained for 1 hour with the Staining solution (0.5 % Bromophenol blue, 50 % 
methanol and 7% glacial acetic acid) and de-stained for 2 hours with the Destaining solution (40% 
Glacial acetic acid, 10% methanol). 
 
7.4.3. Preliminary evaluation of the "cold attitude" of the proteolytic enzymes 
The ability of the extracellular proteases to hydrolyse the different proteins was evaluated 
both at 27 and 6°C. In particular, the supernatants of the various strains were tested on gluten agar, 
skim-milk agar and gelatin.  
Gluten agar was prepared according to Wiese (1995) with some modifications (1.5 % gluten, 
1 % glucose, 0.5 % universal peptone, 1.7 % agar from Oxoid). The media was boiled in stirring 
conditions and then poured into Petri plates. Similarly, skim-milk agar (1 % skim-milk and 1.7 % 
agar from Oxoid) was boiled in stirring conditions and then poured into the Petri plates. Both the 
media contained suspended solid particles which made the agar plates cloudy. 
Gelatin liquefaction was estimated preparing a solution of 12 % gelatin, 1 % glucose, 0.5 % 
universal peptone. After autoclaving it was dispensed into glass tubes. 
Aliquots of 10 µL of the cell-free supernatants were spotted on the centre of the agarized 
media. The plates were incubated at 6 or 27°C in order to assess enzyme activity at cold and control 
temperatures, respectively. After 3 days (when incubation was at 27°C) or 10 days (for the cold 
conditions) plates were checked in respect to growth, contaminants and enzymatic digestion of the 
proteins. In particular proteolytic activity resulted in the formation of clear zones onto the agarized 
media (for skim milk and gluten) or liquefaction (for gelatin). In general, the proteolytic activity 
was carried out at least in triplicate.  
 
7.4.4. Evaluation of the proteolytic profiles generated by Y. lipolytica proteases 
Enzymatic activities of the extracellular proteases of the various strains were determined by 
using the following substrates: α-casein and β-casein from bovine milk (Sigma), commercial 
gelatine and meat protein extract.  
The assay mixture contained Y. lipolytica supernatants, sterile distilled water (1:2) and 1% 
(w/v) of gelatin or meat protein extract, or 0.1% (w/v) of caseins. The hydrolysis was performed in 
stirring conditions. After 48, 72 and 96 hours of incubation at 27°C, the reaction was stopped by 
heating at 100 °C for 5 min and the collected samples were stored at -20°C before their use for 
protein analysis by SDS-PAGE electrophoresys (paragraph 7.4.5), chemical (paragraph 7.6) and 
biological (paragraph 7.7) characterization.  
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7.4.5. SDS-PAGE electrophoresis 
The hydrolysis of the proteins was detected by sodium dodeceyl sulphate polyacrylamide 
(SDS-PAGE) gel electrophoresis. For the denaturation, 70 µL of each sample were mixed with an 
equal volume of Laemmli Sample Buffer 2X (Bio-Rad Laboratories, Milan, Italy) containing β-
mercaptoethanol. The mixture was incubated at 100 °C for 10 min and then charged on a precast 
gel. Different gels (Bio Rad) were used according to the protein analysed: a gradient 4-20 % gel 
was used for the casein samples and a 4-15% gel for the meat protein and the gelatin samples. 10 
µL of Precision Plus Protein Standard All Blue (Bio Rad) was used as standard, and 35 µL of each 
sample were loaded on the gels. Gels were run in a Mini Protean Cell System with a Tris-Glycine 
SDS Running Buffer at 100 V for the first 10 min and at 200 V for 1 h. 
Gels were stained for 1 hour with the Staining solution (0.1 % Bromophenol blue, 50 % 
methanol and 7% glacial acetic acid). Subsequently, 2 hours of Destaining solution (40% Glacial 
acetic acid, 10% methanol) were performed. 
 
7.5.  Improvement of peptides bioactivity 
 
7.5.1. Model System 
7.5.1.1.Model system preparation and UV spectra collection 
A model system consisting of a dipeptide Gly-Gln (0.03 M) and GlcN with different molar 
ratios of 1:1, 1:3 and 1:10 was prepared. Samples were dissolved in 0.05 M (NH4)HCO3/NH4OH 
buffer at pH 8.8 with or without TGase (2 unit/g). TGase was activated with 5 mM calcium chloride 
solution. In addition, 0.03 M and 0.12 M solutions of GlcN in the absence of the peptide were 
prepared separately as control. These solutions were treated in the same way as the mixtures of 
peptide and GlcN. About 5 mL of the mixture was poured into screw-cap tubes (15 mL) and 
incubated at 25 and 37°C with shaking (200 rpm) for 0, 3.5 and 7 h. All aliquots were kept at -20ºC 
upon incubation for further use. The UV-Vis absorbance spectra (250 - 500 nm) of the samples 
were measured using a spectrophotometer SpectroMax M3 plate reader (Molecular devices, 
Sunnyvale, CA) in order to create the UV profiles. 
 
7.5.1.2. LC/MS analysis 
Samples prepared as above described were diluted in aqueous 25 % (v/v) acetonitrile and 0.2 
% (v/v) formic acid, and ionized by using nanoflow HPLC (Easy-nLC II, Thermo Scientific, 
Mississauga, ON) coupled to the LTQ XL-Orbitrap hybrid mass spectrometer (Thermo Scientific, 
Mississauga, ON). Nanoflow chromatography and electrospray ionization were accomplished by 
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using a PicoFrit fused silica capillary column (ProteoPepII, C18) with 100 µm inner diameter (300 
Å, 5 µm, New Objective). Samples were injected onto the column at a flow rate of 3000 nL/min and 
resolved at 500 nL/min using 30 min linear acetonitrile gradients from 5 to 50 % (v/v) aqueous 
acetonitrile in 0.2 % (v/v) formic acid. Mass spectrometer was operated in data-dependent 
acquisition mode, recording high-accuracy and high-resolution survey Orbitrap spectra using 
external mass calibration, with a resolution of 60 000 and m/z range of 100–2000.  
 
7.5.1.3. Production of hydrolysates 
Exactly 5 % (w/v) of gluten was suspended in 0.05 M (NH4)HCO3/NH4OH buffer, the final 
pH of the mixture was pH 7.5 – 8. It was homogenised with an Ultra-Turrax homogenizer, model T 
25 (IKA Works, Inc. Staufen, Germany) at 10,000 rpm for 1 min. Then it was heated at 80 ºC for 10 
min. The gluten mixture was cooled to 50 ºC before adding Alc or Flv, respectively at 1:10 volume 
ratio of enzyme to buffer, followed by incubation in a shaker (50 ºC, 3.5 h, 200 rpm). Incubation 
was terminated at 80 ºC for 10 min, the hydrolysates were centrifuged at 10,000 × g (10 ºC) for 15 
min and filtered by using Whatman No. 1 filter paper. The filtrate was collected, lyophilized and 
stored at -18 ºC before their chemical and biological characterization. 
 
7.5.1.4. Preparation of Glycated/Glycosylated peptides 
Samples of the lyophilized hydrolysate powders (from Alc or Flv respectively) were 
weighed at 1.5 g each and added to GlcN at the weight ratio of 1:1. Each of the weighed powders 
was dissolved in 30 mL of 0.05 M (NH4)HCO3/NH4OH buffer (pH 7.0 ± 0.5) and each incubated at 
25 ºC and 37 ºC for 3.5 h. Samples with GlcN were subjected to incubation with or without TGase 
(2 unit/g of lyophilized hydrolysate) at pH 7.5. 5 mM calcium chloride were added prior to use in 
order to activate TGase. Controls consisiting of the lyophilized hydrolysate were incubated at the 
same temperature without GlcN. At the end of incubation, all the mixtures were passed through a 
0.2 µm nylon syringe filter (13 mm, Mandel, Ontario) followed by ultra-filtration with a molecular 
weight cut-off membrane of 10 kDa (3,900 × g, 20 min, 10 ºC, Amicon Ultra Centrifugal filters 
(Millipore, Cork, Ireland)). Excess of GlcN was removed by dialysis membrane with a molecular 
weight cut-off membrane of 100 – 500 Da (Spectrum Laboratories, TX). The retentates were 
collected and lyophilized, samples were then stored at -18 ºC before their chemical and bioactive 
characterization. 
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7.6. Chemical characterization of the proteins and hydrolysates 
 
  
7.6.1. Degree of hydrolysis (DH) 
The measurement of DH was carried out according to the OPA method as stated by Nielsen 
et al. (2001) by using serine as a standard for hydrolysis determination. Protein contents of gluten 
samples were assessed. The percent of DH was calculated according to Alder-Nissen (1986).  
 
7.6.2. Size exclusion chromatography 
After filtration with 0.2 nm filters, the samples were subjected to size exclusion 
chromatography using a 120 mL HiLoad 16/60 Superdex 200 pg column (GE Healthcare 
Amersham Biosciences) connected to a fast protein liquid chromatography (GE Healthcare 
Amersham Biosciences). A sample volume of 100 µL (1 mg/mL of the freeze-dried peptide 
mixture) was injected and eluted isocratically at a flow rate of 0.5 mL/min with 50 mM phosphate 
buffer containing 0.15 M NaCl. Eluted molecules were detected at 215 nm (for gelatin) or 280 nm 
(for gluten). The mass calibration was performed using a protein mixture (200 to 12.4 kDa) of β-
Amilase, Alcohol Deidrogenase, Albumin, Carbonic Anhydrase and Cytocrome C (Sigma Aldrich).  
 
7.6.3. Determination of peptides and glycopeptides molecular weights by Matrix-
assisted laser desorption ionization-time of flight-mass spectrometry (MALDI/TOF-MS)  
For the MALDI-TOF-MS analysis, the protein hydrolysate samples were diluted tenfold in 
50 % (v/v) acetonitrile/water + 0.1 % (v/v) trifluoroacetic acid/water. One microliter of each sample 
was mixed with 1 µL of a-cyano-4-hydroxycinnamic acid (matrix) (4-HCCA, 10 mg/ml in 50 % 
acetonitrile/water + 0.1 % trifluoroacetic acid/water). One microliter of the sample/matrix solution 
was then spotted onto a stainless steel target plate and allowed to air dry. All mass spectra were 
obtained using a Bruker Ultraflex MALDI/TOF-MS (Bruker Daltonic, GmbH). Ions were analyzed 
in positive mode after acceleration from the ion source 174 by 25 kV. External calibration was 
performed by use of the following standard peptide mixture ((M+H)+ monoisotopic masses are 
reported in Da): Bradykinin fragment 1-7 (757.3997), Angiotensin II (human) (1,046.5423), 
synthetic peptide (1,533.8582), ACTH fragment 18-39 (human) (2,465.1989), Insulin oxidized B 
chain (bovine) (3,494.6513), Insulin (bovine) (5,730.6087) (Sigma Aldrich). 
 
 
 
 
 51 
 
7.7. Biological characterization of the peptides 
 
7.7.1 Antioxidant properties 
7.7.1.1. 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity 
DPPH radical scavenging activity was assessed according to the method of Yen and Wu 
(1999) and modified by Hsu (2010). Exactly 200 µL of each sample (10 mg/mL for gelatin and 
meat extract or 1 mg/ml for caseins, referring to the starting protein utilized) were mixed into a test 
tube containing 400 µL of 0.5 mM DPPH and 1.4 mL of 99.5 % methanol. L-ascorbic acid (0.1 
mg/mL) was used to replace sample and referred to as positive control. The whole mixture was 
mixed thoroughly and incubated for 30 min in the dark at room temperature. Then the absorbance at 
517 nm was measured using a spectrophotometer. The percentage of inhibition of radical 
scavenging activity was calculated as follows: 
 
% DPPH scavenging activity = ((Abs control - Abs sample) / Abs control)) x 100 
 
where: Abs control is the absorbance of reference solution containing only DPPH and water, and Abs 
sample is the absorption of the DPPH solution with sample after 30 min. Methanol was used as a 
blank. A lower absorbance represents a higher DPPH scavenging activity. 
When reported, the EC50 value (concentration required for 50 % reduction of activity) was 
calculated through software Prism 5. 
 
7.7.1.2. Inhibition of linoleic acid peroxidation 
Linoleic acid was oxidised in a model system according to Mendis et al. (2005) with 
modifications from Li et al. (2007) Reagent mixtures consisting of 1.5 mL of 0.1 M sodium 
phosphate buffer (pH 7.0), 1.5 mL of ethanol containing 50 mM linoleic acid and 2 mL of 10 
mg/mL of gelatin or gluten hydrolyxed samples were prepared. For the positive control, peptide 
mixture samples were replaced with 2 mM alpha-tocopherol and 2 mM butylated hydroxytoluene 
(BHT); for the negative control, samples were replaced by water. All the mixtures were kept sealed 
and incubated in the dark at 40 ºC. The oxidation level was measured every 24 h over 7 days by 
using a ferric thiocyanate method as described by Osawa and Namiki (1981). Exactly 50 µL of the 
mixture were mixed with 100 µL of 1 M HCl, 50 µL of 30 % (w/v) aqueous ammonium 
thiocyanate, 50 µL of 20 mM ferrous chloride in 3.5 % HCl and 2.25 mL of 75 % ethanol. The 
mixture was gently agitated and incubated at room temperature for 5 min before reading the optical 
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density at 500 nm. The linoleic acid peroxidation was monitored for 7 days following the increase 
of the absorbance at 500 nm.  
 
7.7.2. Angiotensin I-converting enzyme (ACE) inhibitory activity 
The hydrolysis of N-[3-(2-furyl) acryloyl]-L-phenylalanylglycylglycine (FA-PGG), which 
represents a substrate for angiotensin converting enzyme, was used to assess the angiotensin 
converting enzyme inhibitory activity (Bunning et al., 1983). The assay was performed according to 
Vermeirssen et al. (2002) and Shalaby et al. (2006). Buffers were made according to Hou et al. 
(2003) and the volumes were reduced to fit into 96-well plates. FA-PGG was dissolved at a 
concentration of 1.75 mM in 50 mM Tris-HCl buffer, pH 7.5, containing 0.3 M NaCl. The ACE 
solution (0.25 units/mL) was freshly prepared by adding purified water to a vial containing 0.25 
units of enzyme (Sigma). The assay was performed in a 96-well, clear, flat-bottomed polystyrene 
plate. Exactly 10 µL of ACE solution and 10 µL of protein hydrolysate samples were placed 
separately in the well at room temperature. 150 µL of pre-heated (37 °C) substrate solution (FA-
PGG) was added quickly to each well with an eight channel pipette to start the reaction. The plate 
was immediately transferred into a SpectroMax M3 plate reader. Enzyme activity at 37 °C was 
based on the initial linear rate of change in absorbance at 340 nm, recorded every 3 min for 30 min. 
The control contained all reaction components, and water instead of the protein hydrolysate sample. 
Blanks with no enzyme (substituted by water) or with no substrate (substituted by 50 mM Tris-HCl 
buffer, pH 7.5, containing 0.3 M NaCl) were used. The ACE activity was expressed as the slope (m) 
of the decrease in absorbance at 340 nm and the ACE inhibition (%) was calculated from the ratio 
of the slope in the presence of sample to the slope obtained without added sample, according to the 
formula: 
 
% ACE inhibition = (1- (msample / mcontrol ) x 100 
 
7.7.3. Cytotoxicity of the hydrolyzed and conjugated samples on human HepG2 cells 
HepG2 cells were grown in growth medium (EMEM supplemented with 10 % Fetal Bovine 
Serum - FBS), 50 units/mL penicillin and 50 µg/mL streptomycin) and were maintained at 37°C 
and 5 % CO2 as described by Wolfe and Liu (2007). Cells used in this study were between passages 
5 and 10. Cytotoxicity was determined using the protocols of the Water Soluble Tetrazolium Salts 
(WST1) assay by using protein hydrolyzed samples at 3 different concentration, i.e. 0.1, 0.5 and 1 
mg/ml. The inhibition of cell growth by the tested protein hydrolyseate samples was expressed as 
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the percentage of cell viability with respect to control. Concentrations of samples that decreased the 
absorbance by >10 % when compared to the control were considered to be cytotoxic. 
 
7.7.4. Antimicrobial activity  
The antimicrobial activity of the protein hydrolysate samples was determined by the 
modified micro-dilution technique against some bacteria, i.e. Escherichia coli 555, Listeria 
monocytogenes 56Ly, Bacillus subtilis FAD 110 and Salmonella enteritidis 155, and yeasts, i.e. 
Pichia membranaefaciens OC70, P. membranaefaciens OC71, Pichia anomala CBS 5759 and P. 
anomala DBVPG 3003. The bacterial strains were grown at 37°C in Brain Heart Infusion broth 
(BHI, Oxoid), while those of yeasts at 27°C in Sabouraud (Oxoid). The microbial cultures were 
prepared at 104 cfu/mL in the 96-well microplates. Diluted sample solutions of the protein 
hydrolysates were dispensed into the wells providing final concentrations in the range of 16 to 0.06 
mg/mlfor gelatin and 40 to 0.097 mg/ml for gluten. The same tests were performed simultaneously 
to check for the growth in control conditions (media + microorgaism) using water instead of the 
samples, and sterility control (media + the protein hydrolysate samples tested). The final volume in 
each well was 200 µL; plates were incubated at the optimal growth temperatures typical for each 
microorganism for 24 or 48 hours. The MIC values were defined as the lowest concentrations 
preventing any discernible growth. From the same MIC well, 10 µL of the suspension was plated in 
Luria Broth LB agar plate and incubated at 37 ºC for 24 h (for bacteria) or 27°C for 48 h (for 
yeasts). The absence of growth in the plate represented the MBC value, thus the capacity to 
completely kill all the bacteria or yeasts. All the MIC and MBC values were evaluated in triplicate. 
In order to obtain information on the antimicrobial activity of protein fractions with specific 
molecular weights, samples of gelatine, hydrolysed with the strain 1IIYL4A and collected after 96 
hours, were also ultra-filtered with a molecular weight cut-off membrane of 3 kDa (3,900 × g, 20 
min, 10 ºC) (Amicon Ultra Centrifugal filters (Millipore, Cork, Ireland)). The retentates 
corresponded to the fraction > 3 kDa, whereas the filtered part corresponded to the < 3kDa. Both 
the fractions were used for MIC analysis. 
 
7.8. Statistical Analysis 
 
Data were reported as means ± standard deviation of at least triplicates. Means obtained 
were analysed by one way analysis of variance (ANOVA), separated by Duncan test using 
STATISTICA statistics software (ver. 6.0). Means were considered significant when p < 0.05. As 
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for model study, the results from UV–Vis spectra were analysed by using bidimensional 
hierarchical clustering analyses (heat map) as reported by Hrynets et al. (2013). 
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CHAPTER 8. 
RESULTS 
 56 
 
8.1. Evaluation of the proteolytic activity of Yarrowia lipolytica on different 
proteins 
 
Due to its physiological attributes and biotechnological potentialities, Yarrowia lipolytica is 
one of the most studied "non-conventional" yeasts and it is classified as “generally recognized as 
safe.”  It is able to growth in different environments and many strains have been isolated from oil-
polluted environments, rivers and foods such as refrigerated foods, cheese, irradiated meats, 
sausages, salami and other products (Bankar et al., 2009).  
In addition to its potential use as adjunct as ripening agent of dairy and meat products 
(Suzzi et al., 2001; Lanciotti et al., 2005; Patrignani et al., 2007; 2011a; 2011b), Y. lipolytica has 
been exploited also for the production of single cells proteins for feeds and the treatment of olive 
mill wastewaters (Lanciotti et al., 2005). Without any doubt, the most studied features of this 
microorganism are the production of lipases (Ota et al., 1982), citric acid and γ-decalactone 
(Cohelo, 2010). In particular some strains have been described as producers of "cold" lipases 
(Parfene et al., 2011) and this aspect is progressively getting interesting for industrial applications 
(Joseph et al., 2007). Proteases are another class of enzymes that are produced and secreted by Y. 
lipolytica. In particular, an acidic extracellular protease (AXP) and an alkaline extracellular 
protease (AEP) have been mainly studied (Young et al., 1996). The main element that 
discriminates the production of AEP or AXP is the environmental pH. In general, neutral and 
high pH (6-9) lead to AEP production, while low pH (2-6) favours AXP (Ogrydziak, 1993). 
However, both proteases are similarly induced at the end of the exponential phase (González-
López et al., 2002). The screening of novel enzymes that are capable of generating compounds 
with specific and improved functional bioactivities is constantly necessary. In particular this kind 
of research can have a relevance for the food industry as a possible strategy to transform cheap 
food by-products into active compounds with an increased market value. 
In my research, seven strains of Y. lipolytica have been used to evaluate the capability of 
the extracellular proteases to produce bioactive peptides from different matrices. In particular 
gelatin, gluten, milk and meat by-product proteins have been considered. The possibility to obtain 
biologically active peptides, endowed with technological properties from different matrices 
through the use of lactic acid bacteria has been reported. But on the other hand the biotechonolgal 
properties of yeast concerning this aspect have been not explored. The wide diversity and 
specificity of proteases are used to great advantage in developing effective therapeutic agents. 
Proteases from Aspergillus oryzae have been used as a digestive aid to correct certain lytic 
enzyme deficiency syndromes. An asparaginase isolated from E. coli is used to eliminate 
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asparagine from the blood stream in various forms of leukaemia. In addition microbial proteases 
have been used for the synthesis of dipeptides (Barros et al., 1999) and tripeptides (So et al., 
2000) Nutritionally enhanced meat products have been obtained by using microbial proteases 
able to restructure and improve appearance, texture and nutritional quality of animal parts of 
poorer technological quality (Marques et al., 2010) 
 
8.1.1. Preliminary characterization of proteases by Zymogram 
The Zymograms of the 72 h old supernatants of the 7 strains obtained both on casein and 
gelatin are shown in figures 5A and 5B, respectively. In figure 5A, two main bands were detected, 
one at low molecular waight (MW) nearby 37 kDa (1IIYL4, 16B, Y10) and one at high MW higher 
than 200 kDa (Y16, 1IIYL8 and Y10). While the first one corresponds to the acid protease typical 
of Y. lipolytica reported by many Authors (Young et al., 1996), the other one presents a band with 
an unusual MW never reported in this species. The strains 1IIYL4 and 16B were characterized by 
an intense protein clearness zone nearby 37 kDa, while the strain PO19 showed a weak band 
suggesting either a lower activity or a lower release of the protease. The strain CLCD, isolated from 
salami, did not show any apparent activity. A similar behaviour was observed in the presence of 
gelatin although the bands were less intense (fig. 5B).  
 
8.1.2. "Cold attitude" of the proteolytic enzymes 
In order to evaluate the cold attitude of the proteases, the supernatants were spotted onto 
agar plates containing gluten or skim milk as substrates for the enzymatic reactions. The activity 
was evaluated on the basis of the clearance of the media after 10 days of incubation at 6 °C. 
A 72 h sample incubated at 27 °C was used as a control. In addition, the ability to hydrolyse gelatin 
in the same conditions was assessed in tubes measuring the depth of liquefaction.  
At the optimal temperature (27 °C), 1IILY4A, 16B, Y16 and 1IIYL8A were the strains with 
the highest ability to hydrolyse the skim milk and gluten, whereas CLCD was not active under these 
conditions. The incubation at 6 °C did not affect the final capability of all the strains to work at this 
low temperature, except for 1IIYL8A on gluten agar (tab. 6a and 6b) 
Regarding gelatin, similar behaviours were observed at 27 °C for all the strains, except for 
Y16 and 1IIYL8A which showed a reduction of their activity. On the other hand, the strain Y10, 
which was unable to hydrolyze both skim milk and gluten, showed a significant activity. The 
reduction of the temperature moderately affected the final degree of the proteolysis (tab. 6c). In fact 
the strains 1IIYL4 and 16B presented a band at 37 kDa while the 1IIYL8A and Y16 showed an 
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intense band at 200 kDa. By the comparison of these results with the two Zymogram it is evident 
that the two proteins visualized display their activity both on gelatin and casein. 
 
8.1.3. Proteolytic profiles generated by Y. lipolytica proteases 
Four different protein matrices (meat proteins, α-casein, β-casein and gelatin) were 
resuspended in water and incubated with the supernatants of the 7 strains of Y. lipolytica for 72 h at 
27 °C. The proteolytic profiles were evaluated by SDS-PAGE electrophoresis.  
Figure 6 reports the proteolysis of α-casein. α-casein includes two main isoforms αs1 and 
αs2 that migrate in the SDS PGAE electrophoretogram with a final MW of around 34 kDa. After 
incubation with Y. lipolytica supernatants, a significant proteolytic activity was detected. In 
particular, 1IIYL4A, 16B and Y10 significantly reduced the intensity of the  casein bands. A partial 
hydrolysis, with the formation of several detectable bands having different low MWs, was observed 
with CLCD, PO19 and Y16. Comparing these strains, CLCD and PO19 were the least active since 
both the bands of αs1- and αs2- caseins were still present. Taking into consideration the bands 
present in the control, the bands at 30 and 34 kDa were still visible in the samples of the strains 
1IIYL4A CLCD, PO19 Y16 and 1IIYL8A while they disappeared in 16B and Y10. The band of 24 
kDa disappeared in all the samples except for strains PO19, whereas the band at 22 kDa was 
detected in CLCD, PO19 and Y16. New bands at 20 and 21 kDa were formed with PO19 and Y16, 
and a band at 18 kDa was detected with CLCD, Y16, 1IIYL8A and PO19. It can be noticed that the 
strains 1IILY4A and 16B, which showed in the zymograms a 37 kDa protease, were characterized 
by similar breakdown profiles and a strong proteolysis. On the other hand the strains Y16 and 
1IIYL8A, which displayed in SDS-PAGE electrophoretogram a lower proteolytic activity, were 
characterized in the zymograms by a protease having a MW higher than 200 kDa. 
In figure 7 the β-casein profile of hydrolysis is reported. Also against this protein, the strains 
1IIYL4A and 16B, characterzed by the 37 kDa protease, displayed a very strong proteolytic 
activity. In fact, not only the bands of β-casein including the principal one at 31 kDa but also all the 
bands having MWs ranging from 25 to 15 kDa disappeared. Also the strain PO19, having a weaker 
37 kDa protease in the zymogram, displayed a good proteolytitc activity also if at lower extent than 
the former.  The comparison of all the proteolytic profiles of α- and β-caseins demonstrated that a 
strong activity was displayed by all the strains of Y. lipolytica, except for Y10, against β-casein. In 
fact, also the strains Y16 and 1IIYL8A, characterized by the protease > 200 kDa, showed a strong 
proteolytic activity against β-casein. 
In figure 8, the meat protein breakdown profiles obtained with the supernatants of the 
various strains are showed. With this protein matrix, two different behaviours can be identified: the 
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strains 1IIYL4A, 16B and PO19, characterized by the 37 kDa protease, displayed a strong 
proteolysis with the formation of peptides having MW lower than 10 kDa and the fading of higher 
MW peptides. In particular, the 75, 70, 47, 26, 17 kDa MW bands faded, whereas those at 65, 37 
and 24 kDa disappeared. On the countrary CLCD, Y10, Y16, 1IIYL8A showed only a weak 
hydrolytic activity as most of th bands were as intense ad the control samples. 
 
8.1.4. Proteolysis of gelatin 
The strains having the highest activity in gelatin agar plate (tab. 6), were incubated with 
gelatin for 72 h and the corrisponding hydrlysed samples were analysed through SDS-PAGE gel 
electrophoresis (fig. 9). 
Figure 9 showed that not all the strains were able to hydrolyze gelatin at the same extent. 
Looking at the higher MW, above 100 kDa, it can be observed that the intensities of the two typical 
bands of gelatine were reduced in the samples 16B and 1IIYL8A, while they were completely 
absent in 1IIYL4A. As far as the bands with the intermediate MWs (75-20 kDa), none of the 
samples had the 37 kDa band. Moreover some differences can be detected in the sample 16B, where 
the band at 23 kDa disappeared, while the 25 kDa one became more intense. The same behaviour 
was partially shown by the sample Y16. Comparing all the samples together only the sample 
1IIYL4A showed a general increment in the intensities of the bands in the range 37-20 kDa. 
Instead, molecules below 10 kDa were generated by all the samples, also if with different extents. 
In order to have a wider overview on these profiles, size exclusion chromatography was 
applied to the gelatin hydrolyzed samples. The chromatograms reported in figure 10 showed how in 
many samples, the peak corresponding to gelatin (having an elution volume of 40 mL) reduced 
comparedo figure 10 A, which reprents the gelatin before its hydrolysis. As the extent of the 
hydrolysis increased, more peacks having lower MWs appeared on the left side of the 
chromatogram with higher elution volumes. In some samples, such as CLCD, Y10 and PO19 (fig. 
10 D, F, G) there was mainly an increment of the peaks eluting between 50 and 100 mL, whereas 
peaks eluting between 90 and 140 mL represented the main one for the samples 1IIYL4A, 16B and 
1IIYL8A (fig. 10 B, C, E). Among all these conditions, the sample that showed the best hydrolysis 
with the formation of smaller MWs was the 1IIYL4A. An overlay of the two chromatograms 
(before and after hydrolysis) is reported in figure 11.   
On the basis of the comparative results of the size exclusion chromatograms the strain 
1IIYL4A was chosen for a more detailed characterization of the peptides obtained.  
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8.1.5. Characterization of the products of gelatin hydrolysis obtained by Y. lipolytica 
1IIYL4A protease  
The gelatin hydrolysis by proteases from Y.lipolytica 1IIYL4A was followed over time (time 
0, 48, 72, 96 hours) in stirring conditions (useful for the enzyme activity). In figures 12 the SDS-
PAGE electrophoretograms (A) and size exclusion chromatograms (B) of the hydrolysates collected 
over time are reported, respectively. In particular, figure 12 B represents a closeup of the final 
elution volume of the size exclusion analysis in order to show better the progressive increment of 
the lowest MWs (lower than 10 kDa). It is possible to see that three main regions are 
distinguishable: the first one, ranging between 90-115 mL, the second one between 115-125 mL and 
the third one between 125-135 mL. These three areas were integrated and the relative abundances 
are reported in the figure 13. Among the three areas, the first one, ranging between 90-115 mL, 
reached its maximum abundance already at 48 h and it seamed constant at 72 and 96 h. However, 
looking at figure 12B it is possible to see that even if the final area of 72 h and 96 h samples is the 
same, the peak at 48 h is smaller and broader. This latter aspect has to be taken into consideration 
because it suggests that different MWs are present in that area. On the contrary, in the peaks of 72 
and 96 h samples ranging between 90-115 mL, the MWs should be more similar among them. A 
sensible decrease in the abbundance of the second peak (ranging between 115-125 mL) and a 
sensible increase of the third peak (ranging between 125-135 mL) was observed over time. 
The following analysis were performed only on the peptides with low MWs because it has 
been reported that many peptides having antioxidant, anti-hypertensive, antimicrobial, and cell 
modulating activities are characterized by MWs below 10 kDa (Li et al. 2008; Ryan et al., 2011). 
However, the size exclusion technique is not able to separate and identify the exact MW of the 
peptides, and particularly those lower than 10 kDa. For this reason the samples were analysed also 
with MALDI-TOF after ionization (fig. 14 A and B). The reduction of MWs is well evidenced by a 
shift of the signals towards the left side of the spectrum (fig. 14 B).  In particular all the peaks 
ranging between 7 and 3.3 kDa disappeared, while new signals manly ranging from 4 to 1 kDa 
appeared.  
Taking into consideration all the signals detected, table 7 reports the flow over time of the 
peptide MWs. In this table the evolution of some peptides, present in at least two sampling times, is 
reported. All the red numbers derive from the time 0, in particular from the native gelatin added 
with the supernatant of Y. lipolytica 1IIYL4A; in green the peptides produced after 48 h, and in blue 
that ones released at 72 h. 
The MALDI-TOF results (fig. 14, tab. 7) are comparable with the SDS-PAGE image (fig. 
12A) where it was highlighted that strong differences in the hydrolytic profiles occurred only after 
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how 72 h. Moreover, at 96 h the main peptides are either newly originated or deriving from those 
detected at 72 h, although the number of peptides identified at 72 and 96 h was similar.  
 
8.1.6. In vitro bioactivity evaluation of the peptides  
Preliminary investigations on the biological properties of the peptides obtained were 
performed on the gelatin hydrolysates produced by extracellular protease of Y. lipolytica 1IIYL4A. 
 
8.1.6.1. DPPH radical scavenging activity 
A DPPH assay was performed to establish if the degree of proteolysis, and in particular the 
mixture of peptides whose MWs had been determined with MALDI-TOF analysis, affected the 
antioxidant properties of the hydrolysates collected after 0, 48 72 and 96 h of incubation.  
According to figure 15 a progressive increase of the DPPH activity with the hydrolysis time 
was observed. In particular the antioxidant activity, which was 19.7 ± 6% at time 0 with respect to 
the ascorbic acid chosen as a reference sample, attained values of 39.4 ± 1.4 and 48.3 ± 0.5% after 
72 and 96 h, respectively. The latter differences were significant (p < 0.05).  
 
8.1.6.2. Inhibition of the linoleic acid peroxidation  
The capability to inhibit the peroxidation of linoleic acid by the peptide mixture collected 
over time was also evaluated. As previously shown by the DPPH assay, the progressive incubation 
time gave rise to a significant increase (p < 0.05) of the antioxidant activity in particular for the 
samples at 72 and 96 h (fig. 16). On the other hand the sample collected at time 48 h showed a 
behaviour much more similar to that at time 0. The α-tocopherol, chosen as a reference for the 
inhibition of the peroxidation, has been used at 0.89 mg/ml. Its activity was higher than that of the 
peptide mixture, but it is necessary to outline that I compared the antioxidant properties of a pure 
compound with a mixture of peptides of 20 mg/ml (freeze-dried powder/water) having a peptide 
content of about 1.3 mg/ml. Moreover, it can be assumed that only few peptides included in the 
mixture were endowed with antioxidant properties.   
 
8.1.6.3. Cytotoxicity activity in human cells 
The assessment of the cytotoxicity is a prerequisite for the use of a new ingredients, such as 
peptide mixtures having technological properties, in food formulations. On the basis of the figure 
17 potential cytotoxic molecules are generated only when the proteolysis was extended over 72 h 
and the cells HepG2 were exposed to a concentration of 1 mg/ml.    
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8.1.6.4. Antimicrobial activity 
The bacteria species used for evalutation of the antimicrobial activity were Escherichia coli 
555, Salmonella enteritidis 155, Listeria monocytogenes 56Ly, Bacillus subtilis FAD 110, Pichia 
membranaefaciens OC71, P. membranaefaciens OC70, Pichia anomala CBS 5759, and P. anomala 
DBVPG 3003. None of the bacteria resulted sensitive to the compounds at any concentration tested. 
However, it has been observed a progressive inhibition of the growth of some strains of Pichia 
membranefaciens in relation to the degree of hydrolysis. In particular MIC values of 8 mg/ml were 
observed for gelatin hydrolysates collected at 48 and 72 h. The extension of the hydrolysis up to 96 
h resulted in a two fold reduction of the MIC value. Moreover, when the sample at 96 h was 
separated into fractions with MWs higher than 3 kDa, a MIC value of 2 mg/ml was detected. On the 
contrary, no activity was observed for the fraction below 3 kDa.  
 
8.2. Improvement of peptides bioactivity 
 
The technological attitudes of the peptide mixtures can be regarded as promising, but need 
to be improved. A new frontier to be explored, to enhance the properties of peptides, is their 
transformation into glycopeptides. The enhancement of the functional and biological properties in 
the glycoproteins with respect to the native form has been explored (Bielikowicz et al., 2010; Liu et 
al., 2012) and the importance of this peptide transformation on some physiological processes (such 
as immune-system, inflammation, brain development, endocrine system and fertilization) has been 
emphasised (Spiro, 2002). 
The reaction involving sugars and amino acids can be triggered either through enzymes or 
spontaneously occur under specific conditions. Glycosylation, as an enzyme driven process, is one 
of the main processes occurring in eukaryotic and prokaryotic cells. In fact, it is known that the 
majority of proteins are subjected to post-translational modifications, such as the attachment of 
glycans. This reaction is crucial in many biological pathways (Spiro, 2002). On the contrary, 
"glycation" is the term universally used to define the chemical bounding of sugars with proteins or 
peptides. This second reaction is spontaneous, and can occur both in human body and in food 
systems (Liu et al., 2012). As reviewed by Oliver et al. (2006), glycation via the Maillard reaction 
can improve several important functional properties of food proteins (Liu et al., 2012). One of the 
main requirements for the glycation through the Maillard reaction is the use of high temperatures or 
a prolonged heat treatment, in order to favour the reaction between sugars and aminoacids. A 
controlled Maillard-induced glycosylation is fundamental to limit the  progress of the reaction into 
undesired advanced stages; advanced Maillard reactions may result in reduced food digestibility 
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(Erbersdobler et al., 1981), formation of mutagenic compounds (Brands et al., 2000), development 
of off-flavors (Moor and Ha, 1991), and excessive browning (Guerra- Hernandez et al., 2002). 
(Wang and Ismail, 2012). Due to the low reactivity of sugars and amino acids, high temperatures 
are necessary to promote the reaction (Wang and Ismail, 2012). On the other hand, amino-sugars 
demonstrated to have a higher reactivity comparing to normal sugars (Kraehenbuehl et al.,2008). 
The amino-sugar glucosamine (GlcN) can be obtained through the hydrolysis of chitosan, the main 
by-product from shrimp and other crustacean shells processing. The acetylated form of GlcN is 
fundamental for the building the bacterial cell wall and the particular cartilage in the human body 
(Wang SX et al., 2007). 
Aminosugars binding, exploited through the transglutaminase (TGase) enzymatic process, 
has been already proposed, in particular between GlcN and peptides. However, results have been 
inconclusive (Jiang and Zhao, 2010). The above mentioned enzyme (TGase), discovered in 
eukaryotic and prokaryotic cells, and extensively used in food processing, is responsible for the 
acyl-transfer reaction between the γ-carboxyamide group of glutamine residue and the primary 
amino group. Moreover, this reaction can be driven towards the formation of inter- and intra-
molecular cross-linkages (if the primary amino group derives from other amino acids, such as 
lysine) or deamidation (in absence of primary amino groups, a molecule of H2O is used). The first 
two types of bonds are stable and resist to proteolysis (Greenberg et al., 1991)  
Wheat gluten, a by-product of the wheat starch industry, is massively produced worldwide. 
Due to its modest price, it can industrially compete with milk and soy proteins, as an economic 
protein source (Kong et al., 2007). Because of their functional properties, such as solubility, 
foaming and emulsifying capacity, the wheat gluten peptides obtained by hydrolysis attracted the 
interest of food industries (Kong et al., 2007, Wang et al., 2007) focused on the preparation of 
hypoallergenic nutritional mixtures (Daya et al., 2006). Additional studies have reported antioxidant 
properties of gluten hydrolyzates, including the capability to inhibit the linoleic acid peroxidation or 
to quench DPPH radical. Moreover, Koo et al., (2011) demonstrated that gluten hydrolysates 
exhibited taste-enhancing properties. Wang and Ismail (2012), instead, reported the production of 
some partially glycosylated wheat protein. My strategy to improve the boactivity of peptides 
obtained by enzymatic proteolysis of gluten and other proteic by-products was based on 
glycosylation/glycation. The experiment has been developed in two steps: 
1) a single peptide was employed to prove the occurrence of the glycation (through a mild 
Maillard reaction) and glycosylation (TGase-mediated), and to optimize the main reaction 
parameters to be pursued (such as concentration, temperature). This process is totally new and never 
ever exploited before, 
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2) a more complex system, based on gluten hydrolysates, was taken into consideration and 
the bioactivities of the  glycopeptides mixture obtained was assessed. 
 
8.2.1 Model system 
To establish the novel conjugation method, and in order to determine the most appropriate 
conditions for the reaction, a simplified model system involving glucosamine (GlcN) and the 
dipeptide glycine-glutamine (Gly-Gln) was considered. It has been reported that GlcN at high 
temperature is able to undergo rearrangements, auto-condensation processes and Maillard reaction 
(in presence of amino-acids), with a yield higher than with the simple sugars. Hence, in the first part 
of this model, different concentrations of GlcN were tested to detect the threshold conditions for the 
formation of its side-products and hence to avoid their production. 
The reaction involving the peptide Gly-Gln (chosen because of its simple structure and the 
presence of glutamine) and GlcN (molar ratio 1:1, 1:3 and 1:10, dipeptide/glucosamine) was 
monitored over time (0, 3.5 and 7 hours) at 25 or 37°C. As control, GlcN alone was incubated at the 
same conditions and monitored over time. The UV-spectra (280 - 420nm) of the samples during 
incubation are shown in figure 18. The temperature and the sugar concentration played a 
fundamental role in both the increased and progressive shift of absorbance to high wavelength 
values. The highest absorbance was revealed with the 1:10 ratio at 37°C (fig. 18 A). As the sugar 
ratio increased, its augmented by-products created interferences when monitoring the sugar-peptide 
interaction and evolution. On the other hand, the ratios 1:3 and 1:1 at 25 or 37 °C promoted a 
suitable arrangement (fig. 18 B and 18 C, respectively). At 1:3 ratio, an increase in the absorbance, 
due to the sugar auto-condensation and rearrangement, was reported. However, these absorbance 
increases were < 1 after 3.5 hours (compared to 1:10, where Abs ranged from 1 to values higher 
than 2.5). To monitor the reaction behaviour, the wavelengths corresponding to the typical Maillard 
markers were selected, as follows: 280 nm for furosine, 320 nm for the soluble pre-melanoidin 
compounds, and 420 nm for the melanoidins (Rada-Mendoza et al., 2002; Wijewickreme et al., 
1997). The results are summarized in a heat map (fig. 19). The conditions able to generate 
significant increases of the optical densities at 280, 320 and 420 nm clustered together and were 
characterised by a high amount of sugar (1:10 molar ratio peptide/sugar), long incubation time (> 
3.5 h) and high temperature (37°C). The sugar concentration (1:10 peptide/sugar ratio) promoted 
the highest increase in the selected wavelengths, independently from the peptide presence. For 
instance, following the sample N37C or C37C over time, a progressive increase was initially 
observed in the absorbance at 280 nm, and then at 320 and 420 nm, from the 3.5 h time point. In 
contrast, N37B_7 and C37B_7 reached a comparable absorbance at 280 nm after 7 h. This results 
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confirms that glucosamine generates either Maillard reaction intermediate products (MRP) or 
condensation products; thus, less native sugar would be available for the conjugation. Temperature 
reduction to 25°C required a longer incubation time (7 h) to show an increase of the absorbance 
(which was detectable in N25C_7 and C25C_7). Samples with a low peptide/sugar ratio (1:3 and 
particularly 1:1) had lower or no detectable glucosamine degradation/rearrangement products. 
Therefore, the lowest peptide/sugar ratio (1:1) and the lowest incubation time (3.5 h) were selected 
as the most suitable conditions to carry on the glycosylation reaction.  
To confirm the conjugation (both glycation and glycosylation), the peptide was incubated 
with and without TGase in the presence of glucosamine, and then analysed using Orbitrap-LC/MS. 
The spectrum of peptide plus glucosamine and TGase after incubation is reported in Figures 20. 
The MW of reactants are indicated as follows: m/z 180.08 for GlcN and m/z 204.09 for Gly-Gln. To 
calculate the glycated form of the peptide, the typical release of H2O in the Maillard reaction was 
considered. Hence, a mass shift of +161 Da (i.e. 179-18 Da) from the original MW of the peptide 
was predicted. One mole of ammonia was released from TGase-catalysed reactions (Ramos et al., 
2001). Thus, the MW of glycopeptides resulting from glycosylation of peptides with GlcN, in the 
presence of TGase, can be predicted based on a mass shift of +162 Da (179 - 17 Da).  
In figure 20, products of both glycation and glycosylation are reported: m/z 366.15 is 
related to the MW of the glycosylated glycopeptide, whereas m/z 365.16 corresponds to the  
glycated glycopeptide. The Orbitrap-mass spectrum shows also a protonated ion at 162.07 m/z, 
which is a typical adduct of glucosamine. As showed in figures 20, the intensity of glycoconjugates 
produced are low compared to the intensity of  the reagents. However, this result does not reflect 
the actual concentration of glycopeptides produced. In fact, according to Itoh et al. (2009), 
glycopeptides are poorly ionized in mass spectrometry. Moreover, their MS signal can be reduced 
or suppressed if a mixture of peptides and glycopeptides is analysed. The final hypothesised 
mechanism of the glycosylation and glycation involving GlcN and Gly-Gln is summarised in figure 
21. 
                 
8.2.2. Characterization of wheat gluten and its hydrolyzates 
The first step of the process was the gluten hydrolysis. In this phase, focused on the 
optimisation of the process, I preferred to use commercial proteases (Alcalase and Flavourzyme) 
instead of Yarrowia lipolytica enzymes which have not been purified yet. The chromatograms 
obtained by size exclusion analysis of the hydrolysates confirmed the enzyme activities. In figure 
22, it is possible to observe the shift of the peaks from high to low molecular weights after 
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hydrolysis. The estimated degree of hydrolysis (DH) by Alcalase was 4.70 ± 0.2%, whereas the 
Flavourzyme DH was 11.85±1.2%.  
 
8.2.3. Chemical evaluation of glycoconjugation of gluten peptides by MALDI-
TOF/TOF-MS 
After the glycation/glycosylation process, the MW profiles of the samples were determined 
using MALDI-TOF-MS. The analysis of the controls (GAH and GFH) revealed different profiles 
when Alcalase or Flavourzyme were used. The Alcalase peptides ranged from 500 to 3000 Da, 
whereas those in Flavourzyme were from 300 to 4100 Da. This distribution was expected, because 
Alcalase is an endopeptidase that generates a homogeneous distribution of MW, while Flavourzyme 
produces a more scattered profile including low and higher MW, due to its mixture of endo- and 
exo-peptidases.  
To estimate the glycation of the peptides, all the signals present in the spectra have been 
checked for their mass before and after the reaction. In particular the MWs of glycopeptides were 
calculated adding a mass shift of 161 Da (or any multiple of it, in case of additional sugars attached) 
to the original peptide MWs, due to the production of 1 mole of water. Hrynets et al., (2013) 
proposed that a potential glycation reaction, with an initial release of water, and a subsequent 
ammonia molecule, may occur with an additional mass shift of 144 Da to be add to the peptide 
MW. Hence, a mass shift of 162 Da in the MW of the peptides was considered to identify the 
glycosylated peptide in the presence of TGase.  
The total amount of glycopeptides estimated when the ratio peptide:GlcN was 1:1 (both at 
25 and 37°C) was 5 fold higher than the amount of glycopeptides observed at 1:3 ratio (5 vs. 25); in 
general, GAT25 (1:3) and GFT25 (1:3) presented a minor number of  glycopeptides. This would be 
because GlcN tends to auto-condensate resulting in a lower free GlcN amount available for the 
glycation/glycosylation process when present at higher concentrations (Zhu et al., 2007). Among 
the samples with the lowest (1:1) ratio, at least three different glycopeptides were produced through 
glycation, independently from the temperature used (fig. 22 and 23). Only one glycosylated peptide 
was estimated in GFT37 (fig. 24). The MW profiles of the glycopeptides were different if their 
origin was considered: gluten Alcalase glycopeptides were mainly constituted of 1322 and 1676 Da 
glycopeptides, whereas gluten Flavourzyme glycopeptides presented MWs ranging from 1775 to 
3112 Da.  
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8.2.4. In vitro bioactivity evaluation of glycopeptides mixtures  
8.2.4.1. DPPH Radical Scavenging Activity 
The quenching activity of the samples against DPPH was assessed and the EC50 values 
estimated are reported in table 8.  As shown in table 8, all the samples that underwent glycation 
improved their antioxidant activity, because neither GAH nor GFH (peptides not glycated) had a 
concentration-dependent activity. Among GA samples, GAC37 was the most active, followed by 
GAT25, GAT37 and GAC25. Nevertheless the final EC50 values were not significantly different 
amongst them. GFT37 was the most active among GF samples. Anyway all the samples incubated 
with TGase (GFT25 and GFT37) had a EC50 lower than the corresponding control with no enzyme 
added (GFC37 and GFC25). The reaction mixture with 1:3 peptide/sugar ratio, where glycopetides 
had not been generated, was used as control, in order to assess if other Maillard reaction products 
could prevent oxidation. None of the tested samples showed any activity similarly to GAC37 and 
GFC37, as reported in table 8. 
 
8.2.4.2. Inhibition of Linoleic acid peroxidation  
The capability of the samples to inhibit linoleic acid peroxidation was evaluated in 
comparison to α-tocopherol, generally used as positive control. The results obtained are reported in 
Figures 25 and 26. On the basis of the monitoring of the absorbance over time, GAC25 (1:1) was 
the only sample with a low lipid oxidation level (fig. 25). It was observed that during the first three 
days of the trial, no differences were detectable between GAH and GAC25. However, the oxidation 
curves significantly diverged over time (p < 0.05), reflecting the improved capability of the 
conjugated sample to inhibit the linoleic acid peroxidation. All the other GA samples (both 1:1 and 
1:3 ratio) did not show any significant antioxidant activity (p < 0.05). 
The GF samples (1:1) (fig. 26) not only did not show any antioxidant activity (p < 0.05), but 
also one of them, GFC25, resulted as the most significantly pro-oxidative sample. In fact, it reached 
the highest absorbance after three days, followed by a rapid decline associated with the 
decomposition of (hydro) peroxide.  
 
8.2.4.3. Anti-ACE activity 
Samples were tested for their anti-hypertensive activity, measuring the capacity to inhibit the 
ACE enzyme (fig. 27). In the samples GAH and GFH (with a concentration of 10 mg/ml) the 
enzyme inhibition was 64.1 ± 1.95 % and 50.3 ± 1.00%, respectively. The glycation had negative 
effects in almost all the samples, in particular in those corresponding to the GF. In fact, a half 
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reduction in the final activity was measured in all the GF samples except for the GFC37, whereas in 
the GAC37, GAT25 and the GAT37 a significantly lower reduction was detected (p < 0.05).  
 
8.2.4.4. Antimicrobial activity 
The antimicrobial activity of the samples, before and after glycation/glycosilation, was 
tested against two bacterial strains: Escherichia coli and Bacillus subtilis (Gram negative and Gram 
positive, respectively).  The peptide mixtures before the treatment (GAH and GFH) did not show 
any antimicrobial activity. However, despite the absence of activity in the 1:3 samples, the majority 
of the 1:1 ratio samples resulted active against E. coli (tab. 9). Specifically, all the conjugated GF 
samples inhibited the cell growth at 40 mg/ml, and GFC25 and GFT37 were also bactericidal. 
Among the GA samples, GAT37 was both inhibitor and bactericidal (40 mg/ml) for E. coli. None of 
the samples (1:1) was active against B. subtilis.  
It can be outlined that the peptide mixture includes peptides not glycated and about three 
glycopeptides. Therefore the MICs values are overextimated and presumably the MIC really 
effective against E. coli are lower than that obtained. 
 
8.2.4.5. Cytotoxicity in human cells 
The cytotoxicity of the peptides and glycopeptides (1:1 peptide/sugar ratio) was tested 
against human hepatocyte HepG2, using  three different concentrations (1 mg/ml, 0.5 mg/ml and 
0.1 mg/ml). When comparing GAH vs. GFH, no effects on cell viability were shown on human 
carcinoma cells (fig. 28), even at 1 mg/ml (p < 0.05). However, enhanced cytotoxicity was detected 
in all the conjugated GF samples, resulting in a significant reduction of the cell viability of 
approximately 50% at 1mg/ml (p < 0.05). High cytotoxicity was detected in GFT25 and GFT37 at 
0.5 mg/ml. Similarly GAT37 showed a strong activity at 1 mg/ml (p < 0.05), while the citotoxicity 
of the other GA samples was not significant.  
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8.3 Tables 
 
 
Table 6. Proteolytic activity of different strains of Y. lipolytica towards three different 
matrices (a, milk proteins; b, gluten; c, gelatin) at two different temperature (27 and 6 °C). The 
proteolytic activities on skim milk and gluten agar were evaluated measuring the clear zone formed. 
The proteolytic activity on gelatin was estimated measuring the volume of liquefied gelatin. The 
values were obtained after three (for 27 °C) or ten (for 6 °C) days of incubation. 
 
strain 27 °C 6 °C 27 °C 6 °C 27 °C 6 °C 
CLCD 0.5* 0.5* 0.5* 0.5* 0.5** 0.5**
1IILY4A 3 2.6 2.3 2.3 1.5 0.8
16B 2.5 2.3 2 2 1.8 0.7
PO19 0.5 0.5 1.3 0.5 0.5 0.5
Y10 0.5 0.5 0.5 0.5 1.9 0.5
Y16 3.2 2.3 2.3 2.5 0.8 0.5
1IIYL8A 3 2.3 2 0.5 0.5 0.5
(c) gelatin(a) skim milk agar (b) gluten agar
 
* refers to the clear zone diameter expresses in cm; ** refers to liquefied volume in a glass 
tube expresses in cm 
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Table 7. The evolution of some peptides, present in at least two sampling time, are reported. 
All the red cells correspond to the time 0, in particular to the native gelatine added with the 
supernatant of Y. lipolytica 1IIYL4A; the green ones correspond to the peptides produced after 48 h, 
the blue ones correspond to those released at 72 h. 
 
Y 0 Y 48 Y 72 Y 96
1143
1449
1606
1748
2078
2224
2766
3298
3371
3535
3766
3839
3921
4678
4842
5059
 
 
 
 
 
MW+ (Da) 
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Table 8. DPPH scavenging activity of Alcalase (GAH) and Flavourzyme (GFH) 
hydrolysates (control samples not conjugated) and the corresponding conjugated peptides obtained 
without enzyme (GAC25, GAC37, GFC25, GFC37) or with enzyme (GT25, GAT37, GFT25, 
GFT37). The EC50 values (mg/ml) are reported. All these samples refer to the mixture obtained 
incubating peptide/glucosamine in a 1:1 ratio. Since all the 1:3 ratio did not show any activity, 
GAC37 1:3 is just reported as an example.   
 
 
 
 
 
 
 
 
 
* not detectable. 
sample EC50 R sample EC50 R
Before glycation GAH nd GFH nd
After glyaction with higer 
ammount of sugar (1:3) GAC37 nd G FC37 nd
After glycation GAC25 27.45 0.98 GFC25 32 0.99
GAC37 20.25 0.99 GFC37 35.3 0.97
After +Tgase GAT25 21.82 0.99 GFT25 22.1 0.99
GAT37 25.15 0.99 GFT37 10 0.64
(mg/ml) (mg/ml)
*
Alcalase Flavourzyme
2 2 
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Table 9. Antimicrobial activity of Alcalase (GAH) and Flavourzyme (GFH) hydrolysates 
(control samples not conjugated) and the corresponding conjugated peptides obtained without 
enzyme (GAC25, GAC37, GFC25, GFC37) or with enzyme (GT25, GAT37, GFT25, GFT37) 
against E. coli. MIC and MBC (both expressed in mg/ml) refer to effect exerted by the mixture 
obtained incubating peptide/glucosamine in a 1:1 ratio.  
 
sample MIC MBC sample MIC MBC
Before glycation GAH - - GFH - -
After glycation GAC25 - - GFC25 40 40
GAC37 - - GFC37 40 -
After +Tgase GAT25 - - GFT25 40 -
GAT37 40 40 GFT37 40 40
E. coli
 
"-" no activity was observed for concentration ≤ 40  mg/ml 
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8.4 Figures 
 
 
 
 
 
 
 
 
Figure 5A. Casein zymography of different Y. lipolytica culture supernatants. Culture 
supernatants were recovered by centrifugation of a 4 days culture. The lable of the strains is 
reported above each lane. M: Molecular weight markers are reported in kDa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5B. Gelatin zymography of different Y. lipolytica culture supernatants. Culture 
supernatants were recovered by centrifugation of a 4 days culture. The lable of the strains is 
reported above each lane. M: Molecular weight markers are reported in kDa. 
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Figure 6. SDS-PAGE electrophoresis of α-casein hydrolyzed by different strains of Y. 
lipolytica at 72 h of incubation. C: α-casein alone, M: Molecular weight markers are reported in 
kDa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. SDS-PAGE electrophoresis of β-casein hydrolyzed by different strains of Y. 
lipolytica at 72 h of incubation. C: β-casein alone, M: molecular weight markers were marked in 
kDa. 
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Figure 8.  SDS-PAGE electrophoresis of meat protein extracts hydrolyzed by different 
strains of Y. lipolytica at 72 h of incubation. C: meat protein extracts alone, M: molecular weight 
markers were marked in kDa. 1, CLCD; 2, 1IIYL4A; 3 16B; 4, PO19; 5, Y10; 6, Y16; 7, 1IIYL8A. 
 
 
Figure 9.  SDS-PAGE electrophoresis of gelatin hydrolyzed by different strains of Y. 
lipolytica at 72 h of incubation. C: gelatin alone, M: molecular weight markers were marked in kDa. 
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Figure 10. Size exclusion chromatograms of gelatin incubated for 72 h with the supernatant 
of different strains of Y.lipolytica: Gelatin alone (A), 1IIYL4A (B), 16B (C), CLCD (D), 1IIYL8A 
(E), Y10 (F), PO19 (G), Y16 (H). 
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Figure 11. Overlay of two size exclusion chromatograms representing the gelatin at the 
starting point (time 0) and after hydrolysis with the supernatant of 1IIYL4A (time 72 h). 
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Figure 12. Gelatin hydrolysed by Y. lipolytica 1IIYL4A collected over time (time 0, 48, 72 
and 96 h). (A) SDS-PAGE electrophoretogram of the samples after different incubation times. M: 
molecular weight markers are marked in kDa. (B) Overlay of size exclusion chromatograms of the 
gelatin hydrolysed by Y. lipolytica 1IIYL4A collected over time time 0 (blue and brown), 48 
(green), 72 (red), 96 h (light blue). In particular a closeup of the MW < 25 kDa (estimated on the 
basis of a standard mixture previously injected) is shown.  
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Figure 13. Relative abundance of the three main area referred to the figure 8B. In particular,  
range between 90-115 mL (1), 115-125 mL (2) and 125-135 mL (3) for each chromatogram were 
considered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. MALDI-TOF spectra of ultrafiltered (cut-off < 10 kDa) gelatin hydrolysed by Y. 
lipolytica 1IIYL4A. The spectrum A refers to time 0, the spectrum B refers to time 96 h. 
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Figure 15. DPPH radical scavenging activity of gelatin incubated with the supernatant of Y. 
lipolyica 1IIYL4A and collected over time (0, 48, 72 and 96 h). Ascorbic acid (0.1 mg/ml) was used 
as reference standard. Values are expressed as means ± SD in triplicate experiments.  
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Figure 16. Antioxidant activity, in a linoleic acid oxidation model system, played by gelatin 
hydrolysates by Y. lipolyica  1IIYL4A protease collected over time (Y0, 48, 72, 96 h). BHT and α-
tocopherol were used as reference standards. Control was prepared with linoleic acid and water 
instead of the sample. Values are expressed as means ± SD in triplicate experiments.  
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Figure 17. The cytotoxic effect of the gelatin hydrolysates, obtained at different times, 
against Hepatocellular carcinoma (HepG2). Cells were treated with different concentrations of the 
gelatin hydrolyzed (1, 0.5 ad 0.1 mg/ml). Values are expressed as means ± SD in quadruplicate 
experiments. Control refers to untreated cells; gelatin refers to cells treated just with gelatin. 
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Figure 18. UV-spectra of samples absorbance (Abs) of the Glucosamine (N) and peptide 
plus glucosamine (PN) were monitored during incubation at two different temperatures (25 or 
37°C), for different incubation times (0, 3.5 and 7h). A, B and C represents the 1:10, 1:3 and 1:1 
molar ratio of peptide/GlcN or GlcN alone, respectively. Values are expressed as  triplicate 
experiments. 
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Figure 19. Hierarchal clustering of peptide–sugar (or just sugar) UV–Vis absorbance data 
for Gly-Gln and glucosamine (GlcN). The vertical axis represent individual wavelengths (280, 320 
and 420 nm). The horizontal axis represents individual glycation treatments. The colours in each 
cell indicate the absorbance of a particular sample relative to the mean level from all samples for 
the specific wavelength. The colour scale extends from bright green (maximum absorbance) to 
bright red (minimum absorbance). The samples GlcN (N), GlcN plus peptide (C) were followed 
during the incubation, under different temperatures (25 or 37°C), different peptide:GlcN ratios (1:1 
(A) , 1:3 (B) or 1:10 (C)) and incubation times (0, 3.5 and 7h). 
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Figure 20. Orbitrap LC-MS spectrum of products resulting from TGase mediated 
Glycosylation of peptides with GlcN.   
 
 
 
 
Figure 21. Proposed mechanism of reaction at 37 ºC for 3.5 h: glycosylation and glycation 
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Figure 22. Size exclusion chromatogram of gluten (solid line) and the hydrolysates 
subjected to Alcalase (GA, dots) and Flavourzyme (GF, dotted line) hydrolysis, respectively.  
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Figure 23. MALDI-TOF-MS spectra of gluten hydrolysated by Alcalase (GAH), gluten 
hydrolysate glycated at 25 or 37 °C (GAC25 and GAC37), gluten hydrolysate enzymatically 
glycosylated at 25 and 37 °C (GAT25 and GAT 37). Glycated peptides are marked with an asterisk 
(*), while glycosylated peptides are marked with a filled circle (•). 
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Figure 24. MALDI-TOF-MS spectra of gluten hydrolysated by Flavourzyme (GFH), gluten 
hydrolysate glycated at 25 or 37 °C (GFC25 and GFC37), gluten hydrolysate enzymatically 
glycosylated at 25 and 37 °C (GFT25 and GFT 37). Glycated peptides are marked with an asterisk 
(*), while glycosylated peptides are marked with a filled circle (•). 
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Figure 25. Antioxidant activities of Alcalase gluten hydrolysate and its 
glycacted/glycosylated samples in a linoleic acid oxidation system. The antioxidant activity was 
measured on the basis of the ability to keep constant the absorbance at 500 nm over time. α-
tocopherol was used as reference positive control. Linoleic acid plus water was used as negative 
control. Values are expressed as means ± SD of at least triplicate experiments. 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
0 1 2 3 4 5 6 7
time (day)
A
bs
o
rb
an
ce
 
(50
0 
n
m
) H20+LA
NO LA
2mM Alpha-Toco
GFH 1:1
GFC25 1:1
GFC37 1:1
GFT25 1:1
GFT37 1:1
 
 
Figure 26. Antioxidant activities of Flavourzyme gluten hydrolysate and its 
glycacted/glycosylated samples in a linoleic acid oxidation system. The antioxidant activity was 
measured on the basis of the ability to keep constant the absorbance at 500 nm over time. α-
tocopherol was used as reference positive control. Linoleic acid plus water was used as negative 
control. Values are expressed as means ± SD of at least triplicate experiments. 
 94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Anti-ACE activity of gluten samples hydrolysed with Alcalase (GA) and 
Flavourzyme (GF). The samples were incubated with GlcN (C) and glucosamine + TGase (T) at 25 
and 37°C. Values are expressed as means ± SD of at least triplicate experiments. 
 
 
 
Figure 28. The cytotoxic effect of of Alcalase (GAH) and Flavourzyme (GFH) hydrolysates 
(control samples not conjugated) and the corresponding conjugated peptides obtained without 
enzyme (GAC25, GAC37, GFC25, GFC37) or with enzyme (GT25, GAT37, GFT25, GFT37) 
against Hepatocellular carcinoma (HepG2). Cells were treated with different concentrations (1, 0.5, 
0.1 mg/ml) of the mixture obtained incubating peptide/glucosamine in a 1:1 ratio. Values are 
expressed as means ± SD in quadruplicate experiments. Control refers to cells not treated. 
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CHAPTER 9.  
DISCUSSION AND CONCLUSIONS 
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The extracellular proteases are widely studied in Y. lipolytica, in particular genes encoding 
for an alkaline protease (AEP) and an acidic protease (AXP) have been cloned and sequenced 
(Hernández-Montañez et al., 2007). However, since Y. lipolytica is an attractive host for the 
production of foreigner proteins, its proteolytic system must be further studied further because 
unspecific proteases may degrade the heterologous proteins or in many case protolytic processing is 
necessary for the expression of activities such as aminopeptidase, or dipeptidil-aminopeptidase by 
the host cells. Young et al. (1996) cloned and sequenced the gene and potential regulatory region of 
the extrcellular acid protease of a strain of Y. lipolytica and showed that the transcription of both the 
genes for acid and alkaline is regulated by the pH of the medium. Investigation relative to the strain 
diversity, the effect of the temperature or the occurence of dimeric or complex forms of the 
enzymes are lacking.  
A novel finding resulting from my experimental results is the detection of a new high MW 
protease in strains of Y. lipolytica. On the basis of the results some of the tested strains released 
prevalently or only a protease having MW higher than 200 kDa active both on casein and gelatin, 
while others released only protease, active on gelatin and casein, having a MW of 37 kDa. Both the 
proteins are released at the end of the exponential phase. Proteases having MW higher than 150 kDa 
have never been reported in Y. lipolytica and other yeasts, except for an extracellular protease 
having a MW of approximately 200 kDa has been described in M. pulcherrima (Reid et al., 2012). 
Reid et al., (2012) reported a protein, or a protein complex, having a protease activity characterized 
by 180-200 kDa MW. Moreover Chen et al., (1997) characterized, in Cryiptococcus spp., an 
extracellular proteolytic activity in vitro as a serine proteinase and found it associated with proteins 
of approximately 200 kDa. Goodley and Hamilton (1993) isolated a 200 kDa proteinase from the 
filtrate of C. neoformans.  
It has been reported that the initial size of intracellular and extracellular enzymes can change 
over time. In fact the MW of a protease can change because of the removal of a molecular fragment 
that obstruct the catalytic size. This has been documented as a common activation step of some 
mammalian proteases (Nagase et al., 1990). In order to avoid dangerous degradation of intracellular 
proteins, proteases are often synthesised with an additional segment that obstructs the catalytic site. 
This latent form (called either pro-enzyme or zymogen) displays up to 60% of the activity of the 
fully active molecule (Woessner, 1995). Outside the cells the fragment is cleaved off and full 
activity is achieved. This hypothesis does not fit the experimental results. In fact, generally the MW 
of the removed fragment did not significantly change the MW of the active protease (Hoffman and 
Decho, 2000). Moreover an activity of 37 kDa was not observed in the supernatant of strains 
showing proteolytic activity at 200 kDa, and vice versa. 
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Microorganisms evoluted in stressful environments, like marine ones, produce an array of 
enzymes having different MWs. In particular the marine bacterium Pseudomonas atlantica releases 
high MW (103 kDa) proteases during the exponential phase. These enzymes are degraded over time 
and new low MW enzymes (34, 31, 75, 69 kDa) are formed (Hoffman and Decho, 2000). 
Also this temporal evolution of released enzymes does not fit my data because both the 
enzymes at 200 and 37 kDa are alternatively produced in samples processed the same time, stored 
and run under the same conditions and using the same reagents. The possibility of artefacts can be 
considered negligible.  
In Y. lipolytica the aminoacid sequence, deduced by Young et al., (1996) from the 
nucleotide sequence encoding for AXP, consists of 353 aminoacids and a MW of 37 kDa. 
According to Young et al. (1996), the mature extracellular enzyme is produce from a propeptide by 
cleavage between Phenylalanine and Alanine. Likewise Y. lipolytica releases an alkaline 
extracellular protease from a 55 kDa precursor produced after cleavage of a 15 aminocid signal 
peptides. This precursor is then processed by a diamonopeptidase to generate a 52 kDa proprotein 
which is subsequently cleaved to give the mature 32 kDa secreted protein. Generally a 
propolypeptide is inactive and can be converted to mature active polypeptide by catalytic or 
autocatalytic cleavage of the propeptide.  
If, as suggested by Young et al. (1996), Y. lipolytica is characterized by just one specific 
gene for an acidic protease of a MW of 37 kDa, it can be hypothesised that the band having 
proteolytic activity and having a MW higher than 200 kDa corresponds to a complex of  the acid 
proteases. However, further studies would be necessary to demonstrate why a such a complex of 
proteins is active. Moreover all the proprotein or the obstructed proteases generally present a 
significantly lower MW. In any case a proteolyticic activity of a protein or protein aggregate having 
MW higher than 200 kDa has not been reported in Y. lipolytica and in genetically related yeast yet 
(Rao et al., 1998). Moreover our preliminary results showed that the two hypothetical acid 
proteases (with a MW of 37 and higher than 200 kDa), associated to different strains, generated 
different profiles from caseins, meat extract and gelatin. It could be wondered why a protease coded 
by the same gene from the same organism produces different profiles on the same protein. Y. 
lipolytica strains used in my thesis presented different RAPD profiles and different physiological 
characteristics as well as different ecological origins. Therefore it can be postulated that, due to 
subsequent environment-induced mutations, the protease acquires a different substrate specificities 
compared to the starting one (Craik et al., 1985). It must be considered that the genome of Y. 
lipolytica has been sequenced only in the strain Y. lipolytica CLIB122 provided by the Genolevures 
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Consortium. Therefore it can hypothesised that other strains of the same species harbour different 
genes and protein/enzymes not described yet. 
Concerning the biotechnological properties, most of the strains used in my work were 
endowed with proteolytic activity on gelatin, skim milk and gluten at T 6°C. The intracellular and 
extracellular proteolytic systems of Y. lipolytica have been object of several investigation and 
exploited for different technological uses (González-López et al., 2002). Different strains of Y. 
lipolytica used as cheese and dried sausage ripening adjuncts (Guerzoni et al., 1998, Vannini et al., 
2001, Lanciotti et al., 2005; De Wit et al., 2005; Patrignani et al., 2007) gave rise to different 
proteolysis patterns as well as strain dependent sensory and texture properties. 
In any case the physiological attribute that mosly distinguishes Y. lipolytica or its ecological 
biotypes from other yeasts species having biotechnological potential such as Debaryomyches 
hensenii, Geotrichum spp., Candida spp., (Vakhlu and Kour 2006; Bankar et al., 2009) is the ability 
to produce cold active enzymes. The possible application of cold active enzymes in the food 
industries are numerous (Gerday et al., 2000). Cold proteases offer potential economic benefits 
particularly through substantial energy saving in large scale processes that would not require the 
expensive heating of reactors. The typical example is the industrial peeling of leather by proteases 
which can be done with cold enzymes at temperature under 10°C instead of 37°C. In general the 
cold active enzyme have a more flexible structure and undergo the conformational changes 
necessary for catalysis with a lower energy demand. More recently enzymes from psychrotropic 
species have become interesting for industrial applications partially because  of the ongoing efforts 
to decrease energy consumption during industrial processes. When enzymes from psychrotropic 
species are used it becomes feasible to develop for instant laundry applications that can be 
performed at lower temperatures.  
Concerning the valorisation of meat by-products, the enzymes currently used are 
characterized by mesophylic or thermophylic characteristics. The quest for valuable proteases with 
distinct specificity for industrial applications is always a continuous challenge. Proteolytic enzymes 
from plant and fungal sources have received special attention for being active over a wide range of 
temperatures and pH. In general the commercial enzymes currently used present an optimal activity 
near 50-60°C. 
The strains of Y. lipolytica taken into consideration are characterized by cold attitude, 
versatile proteases and diversity as far as the peptides profiles obtained on all the protein sources 
considered. 
One of the strains taken into consideration has been selected, due to its intense proteolytic 
activity in the range from 4 to 28°C, to evaluate its performance in the production of peptides 
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having antioxidant, antimicrobial and cytotoxic, anti-ACE properties. The selected protein was 
gelatin due to its large availability as industrial by-product. The whole peptide mixture obtained 
during proteolysis over time were characterized by an increasing antioxidant activity. The peptides 
playing this effect are formed during the last 72 and 96 h. The latter samples were characterized by 
the presence of peptides having prevalently a MW lower than 3 kDa.  
The selection of strains having good biotechnological potential is a fundamental tool to 
identify natural active compound. However, wild strains and reactions performed with their 
enzymes generally give rise to a low level of active molecules. In order to increase the bioactivities 
of the peptides produced by the enzymes released by Y. lipolytica, I developed a chemico/enzymatic 
approach that has only been suggested in literature, but not explored yet. I would like to highlight 
that this process can be exploited not only for the peptides produced by proteases from Y. lipolytica, 
but also for peptides obtained from other protein hydrolysates of food by-products, thus increasing  
their added-value. 
The formation of a bound between a sugar and an amino acid occurs through enzymatic 
(glycosylation) and non-enzymatic (glycation) reactions. Although various techniques are available 
to prepare synthetic glycoproteins or glycopeptides (Caer et al., 1990; Christopher et al., 1980; 
Colas et al., 1993; Hattori et al., 1996; Kitabatake et al., 1985), the glyco-conjugates of proteins and 
polysaccharides obtained by the Maillard reaction have received much attention only in recent years 
(Liu et al., 2012). In fact the role of Maillard reaction on the improvement of functional properties 
of food proteins has been only recently proposed (Oliver et al., 2006). The main disadvantage of the 
Maillard reaction is the use of high temperature or prolonged heat treatments, to obtain the 
glycation (Liu et al., 2012).  In my work, I proposed a novel procedure to conjugate sugars and 
peptides, exploiting the particular behaviour of the amino-sugar GlcN, and the use of temperature 
not exceeding 37 °C. In the model system development the conditions and the validation of the 
glycation between GlcN and Gly-Gln at 25-37°C were shown. Further, the same model system was 
used to demonstrate the feasibility of using GlcN as a substrate for TGase, and for the production of 
glycosylated peptides. TGase is a universal enzyme capable of modifying proteins through the 
incorporation of amines; it is used in the food industry to improve the texture of vegetable and 
animal proteins and to create innovative food products with different properties (Seguro et al., 
1996).  
Based on the results of the UV spectra, the experimental conditions optimal to reduce, to a 
feasible extent the formation of GlcN side-products generated by its high reactivity, were 
determined. Lanciotti et al. (1999) reported that Maillard reactions (> 90°C) between sugars and 
aminoacids produced antimicrobial and antioxidant compounds. For this reason, even though lower 
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absorbance curves were detected in 1:1 ratio samples, 1:3 ratio was subsequently considered to 
assess the possible interference with the final activities. In general, conjugation leads to the 
formation of compounds with different properties, compared with the native structure. For example, 
it has been reported that the presence of sugars bounded to the peptides enhances the antimicrobial 
effect of the native peptide by approximately 100 times (Otvos et al., 2002).  
Once proved the conjugation in a model system, I tried to transfer the process into a more 
complex mixture of peptides. Wheat gluten, a by-product of the wheat industry, is a heterogeneous 
mixture of peptides with more than 60 different molecular weights ranging from 30 to 90 kDa. In 
particular, the main abundant forms are represented by the polymeric glutenin and the monomeric 
gliadin (Wang J. et al., 2007). Glutenin can also rearrange forming disulfide bonds and create 
structures with MW of 50 to 2000 kDa (Bietz and Wall, 1972). In my work, gluten was employed 
after proteolysis with Alcalase and Flavourzyme.  
The estimated degree of hydrolysis (DH) was not elevated for Alcalase. In fact higher DH 
for wheat gluten has been previously reported (Kong et al., 2007). On the contrary, the 
Flavourzyme generated a more common DH already described for protein hydrolysis. Even if 
differences in DH may depend on the selected method for its assessment, the low solubility of 
gluten at neutral pH could have also played an important role (Takeda et al., 2001).  
The hydrosylated samples obtained were then employed for the conjugation. All the samples 
were mainly glycated rather than glycosylated, and at least three glycopeptides were present in all 
samples. The excess of GlcN in the 1:3 ratio samples did not interfere with the tested activities. In 
these samples very low glycopeptides were detected and no interferences, due to possible GlcN 
side-products, were induced. Hence, it can be suggested that the reactivity of glucosamine at higher 
concentrations can form auto-condensed and rearrangement products that were not suitable for the 
glycation/glycosylation process. On the other hand, low amounts of sugar (1:1) generated more 
glycopeptides, and showed enhanced modulation of the final bio-activities.  
The assessed bioactivities were: DPPH scavenging activity, inhibition of linoleic acid 
peroxidation, anti-ACE, antimicrobial and cytotoxicity. As already mentioned, DPPH measures the 
free radical scavenging capacity of a sample, based on a combination of hydrogen atom and 
electron transfer reactions (Huang et al., 2005). With this assay all the conjugated samples showed 
an improvement of the final activity compared to the control ones (GAH and GFH). In particular 
GFT37, the sample having a glycopeptide obtained through glycosylation, was the most active. I 
would like to outline that in all the samples the contribution of the classical Maillard products can 
be regarded as negligible. These activities may depend on the sugar moiety of glycopeptides, which 
could be both electron donors and electron acceptors (van Boekel, 2001). The 1:3 peptide/sugar 
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ratio was also tested to determine whether the increased sugar content in the solution could 
influence the reducing power. However, no activity was detected in any sample when comparing 
GAH and GFH (data not shown) because of the lower content or absence of glycation of the 
peptides. It was also confirmed that under these reaction conditions, the possibile formation of some 
Maillard Reaction Products (MRPs) did not influence the antioxidant activity.  
The linoleic acid assay measures the capability of a specific sample to inhibit or reduce the lipid 
oxidation. However, the antioxidant reactions that occur in this case are different from those in the 
DPPH analysis. Zhang et al. (2008) reported that hydrophobic amino acids represent a key element 
to protect against lipid derived-radicals, due to their ability to interact with lipids (Ajibola et al., 
2011). In contrast, the presence of the sugar moiety within a glycopeptide (glycoprotein) could lead 
to an increase on the overall hydrophilicity (Wang and Ismail, 2012). This could explain the pro-
oxidative activity found in GFC25, the highest glycated sample as compared to the others. On the 
other hand, the antioxidant activity of GAC25 may depend on the relatively lower MW (1095 Da), 
with respect to all the other glycated peptides. Li et al. (2008) reported that protein hydrolysates 
prepared from corn gluten meal had increased effective antioxidant capacity when the MWs of 
peptides were between 500 - 1500 Da. Hence, glycopeptides with low MW may also be more 
effective in the linoleic acid assay. 
The ability of a peptide to inhibit ACE was also tested. This activity is strongly linked to the 
peptide amino acid composition and their primary sequence. Anti-ACE gluten peptides have been 
already reported (Kim et al., 2004); in particular, the main activity of the hydrolyzates can be 
attributed to the low molecular weight peptides. In fact, after fractionation of the samples, the 
inhibitory activity increased by fourf-old. Kinoshita et al. (1993) reported that high molecular 
weight peptides fraction reduced the blood pressure in hypertensive rats. The conjugation of gluten 
peptides had shown negative effects in almost all the samples. Je et al. (2004) described that the 
presence of hydrophobic amino acids in the sequence enhances the ACE-inhibitory ability of the 
peptides.  As a result, the perturbation of the final hydrophobicity of the peptide (once glycation has 
occurred) can have a negative effect in all activities depending on the proportion of 
hydrophobic/hydrophilic region inside the molecule.  
The antimicrobial activity of these samples demonstrated that the glycation was essential for 
the improvement of the antimicrobial activity. In particular, this effect is more relevant in GF than 
GA. Although the antimicrobial activity of glycopeptides has been reported, (Kahne et al., 2005; 
Bullet and Stocklin, 2005) the mechanisms of action have not been completely described. 
Glycopeptides active specifically against Gram-negative bacteria have been reported; for example, 
Drosocin, a well-studied glycopeptide isolated from Drosophila melanogaster, is a small proline-
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rich peptide (around 2-4 kDa) with a disaccharide (galactose and N-acetylgalactosamine) (Bulet and 
Stocklin, 2005). Gluten, on the other hand, is mainly constituted by glutamine/glutamic acid 
(around 40%), and proline (around 17-20%) (Wieser, 2007). The sugar moiety enhances the 
antimicrobial effect of the native peptide by approximately 100 times in Drosocin (Otvos et al., 
2002). Thus, the peptide sequence and the presence of a hydrophilic part in a specific position of the 
peptide are suggested to be important for the antimicrobial action. Kragol et al. (2001) reported that 
these glycopeptides may inhibit the protein folding through a mechanism involving the bacterial 
chaperonine/heat shock proteins GroEL and DnaK, once entered into the cells. 
The bioactivity of the samples was also assessed in relation to human tumor cells (HepG2). 
The enhanced cytotoxicity detected in the conjugated peptides implies that the formation of 
glycopeptides through a glycation process can be responsible for the main production of molecules 
with higher cytotoxicity. The low TGase-dependent effect could depend on the low/absent 
glycosylation reported or on the low affinity of the peptides for TGase. The cytotoxicity of 
glycopeptides has been previously described; although the role of sugar remains unknown, the 
carbohydrate moiety is likely to be involved in cell recognition, cellular uptake and DNA binding 
(La Ferla et al., 2011). Indeed, Brahim et al. (2008) demonstrated that the deglycosylated 
Bleomycin-A2 (a cytotoxic glycopeptide) was less toxic than its native form, due to the inability to 
induce ROS formation. Therefore, the two main elements influencing the studied properties were: 
1) the type of starting peptides (which are affected by the enzyme used for the hydrolysis and the 
MWs of the resulting peptides); 2) the reduction of the final hydrophobicity of the peptides.  
Although it was demonstrated the formation of glycopeptides through TGase both in the 
model system and in the gluten system, these results pointed out that the enzymatic process was not 
able to create sufficient glycosylated gluten peptides with improved activities. Indeed, studies 
regarding TGase and gluten have been reported. Dekking et al. (2008) demonstrated that 
transglutaminase can deamidate gluten peptides by introducing negative charges. This process was 
responsible for the enhanced immunogenicity of gluten. Similarly, Elli et al. (2012) reported the use 
of TGase as a tool to incorporate lysine, the first limiting amino acid in wheat products, into gluten. 
Cross-linking with glutamine using TGase promoted lysine availability. However, the incorporation 
of molecules to "protect" glutamines as a way to reduce the toxicity of gluten has not been exploited 
yet. The attachment of GluN can represent a potent tool in this direction. In this way, the 
conjugation method could be highly effective to modify peptides. The use of GluN and TGase can 
be employed to create innovative functional peptides or mixtures of peptides, using a mild 
temperature process. Additional studies have to be performed to improve the final yield of 
glycation/glycosylation process and to test the stability of these new compounds over time. 
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I can summarize the results of my thesis taking into consideration the steps included in the 
original project. 
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My research can not be regarded as exhaustive. In fact several points need to be further 
elucidated and developed: i.e. the nature of the high MW protease release by Y. lipolytica, the 
identification of the most active peptides in relation to their specific bioactivities, and the 
optimisation of the glycation reaction in relation to the food by-products and their hydrolysis when 
proteases released by Y. lipolytica are employed. However, I tried to integrate the selection and 
development of strains endowed with valuable biotechnological potential with a 
chemico/technological approach aimed at enabling the enhancement of the bioactivities of the 
resulting compounds.  
 
 105 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 10. 
REFERENCES 
 106 
 
Adler-Nissen J (1986) Methods in food protein hydrolysis. In "Enzymic hydrolysis of food 
proteins", Adler-Nissen J (Ed.), Elsevier Applied Science Publishers: (New York), USA, pp. 
116-124. 
Ajibola CF, Fashakin JB, Fagbemi TN, Aluko RE (2011) Effect of Peptide Size on Antioxidant 
Properties of African Yam Bean Seed (Sphenostylis stenocarpa) Protein Hydrolysate 
Fractions. Int J Mol Sci, 12: 6685-6702. 
Akpınar O, Uçar F, Yalçın HT (2011) Screening and regulation of alkaline extracellular protease 
and ribonuclease production of Yarrowia lipolytica strains isolated and identified from 
different cheeses in Turkey. Ann Microbiol, 61(4): 907-915 
Awarenet (2004) Handbook for the Prevention and Minimisation of Waste and Valorisation of By-
products in European Agro-Food Industries. Waldron K. (Ed.). 
Badiali F (2004) Biodiversità e proprietà tecnologiche di Yarrowia lipolytica in relazione all’origine 
ambientale. Ph.D: Thesis in Food Biotechnology, Alma Mater Studiorum, Università di 
Bologna. 
Bankar AV, Kumar AR, Zinjarde SS (2009) Environmental and industrial applications of Yarrowia 
lipolytica. Appl Microbiol Biotechnol, 84: 847–865. 
Barth G, Gaillardin C (1997) Physiology and genetics of the dimorphic fungus Yarrowia lipolytica. 
FEMS Microbial Rev, 19: 219-237. 
Bielikowicz K, Wojtacha P, Kostyra E, Iwan M, Jarmołowska B, Kostyra H (2010) Influence of 
glycation of wheat albumins and globulins on their immunoreactivity and physicochemical 
properties. Pol J Food Nutr Sci, 60(4): 335-340.  
Bietz JA, Wall JS (1972) Wheat gluten subunits: Molecular weights determined by sodium sulfate-
polyacrylamide gel electrophoresis. Cereal Chem, 49: 416-430. 
Bintsis T, Robinson RK (2004) Study of the effects of adjunct cultures on the aroma compounds of 
Feta-type cheese. Food Chem, 88: 435−441. 
Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol, 13: 
61-92. 
Bougatef A, Nedjar-Arroume N, Manni L, Ravallec R, Barkia A, Guillochon D, Nasri M (2010) 
Purification and identification of novel antioxidant peptides from enzymatic hydrolysates of 
sardinelle (Sardinella aurita) by-products proteins. Food Chem, 118: 559–565. 
Brahim S, Bettaieb A, Kenani A (2008) Deglycosylated bleomycin triggers apoptosis in laryngeal 
carcinoma cells in a caspase and reactive oxygen species independent manner. J Oral Pathol 
Med, 37(6): 352–357. 
 107 
 
Brands CMJ, Alink GM, Boekel MA, Jongen WMF (2000) Mutagenicity of heated sugar-casein 
systems: effect of the Maillard reaction. J Agr Food Chem, 48: 2271-2275. 
Brantl V, Gramsch C, Lottspeich F, Mertz R, Jager KH, Heltz A (1986) Novel opioid peptides 
derived from hemoglobin: hemorphins. Eur J Pharmacol, 125: 309-310. 
Bulet P, Stöcklin R (2005) Insect Antimicrobial Peptides: Structures, Properties and Gene 
Regulation. Prot Pep Lett 12: 3-11. 
Bunning P, Holmquist B, Riordan JF (1983) Substrate specificity and kineticcharacteristics of 
angiotensin converting enzyme. Biochem, 221, 110-116. 
Caer D, Baniel A, Subirade M, Gueguen J,Colas B (1990) Preparation and physicochemical 
properties of glycosylated derivatives of pea legumin. J Agr Food Chem, 38: 1700-1706. 
Chan KM, Decker EA (1994) Endogenous skeletal muscle antioxidants. Crit Rev Food Sci Nutr, 
34:403–26. 
Chen HM, Muramoto K, Yamauchi F, Fujimoto K, Nokihara K (1998) Antioxidant properties of 
histidine-containing peptides designed from peptide fragments found in the digests of a 
soybean protein. J Agric Food Chem, 46:49–53. 
Chen LC, Pirofski L, Casadevall A (1997) Extracellular Proteins of Cryptococcus neoformans and 
Host Antibody Response. Infect Immun, 65(7): 2599–2605. 
Chen Z, Eggert US, Dong SD, Shaw SJ, Sun B, LaTour JV, Kahne D (2002) Structural 
requirements for VanA activity of vancomycin analogues. Tetrahedron, 58(32): 6585–6594. 
Christopher P, Stowell P, Lee YC (1980) Neoglycoproteins. The preparation and application of 
synthetic glycoproteins. Adv Carbohyd Chem Bio, 37: 225-281. 
Coelho MAZ, Amaral PFF, Belo I (2010) Yarrowia lipolytica: an industrial workhorse. In “Current 
Research, Technology and Education Topics in Applied Microbiology and Microbial 
Biotechnology”, Méndez-Vilas A. (Ed.), 2: 930-940, Formatex, Badajoz (Spain) 
Colas B, Caer D, Fournier E (1993) Transglutaminase-catalyzed glycosylation of vegetable 
proteins. Effect on solubility of pea legumin and wheat gliadines. J Agr Food Chem, 41: 
1811-1815. 
Contreras MM, Carron R, Montero MJ, Ramos M, Recio I (2009) Novel casein-derived peptides 
with antihypertensive activity. Int Dairy J, 19: 566–573 
Córdoba JJ, Antequera T, Ventanas J, López-Bote C, García C, Asensio MA (1994)  Hydrolysis 
and loss of extractability of proteins during ripening of Iberian ham. Meat Sci, 37(2): 217-
27. 
Craik CS, Largman C, Fletcher T, Roczniak S, Barr PJ, Fletterick R, Rutter WJ (1985) Redesigning 
trypsin: alteration of substrate specificity. Science, 237: 291-297. 
 108 
 
Davidow LS, O'Donnell MM, Kaczmarek FS, Pereira DA, DeZeeuw JR, Franke AE (1987) 
Cloning and sequencing of the alkaline extracellular protease gene of Yarrowia lipolytica. J 
Bacteriol, 169(10): 4621-4629. 
Daya L, Augustina MA, Bateyb IL, Wrigleyb CW (2006) Wheat-gluten uses and industry needs. 
Trends Food Sci Technol, 17(2): 82–90. 
De Wit M, Osthoff G, Viljoen BC, Hugo A (2005) A comparative study of lipolysis and proteolysis 
in Cheddar cheese and yeast-inoculated Cheddar cheeses during ripening. Enzyme Microb 
Technol, 37: 606–616. 
Dekking EHA, Van Veelen PA, de Ru A, Kooy-Winkelaar EMC, Gröneveld T, Nieuwenhuizen 
WF, Koning F (2008) Microbial transglutaminases generate T cell stimulatory epitopes 
involved in celiac disease. J Cereal Sci, 47(2): 339–346. 
Dziuba J, Minkiewicz P, Plitnik K (1996) Chicken meat proteins as potential precursors of 
bioactive peptides. Pol J Food Nutr Sci, 5/46 (4): 87-98 
Elleuch M, Bedigian D, Roiseux O, Besbes S, Blecker C, Attia H (2011) Dietary fibre and fibre-
rich by-products of food processing: Characterisation, technological functionality and 
commercial applications: A review. Food Chem, 124(2): 411-421. 
Elli L, Roncoroni L, Hils M, Pasternack R, Barisani D, Terrani C, Vaira V, Ferrero S, Bardella MT 
(2012) Immunological effects of transglutaminase-treated gluten in coeliac disease. Hum 
Immunol, 73(10): 992-997. 
Erbersdobler HF, Brandt A, Scharrer E, Wangenheim B (1981) Transport and metabolism studies 
with fructose amino acids. Prog Food Nutr Sci, 5: 257-263. 
Erdmann K, Cheung BW, Schröder H (2008) The possible roles of food-derived bioactive peptides 
in reducing the risk of cardiovascular disease. J Nutr Biochem, 19(10): 643-54. 
Fanciulli G, Dettori A, Fenude E, Demontis MP, Alberico E, Delitala G, Anania V (2003) 
Intravenous administration of the food-derived opioid peptide gluten exorphin B5 stimulates 
prolactin secretion in rats. Pharmacol Res, 47(1): 53-58. 
Fang YZ, Yang S, Wu G (2002) Free radicals, antioxidants, and nutrition. Nutrition, 18: 872–879. 
FAO (2012) Crop residue based densified total mixed ration – A user-friendly approach to utilise 
food crop by-products for ruminant production, by Walli TK, Garg MR, Harinder PS 
Makkar. FAO Animal Production and Health Paper No. 172. Rome (Italy). 
Farnaud S, Evans RW (2003) Lactoferrin - a multifunctional protein with antimicrobial properties. 
Mol Immunol, 40: 395–405. 
Federalimentare, (2006) I sottoprodotti dell’Industria alimentare, 1-2 
 109 
 
Fickers P, Benetti PH, Waché Y, Marty A, Mauersberger S, Smit MS, Nicaud JM (2005) 
Hydrophobic substrate utilisation by the yeast Yarrowia lipolytica, and its potential 
applications. FEMS Yeast Res, 5: 527-543. 
Froehlich JC (1997) Opioid peptides. Alcohol Health Res World, 21(2): 132-136 
Fujita H, Sasaki R, Yoshiwaka M (1995) Potentiation of the antihypertensive activity of orally 
administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in 
egg phosphatidylcholine. Biosci Biotechnol Biochem, 59: 2344–2345 
Galanakis CM (2012) Recovery of high added-value components from food wastes: conventional, 
emerging technologies and commercialized applications. Trends Food Sci Technol, 26(2): 
68-87. 
Gamblin, D.P.; Scanlan, E.M.; Davis, B.G. (2009) Glycoprotein Synthesis: An Update. Chem Rev, 
109: 131-163. 
Ganz T (2003) Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol, 3(9): 710-
720. 
Gardini F, Tofalo R, Belletti N, Iucci L, Suzzi G, Torriani S, Guerzoni ME, Lanciotti R (2006) 
Characterization of yeasts involved in the ripening of Pecorino Crotonese cheese. Food 
Microbiol, 23: 641–648. 
Gauthier SF, Pouliot Y, Saint-Sauveur D (2006) Immunomodulatory peptides obtained by the 
enzymatic hydrolysis of whey proteins. Int Dairy J, 16(11): 1315–23. 
Gerday C, Aittaleb M, Bentahir M, Chessa JP, Claverie P, Collins T, D'Amico S, Dumont J, 
Garsoux G, Georlette D, Hoyoux A, Lonhienne T, Meuwis MA, Feller G (2000) Cold-
adapted enzymes: from fundamentals to biotechnology. Trends Biotechnol. 18(3): 103-107. 
Gobbetti M, Smacchi E, Corsetti A, Bellucci M (1997) Inhibition of proteolytic enzymes 
from Pseudomonas fluorescens ATCC 948 and Angiotensin I-converting enzyme by 
peptides from zein, hordein and gluten hydrolyzates. J Food Protect, 60: 499-504. 
Gobbo M, Biondi L, Filira F, Gennaro R, Benincasa M, Scolaro B, Rocchi R (2002) Antimicrobial 
Peptides: Synthesis and Antibacterial Activity of Linear and Cyclic Drosocin and Apidaecin 
1b Analogues. J Med Chem, 45: 4494-4504. 
Godfrey T, West S (1996) In ”Industrial Enzymology”, Macmillan Publishers Inc., New York 
(USA). 
González-López CI, Czabo R, Blanchin-Roland S, Gaillardin C (2002) Genetic control of 
extracellular protease synthesis in the yeast Yarrowia lipolytica. Genetics, 160: 17–427. 
 110 
 
Goodley JM, Hamilton AJ (1993) A novel extracellular high molecular weight proteinase from 
Cryptococcus neoformans. In “proceedings of the 2nd International Conference on 
Cryptococcus and Cryptococcosis”, P1-3. 
Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking 
enzymes that stabilize tissues. FASEB J, 5(15): 3071-3077. 
Guerra-Hernandez E, Gomez CL, Garcia-Villanova B, Sanchez NC, Gomez JMR (2002) Effect of 
storage on non-enzymatic browning of liquid infant milk formulae. J Sci Food Agric, 82: 
587-592. 
Guerzoni ME, Gobbetti M, Lanciotti R, Vannini L, Chaves lopez C (1998) Yarrowia lipolytica as 
potential ripening agent in milk products. In “Proceedings of the IDF Symposium on Yeasts 
in Dairy Industry: Positive and Negative Aspects” Jakobsen M, Narvhus J, Viljoen BC 
(Eds.), Copenhagen, Denmark, 1996. International Dairy Federation, Brussels, Belgium, pp. 
23–33. 
Gupta R, Beg QK, Lorenz P (2002) Bacterial alkaline proteases: molecular approaches and 
industrial applications. Appl Microbiol Biotechnol, 59: 15-32. 
Hajji M, Rebai A, Gharsallah N, Nasri M (2008) Optimization of alkaline protease production by 
Aspergillus clavatus ES1 in Mirabilis jalapa tuber powder using statistical experimental 
design. Appl Microbiol Biotechnol, 79(6): 915-923. 
Hansen-Møller J, Hinrichsen L, Jacobsen T (1997) Evaluation of Peptides Generated in Italian-
Style Dry-Cured Ham during Processing. J Agric Food Chem, 45 (8): 3123–3128. 
Harding MM, Anderberg PI, Haymet ADJ (2003) ‘Antifreeze’ glycoproteins from polar fish. Eur J 
Biochem, 270: 1381–1392. 
Hartmann R, Meisel H (2007) Food-derived peptides with biological activity: from research to food 
applications. Curr Opin Biotechnol, 18: 163–9. 
Hattori M, Aiba Y, Nagasawa K, Takahashi K (1996) Functional improvement of alginic acid by 
conjugating with β-lactoglobulin. J Food Sci, 61: 1171-1176. 
Hayes M, Ross RP, Fitzgerald GF, Hill C, Stanton C (2006) Casein-Derived Antimicrobial Peptides 
Generated by Lactobacillus acidophilus DPC6026. Appl Environ Microbiol, 72(3): 2260–
2264. 
Hernandez-Ledesma B, Hsieh C-C, de Lumen BO (2009) Lunasin, a novel seed peptide for cancer 
prevention. Peptides, 30: 426–30. 
Hernández-Montañez Z, Araujo-Osorio J, Noriega-Reyes Y, Chávez-Camarillo G, Villa-Tanaca L 
(2007) The intracellular proteolytic system of Yarrowia lipolytica and characterization of an 
aminopeptidase. FEMS Microbiol Lett, 268(2): 178-86.  
 111 
 
Hindley ML, Lee KC, Davis JT (2005) The Peptide Can Influence Sugar Conformation in Small 
Asn Glycopeptides. J Carbohydr Chem, 24: 261–273. 
Hoffman M, Decho AW (2000) Proteolytic enzymes in the marine bacterium Pseudoalteromonas 
atlantica: post-secretional activation and effects of environmental conditions. Aquat Mic E, 
23(1): 29-39 
Hou CW, Chen HJ, Yaw-Huei L (2003) Antioxidant peptides with angiotensin converting enzyme 
inhibitory activities and applications for angiotensin-I-converting enzyme purification. J Agr 
Food Chem, 51: 1706-1709. 
Hrynets Y, Ndagijimana M, Betti M (2013) Non-enzymatic glycation of natural actomyosin (NAM) 
with glucosamine in a liquid system at moderate temperatures. Food Chem, 139: 1062–
1072. 
Hrynets Y, Ndagijimana M, Betti M (2013) Non-enzymatic glycation of natural actomyosin (NAM) 
with glucosamine in a liquid system at moderate temperatures. Food Chem, 139: 1062–
1072. 
Hrynets Y, Ndagijimana M, Betti M (2013) Non-enzymatic glycation of natural actomyosin (NAM) 
with glucosamine in a liquid system at moderate temperatures. Food Chem, 139: 1062–
1072. 
Hsu K (2010) Purification of antioxidative peptides prepared from enzymatic hydrolysates of tuna 
dark muscle by-product. Food Chem, 122: 42-48. 
Hsu K, Li-Chan ECY, Jao C (2011) Antiproliferative activity of peptides prepared from enzymatic 
hydrolysates of tuna dark muscle on human breast cancer cell line MCF-7. Food Chem, 126: 
617–622. 
Huang D, Ou B, Prior RL (2005) The chemistry behind antioxidant capacity assays. J Agric Food 
Chem, 53(6): 1841-1856. 
Itoh S, Takakura D, Kawasaki N, Yamaguchi T (2009) Glycopeptide analysis using LC/MS and 
LC/MSn. Site-specific glycosylation analysis of glycoprotein. In “The Protein Protocols 
Handbook”. Walker J.M. (Ed.), Third edition, Humana Press, New York (New York), pp., 
1419-1430. 
Jang A, Jo C, Kang KS, Lee (2008) Antimicrobial and human cancer cell cytotoxic effect of 
synthetic angiotensin converting enzyme (ACE) inhibitory peptides. Food Chem, 107: 327-
336. 
Jany KD, Lederer G, Mayer B (1986) Amino acid sequence of proteinase K from the mold 
Tritirachium album Limber. FEBS Lett, 199:139-144. 
 112 
 
Je JY, Park PJ, Kwon JY, Kim SK (2004) A novel angiotensin I converting enzyme inhibitory 
peptide from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. J Agr 
Food Chem, 52: 7842-7845. 
Jenssen H, Hamill P, Hancock REW (2006) Peptide Antimicrobial Agents. Clin Microbiol Rev, 
19(3): 491–511. 
Jiang SJ, Zhao XH (2010) Transglutaminase-induced cross-linking and glucosamine conjugation in 
soybean protein isolates and its impacts on some functional properties of the products. Eur 
Food Res Technol, 231(5): 679-689. 
Joseph B, Ramteke PW, Thomas G, Shrivastavan N (2007) Review Cold-active Lipases: a versatile 
tool for industrial applications. Biotech Mol Biol Rev, 2: 39–48. 
Kahne D, Leimkuhler C, Lu W, Walsh C (2005) Glycopeptide and Lipoglycopeptide Antibiotics. 
Chem. Rev, 105: 425-448. 
Kalisz HM (1988) Microbial proteinases. Adv Biochem Eng Bio-technol. 36: 1-65. 
Kaur KJ, Pandey S, Sakunke DM (2006) Design of a functionally equivalent nonglycosylated 
analog of the glycopeptide antibiotic formaecin I. Prot Science, 16: 309-315. 
Kim J, Whang J, Suh H (2004) Enhancement of angiotensin I converting enzyme inhibitory activity 
and improvement of the emulsifying and foaming properties of corn gluten hydrolysate 
using ultrafiltration membranes. Eur Food Res Technol, 218(2): 133-138. 
Kinoshita E, Yamakoshi J, Ikuchi M (1993) Purification and identification of an antiotensin I-
converting enzyme inhibitor from soy sauce. Biosci Biotech Biochem, 57: 1107-1110. 
Kitabatake N, Cuq JL, Cheftel JC (1985) Covalent binding of glycosyl residues to β-lactoglobulin: 
Effects on solubility and heat stability. J Agr Food Chem, 33: 125-130. 
Kong X, Zhou H, Qian H (2007) Enzymatic hydrolysis of wheat gluten by proteases and properties 
of the resulting hydrolysates. Food Chem, 102: 759–763. 
Koo SH, Bae IY, Lee S, Lee DH, Hur BS, Lee HG (2011) Evaluation of wheat gluten hydrolyzates 
as taste-active compounds with antioxidant activity. J Food Sci Technol, 1-8. 
Korhonen H, Pihlanto A (2006) Bioactive peptides: production and functionality. Int Dairy J,  
16(9): 945–60. 
Kosseva MR (2009) Processing of Food Wastes. In “Advances in Food and Nutrition Research”, 
Taylor S.T. (Ed.), Academic Press, 58:, pp. 57-136. 
Kraehenbuehl K, Davidek T, Devaud S, Mauroux O (2008) Basic and acidic sugars as flavour 
precursors in the Maillard reaction. Expression of Multidisciplinary Flavour Science. In 
“Proceedings of the 12th 491 Weurman Symposium: Expression of multidisciplinary flavor 
 113 
 
science”, Blank I, Wust M, Yeretzian C. (Eds.), Zurich University of Applied Sciences: 
Interlaken, Switzerland, pp. 267-270. 
Kragol G, Lovas S, Varadi G, Condie BA, Hoffmann R, Otvos L Jr (2001) The Antibacterial 
Peptide Pyrrhocoricin Inhibits the ATPase Actions of DnaK and Prevents Chaperone-
Assisted Protein Folding. Biochem, 40: 3016-3026. 
Krasnowska G, Rudownik E, Hyliński A, Nowak A (2006). Forming the tenderness of beef using of 
elected enzymatic preparations of microbiological origin. EJPAU 9(4): #27. 
http://www.ejpau.media.pl/volume9/issue4/art-27.html. 
Kudoh Y, Matsuda S, Igoshi K, Oki T (2001). Antioxidative peptide from milk fermented with 
Lactobacillus delbrueckii subsp. bulgaricus IFO13953. Nippon Shokuhin Kagaku Kaishi, 
48: 44–55. 
Kumar CG, Takagi H (1999) Microbial alkaline proteases: from abioindustrial viewpoint. 
Biotechnol Adv, 17: 561-594. 
La Ferla B, Airoldi C, Zona C, Orsato A, Cardona F, Merlo S, Sironi E, D’Orazio G,  Nicotra F 
(2011) Natural glycoconjugates with antitumor activity. Nat Prod Rep, 28: 630-648. 
Lanciotti R, Anese M, Sinigaglia M, Severini C, Massini R (1999) Effects of Heated Glucose-
fructose-glutamic Acid Solutions on the Growth of Bacillus stearothermophilus. LWT - 
Food Sci Technol, 32: 223-230. 
Lanciotti R, Chaves-López C, Patrignani F, Paparella A, Guerzoni ME, Serio A, Suzzi G (2004) 
Effects of milk treatment with dynamic high pressure on microbial populations, and lipolytic 
and proteolytic profiles of Crescenza cheese. Int J Dairy Technol, 57(1): 19-25. 
Lanciotti R, Gianotti A, Baldi D, Angrisani R, Suzzi G, Mastrocola D, Guerzoni ME (2005) Use of 
Yarrowia lipolytica strains for the treatment of olive mill wastewater. Biores Technol, 96(3): 
317–322. 
Lanciotti R, Vannini L, Chaves Lopez C, Gobbetti M, Guerzoni ME (2005) Evaluation of the 
ability of Yarrowia lipolytica to impart strain-dependent characteristics to cheese when used 
as a ripening adjunct. Int J Dairy Technol, 58: 89−99. 
Li B, Chen F, Wang X, Ji B, Wu Y (2007) Isolation and identification of antioxidative peptides 
from porcine collagen hydrolysate by consecutive chromatography and electrospray 
ionization-mass spectrometry. Food Chem, 102: 1135-1143. 
Li J, Chi Z, Wang X, Peng Y, Chi Z (2009) The selection of alkaline protease-producing yeasts 
from marine environments and evaluation of their bioactive peptide production. Chin J 
Oceanol Limnol, 27(4): 753-761.  
 114 
 
Li XX, Han LJ, Chen LJ (2008) In vitro antioxidant activity of protein hydrolysates prepared from 
corn gluten meal. J Sci Food Agric, 88: 1660-1666. 
Lima CA, Rodrigues PMB, Porto TS, Viana DA, Lima Filho JL, Porto ALF, Carneiro da Cunha 
MG (2009) Production of a collagenase from Candida albicans URM3622. Biochem Eng J, 
43(3): 315–320. 
Liu J, Ru Q, Ding Y (2012) Glycation a promising method for food protein modification: 
Physicochemical properties and structure, a review. Food Res Int, 49: 170–183. 
Liu ZY, Dong SY, Xu J, Zeng MY, Song HX, Zhao YH (2008) Production of cysteine-rich 
antimicrobial peptide by digestion of oyster (Crassostrea gigas) with alcalase and bromelin. 
Food Control, 19: 231–235. 
Mackintosh JA, Veal DA, Beattie AJ, Gooley AA (1998) Isolation from an Ant Myrmecia gulosa of 
Two Inducible O-Glycosylated Proline-rich Antibacterial Peptides. J Biol Chem, 273(11): 
6139-6143 
Mancini L, Lettenmeier M., Rohn H., Liedtke C (2011) Application of the MIPS method for 
assessing the sustainability of production-consumption systems of food. J Econ Behav 
Organ, 81(3): 779–793. 
Martínez-Maqueda D, Miralles B, Recio I, Hernández-Ledesma B (2012) Antihypertensive 
peptides from food proteins: a review. Food Funct, 3: 350-361 
Matoba S, Fukayama J, Wing RA, Ogrydziak DM (1988) Intracellular precursors and secretion of 
alkaline extracellular protease of Yarrowia lipolytica. Mol Cell Biol, 8(11): 4904-4916. 
Mazur RH, Schlatter JM, Goldkamp AH (1969) Structure–taste relationships of some dipeptides. J 
Am Chem Soc, 91: 2684–2691. 
Meisel H (1997) Biochemical properties of regulatory peptides derived from milk proteins. 
Biopolymers, 43: 119–128. 
Meisel H (2004) Multifunctional peptides encrypted in milk proteins. BioFactors, 21: 55-61. 
Meloun B, Baudys M, Kostka V, Hausdorf G, Frommel C, Hohne WE (1985). Complete primary 
structure of thermitase from Thermoactinomyces vulgaris and its structural features related 
to the subtilisin-type proteinases. FEBS Lett, 183: 195-200. 
Mendis E, Rajapakse N, Kim S (2005) Antioxidant properties of a radical-scavenging peptide 
purified from enzymatically prepared fish skin gelatin hydrolysate. J Agric Food Chem, 3: 
581-587. 
Mills S, Stanton C, Hill C, Ross RP (2011) New Developments and Applications of Bacteriocins 
and Peptides in Foods. Ann Rev Food Sci Technol, 2: 299-329 
 115 
 
Mine Y, Kovacs-Nolan J (2006) New insights in biologically active proteins and peptides derived 
from hen’s egg. Worlds Poult Sci J, 62: 87–95. 
Mizuno K, Matsuo H (1984) A novel protease from yeast with specificity towards paired basic 
residues. Nature, 309: 558–560. 
Moor CV, Ha EYW (1991) Off-flavors of whey protein concentrates: a literature review. Int Dairy 
J, 1: 1-11. 
Mullally MM, Meisel H, FitzGerald RJ (1997) Identification of a novel angiotensin-I-
convertingcenzyme inhibitory peptide corresponding to a tryptic fragment of bovine beta-
lactoglobulin. FEBS Lett, 402: 99-101. 
Nagase H, Enghild JJ, Suzuki K, Salvesen G (1990) Stepwise activation mechanisms of the 
precursor of matrix metalloproteinase and (4-aminophenyl) mercuric acetate. Biochem, 29: 
5783-5789. 
Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995) Purification and 
characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci, 
78(4): 777-783. 
Nedkov P, Oberthur W, Braunitzer G (1983) Die primarstruktur von Subtilisin DY. Hoppe-Seyler's 
Z Physiol Chem, 364: 1537-1540. 
Neelakantan S, Mohanty AK, Kaushik JK (1999) Production and use of microbial enzymes for 
dairy processing. Curr Sci, 77: 143–148. 
Nelson G (1986) Yeast extracellular proteases and their applications in the brewing industry. Ph.D. 
thesis, University of Birmingham. 
Nelson G, Young TW (1986) Yeast extracellular proteases for chill-proofing beer. J Inst Brew, 92: 
599-603. 
Nielsen PM, Petersen D, Dambmann C (2001) Improved method for determining food protein 
degree of hydrolysis. J Food Sci, 66: 642-646. 
O’Mahony JA, Lucey JA, McSweeney PLH (2005) Chymosin-Mediated Proteolysis, Calcium 
Solubilization, and Texture Development During the Ripening of Cheddar Cheese. J Dairy 
Sci, 88: 3101–3114  
Ogrydziak DM (1993) Yeast extracellular proteases. Crit Rev Biotecbnol, 13: 1-55. 
Oliver CM, Stanley RA, Melton L D (2006) Creating proteins with novel functionality through the 
Maillard reaction. Cr Rev Food Sci Nutr, 46: 337–350. 
Osawa T, Namiki M (1981) A novel type of antioxidant isolated from leaf wax of Eucalyptus 
leaves. Agric Biol Chem, 45: 735-739. 
 116 
 
Ota Y, Gomi K, Kato S, Sugiura T, Minoda Y (1982) Purification and some properties of cell-bond 
lipase from Saccharomycopsis lipolytica. Agr Biol Chem, 46: 2885-2893 
Otagiri K, Nosho Y, Shinoda I, Fukui H, Okai H (1985) Studies on a model of bitter peptides 
including arginine, proline and phenylalanine residues. I. Bitter taste of di- and tripeptides, 
and bitterness increase of the model peptides by extension of the peptide chain. Agric Biol 
Chem, 49(4): 1019-1026. 
Otvos L Jr, O I, Rogers ME, Consolvo PJ, Condie BA, Lovas S, Bulet P, Blaszczyk-Thurin M 
(2000) Interaction between Heat Shock Proteins and Antimicrobial Peptides. Biochem, 39: 
14150-14159. 
Otvos L, Bulet P, Varga I, Hoffmann R (2002) Antibacterial insect glycopeptides: Synthesis, 
structure and activity. Peptides frontiers of peptide science. In “Proceedings of the Fifteenth 
American Peptide Symposium”, Tam PJ, Kaumaya TP (Eds.), Vol 5 Session IX, June 14-19, 
1997, Nashville (Tennessee),, 2002, pp. 703-704.  
Outtrup H, Boyce COL (1990) Microbial proteinases and biotech-nology. In “Microbial enzymes 
and biotechnology”, Fogarty CT, Kelly K (Eds.). Elsevier (London), pp 227-254. 
Parfene G, Hornicar VB, Bahrim G, Vannini L, Gottardi D, Guerzoni ME (2011) Lipolytic activity 
of lipases from different strains of Yarrowia lipolytica in hydrolysed vegetable fats at low 
temperature and water activity. Rom Biotech Lett, 16(6): 46-52 
Patrignani F, Iucci L, Vallicelli M, Guerzoni ME, Gardini F, Lanciotti R (2007) Role of surface-
inoculated Debaryomyces hansenii and Yarrowia lipolytica strains in dried fermented 
sausage manufacture. Part 1: Evaluation of their effects on microbial evolution, lipolytic and 
proteolytic patterns. Meat Sci, 75(4): 676-686. 
Patrignani F, Vannini L, Gardini F, Guerzoni ME, Lanciotti R (2011a) Variability of the lipolytic 
activity and volatile molecules production by a strain of Yarrowia lipolytica in pork fat and 
its dependence on environmental conditions. Meat Sci, 89(1): 21-26.  
Patrignani F, Vannini L, Gardini F, Guerzoni ME, Lanciotti R (2011b) Variability of the lipolytic 
activity in Yarrowia lipolytica strains in pork fat. Meat Sci, 88(4): 689-693. 
Pellegrini A (2003) Antimicrobial Peptides from Food Proteins. Curr Pharm Des, 9(16): 1225- 
1238. 
Perez Espitia PJ, de Fátima Ferreira Soares N, dos Reis Coimbra JS, de Andrade NJ, Souza Cruz R, 
Alves Medeiros EA (2012) Bioactive Peptides: Synthesis, Properties, and Applications in 
the Packaging and Preservation of Food. Compr Rev Food Sci , 11(2): 1541-4337. 
 117 
 
Phadatare SU, Srinivasan MC, Deshpande VV (1993) High activity alkaline protease from 
Conidiobolus coronatus (NCL 86.8.20): enzyme production and compatibility with 
commercial detergents. Enzyme Microb Technol, 15: 72–76. 
Rada-Mendoza M, Olano A, Villamiel M (2002) Furosine as indicator of Maillard reaction in jams 
and fruit-based infant foods. J Agric Food Chem, 50: 4141-4145. 
Rajanbabu V, Chen JY (2011) Applications of antimicrobial peptides from fish and perspectives for 
the future. Peptides, 32(2): 415–20. 
Raksakulthai R, Haard NF (2003) Exopeptidases and Their Application to Reduce Bitterness in 
Food: A Review. Crit Rev Food Sci Nutr, 43(4): 401-445. 
Rao MB, Tanksale AM, Ghatge MS, Deshpande VV (1998) Molecular and Biotechnological 
Aspects of Microbial Proteases. Microbiol Mol Biol Rev, 62(3): 597–635. 
Razanarnparany V, Jara P, Legoux R, Delrnas P, Msayeh F, Kaghad M, Loison G (1992) Cloning 
and mutation of the gene encoding endothiapepsin from Crypbonectria parasitica. Curr 
Genet, 21: 455-461. 
Reddy KVR, Yedery RD, Aranha C (2004) Antimicrobial peptides: premises and promises. Int J 
Antimicrob Agents, 24(6): 536–47. 
Reid VJ, Theron LW, du Toit M, Divol B (2012) Identification and Partial Characterization of 
Extracellular Aspartic Protease Genes from Metschnikowia pulcherrima IWBT Y1123 and 
Candida apicola IWBT Y1384. Appl Environ Microbiol, 78(19): 6838–6849. 
Rival SG, Boeriu CG, Wichers H. J (2001) Caseins and casein hydrolysates. 2. Antioxidative 
properties and relevance to lipoxygenase inhibition. J Agr Food Chem, 49: 295–302. 
Roberts PR, Burney JD, BlackKW, Zaloga GP (1999) Effect of chain length on absorption of 
biologically active peptides from the gastrointestinal tract. Digestion, 60: 332–337. 
Rodriguez C, Domínguez A (1984) The growth characteristics of Saccharomycopsis lipolytica: 
morphology and induction of mycelium formation. Can J Microbiol, 30(5): 605-612. 
Romeo D, Skerlavaj B, Bolognesi M, Gennaro R (1988) Structure and bactericidal activity of an 
antibiotic dodecapeptide purified from bovine neutrophils. J Biol Chem, 263(20): 9573–
9575 
Ryan JT, Ross RP, Bolton D, Fitzgerald GF, Stanton C (2011) Bioactive Peptides from Muscle 
Sources: Meat and Fish. Nutrients, 3(9): 765-791. 
Sarmadi BH, Ismail A (2010) Antioxidative peptides from food proteins: a review. Peptides, 
31(10): 1949-1956. 
Sauer M, Porro D, Mattanovich D, Branduardi P (2007) Microbial production of organic acids: 
expanding the markets. Trends Biotechnol, 26(2): 100-108 
 118 
 
Seguro K, Nio N, Motoki M (1996) Some Characteristics of a Microbial Protein Cross-Linking 
Enzyme: Transglutaminase. Acs Sim Ser, 21: 271–280 
Seki T, Kawasaki Y, Tamura M, Tada M, Okai H (1990) Further study on the salty peptide, 
ornithyl-beta-alanine. Some effects of pH and additive ions on the saltiness.  J Agric Food 
Chem, 38(1): 25–29. 
Shalaby SM, Zakora M, Otte J (2006) Performance of two commonly used angiotensin-converting 
enzyme inhibition assays using FA-PGG and HHL as substrates. J Dairy Res, 73: 178-186. 
Sharpe FR, Jacques D, Rowsell AG, Whitear AL (1981) Rapid methods of measuring the foam-
active nitrogenous components of worts and beers. In “Proceedings of the the European 
Brewery Convention Congress, 18th Congress, Copenhagen (Denmark), pp. 607- 614.  
Shimizu M, Lee SW, Kaminogawa S, Yamauchi K (1984) Emulsifying properties of an N- terminal 
peptide obtained from the peptic hydrolyzates of αs1-casein. J Food Sci, 49:1117-1120. 
Smacchi E, Gobbetti M (2000) Bioactive peptides in dairy products: synthesis and interaction with 
proteolytic enzymes. Food Microbiol, 17(2): 129-141. 
Smith JE (1998) Biotecnologie. Zanichelli (Bologna), pp. 22-25.Spiro RG (2002) Protein 
glycosylation: nature, distribution, enzymatic formation, and disease implications of 
glycopeptide bonds. Glycobiol, 12: 43R–56R. 
Srinivas S, Prakash V (2010) Bioactive peptides from bovine milk α-casein: isolation, 
characterization and multifunctional properties. Int J Pept Res Ther, 16: 7-15. 
St Georgiev V (1990) Immunomodulatory activity of small peptides. Trends Pharmacol Sci, 
11(9):373–8. 
Sudha ML,Baskaran V, Leelavathi K (2007) Apple pomace as a source of dietary fibre and 
polyfenols and its effect on the rheological characteristics and cake making. Food Chem, 
104: 686-692. 
Sujatha S and Praharaj I (2012) Glycopeptide Resistance in Gram-Positive Cocci: A Review. 
Interdiscip Perspect Infect Dis, 2012: 1-10. 
Sumantha A, Larroche C, Pandey A (2006) Microbiology and industrial biotechnology of food-
grade proteases: a perspective. Food Technol Biotechnol, 44(2): 211-220. 
Suzzi G, Lanorte MT, Galgano F, Andrighetto C, Lombardi A, Lanciotti R, Guerzoni ME (2001) 
Proteolytic, lipolytic and molecular characterisation of Yarrowia lipolytica isolated from 
cheese. Int J Food Microbiol, 69(1-2): 69-77. 
Takahashi M, Moriguchi S, Yoshikawa M, Sasaki R (1994) Isolation and characterization of 
oryzatensin: a novel bioactive peptide with ileum-contracting and immunomodulating 
activities derived from rice albumin. Biochem Mol Biol Int, 33: 1151–1158. 
 119 
 
Takeda K, Matsumura Y, Shimizu M (2001) Emulsifying and Surface Properties of Wheat Gluten 
under Acidic Conditions. J Food Sci, 66(3): 393-399. 
Temussi PA (2012) The good taste of peptides. J Pept Sci, 18: 73–82. 
Tong LM, Sasaki S, McClements DJ, Decker EA (2000) Mechanisms of the antioxidant activity of 
a highmolecular weight fraction of whey. J Agric Food Chem, 48: 1473–1478. 
Udenigwe CC, Aluko RE (2012) Food Protein-Derived Bioactive Peptides: Production, Processing, 
and Potential Health Benefits. J Food Sci, 71(1): 11-24. 
Vakhlu J, Kour A (2006) Yeast lipases: Enzyme purification, biochemical properties and gene 
cloning. Electron J Biotechnol, 9: 69-85. 
van Boekel MAJS (2001) Kinetic aspects of the Maillard reaction: a critical review. Nahrung, 45: 
150-159. 
Van De Weert M, Randolfh TW (2012) Physical Instability of peptides and proteins. In: 
“Pharmaceutical Formulation Development of Peptides and Proteins”, Hovgaard L, Frokjaer 
S, Van De Weert M (Eds), 2nd ed, CRC Press, pp 107-130. 
van den Tempel T, Jakobsen M (2000) The technological characteristics of Debaryomyces hansenii 
and Yarrowia lipolytica and their potential as starter cultures for production of Danablu. Int 
Dairy J, 10: 263-270. 
Vannini L, Baldi D, Lanciotti R (2001) Use of Fourier transform infrared spectroscopy to evaluate 
the proteolytic activity of Yarrowia lipolytica and its contribution to cheese ripening. Int J 
Food Microbiol, 69(1–2): 113–123. 
Vermeirssen V, Van Camp J, Verstraete W (2002) Optimisation and validation of an Angiotensin-
converting enzyme inhibition assay for the screening of bioactive peptides. J Biochem 
Biophys Methods, 51: 75-87. 
Wang HX, Ng TB (1999) Natural products with hypoglycemic, hypotensive, hypocholesterolemic, 
antiatherosclerotic and antithrombotic activities. Life Sci, 65(25): 2663–2677. 
Wang J, Zhao M, Zhao Q, Bao Y, Jiang Y (2007) Characterization of Hydrolysates Derived from 
Enzymatic Hydrolysis of Wheat Gluten. J Food Sci, 72(2): C103-C107.  
Wang Q, Ismail B (2012) Effect of Maillard-induced glycosylation on the nutritional quality, 
solubility, thermal stability and molecular configuration of whey proteinv. Int Dairy J, 25: 
112-122. 
Wang S and Damodaron S (2009) Ice-Structuring Peptides Derived from Bovine Collagen. J Agric 
Food Chem, 57: 5501–5509. 
 120 
 
Wang SX, Laverty S, Dumitriu M, Plaas A, Grynpas MD (2007) The effects of glucosamine 
hydrochloride on subchondral bone changes in an animal model of osteoarthritis. Arthritis 
Rheum, 56(5): 1537-1548. 
Wiese B (1995) Die Mikroflora von Weizenvorteigen und ihr Einfluss auf die Aromabildung. 
Dissertation Universität Hannover, Fachbereich Biologie. 
Wieser H (2007) Chemistry of gluten proteins. Food Microbiol, 24(2): 115-119. 
Wijewickreme AN, Kitts DD, Durance TD (1997) Reaction conditions influence the elementary 
composition and metal chelating affinity of nondialyzable model Maillard reaction products. 
J Agric Food Chem, 45: 4577-4583. 
Wirsenius S (2008) The Biomass Metabolism of the Food System: A Model-Based Survey of the 
Global and Regional Turnover of Food Biomass. J Ind Ecol, 7(1): 47-80. 
Woessner J Jr (1995) Quantification of matrix metalloproteinases in tissue samples. In: “Methods in 
enzymology-proteolytic enzymes: aspartic and metallopeptidases”, Barrett AJ (Ed.), 
Academic Press, San Diego (CA), pp. 510–528. 
Wohrmann APA (1996) Antifreeze glycopeptides and peptides in Antarctic fish species from the 
Weddell Sea and the Lazarev Sea. Mar Ecol Prog Ser, 130: 47-59. 
Wolfe KL, Liu RH (2007) Cellular antioxidant activity (CAA) assay for assessing antioxidants, 
foods and dietary supplements. J Agric Food Chem, 55: 8896-8907. 
Wu Y and Wang D (2009) A New Class of Natural Glycopeptides with Sugar Moietydependent 
Antioxidant Activities derived from Ganoderma lucidum Fruiting Bodies. J Proteome Res, 
8(2): 436–442. 
Yamada T, Ogrydziak DM (1983) Extracellular acid proteases produced by Saccharomyces 
lipolytica. J Bacteriol, 154: 23–31. 
Yang B, Zhang X, Bao X, Lv Y, Zhang J, Guo S (2008) Glycopeptide derived from soybean b-
conglycinin inhibits the adhesion of Escherichia coli and Salmonella to human intestinal 
cells. Food Res Int, 41: 594–599. 
Yang JK, Shih IL, Tzeng YM, Wang SL (2000) Production and purification of a protease from a 
Bacillus subtilis that can deproteinize crustacean wastes. Enzyme Microb Technol, 26: 406–
413. 
Yang R, Pei X, Wang J, Zhang Z, Zhao H, Li Q, Zhao M, Li Y (2010) Protective effect of a marine 
oligopeptide preparation from chum salmon (Oncorhynchus keta) on radiation-induced 
immune suppression in mice. J Sci Food Agric, 90: 2241–2248. 
 121 
 
Yang WH, Zhang WC, Lu XM, JiangGS and Gao PJ (2009) Characterization of a novel 
antibacterial glycopeptide produced by Penicillium sp. M03. Lett Appl Microbiol, 48: 393–
397. 
Yegin S, Fernández-Lahore M, Guvenc U, Goksungur Y (2010) Production of extracellular aspartic 
protease in submerged fermentation with Mucor mucedo DSM 809. Afr J Biotechnol, 9(38): 
6380-6386. 
Yen G, Wu J (1999) Antioxidant and radical scavenging properties of extracts from Ganoderma 
tsugae. Food Chem, 65: 375-379. 
Young TW, Wadeson A, Glover DJ, Quincey RV, Butlin MJ, Kamei EA (1996) The extracellular 
acid protease gene of Yarrowia lipolytica: sequence and pH-regulated transcription. 
Microbiol, 142(10): 2913-2921. 
Zhang SB, Wang Z, Xu SY (2008) Antioxidant and antithrombotic activities of rapeseed peptides. J 
Am Oil Chem Soc, 85: 521:527. 
Zhu A, Huang JB, Clark A, Romero R, Petty HR (2007) 2,5-Deoxyfructosazine, a D-glucosamine 
derivative, inhibits T-cell interleukin-2 production better than D-glucosamine. Carbohydr 
Res, 342: 2745-2749. 
Zioudrou C, Streaty RA, Klee WA (1979) Opioid peptides derived from food proteins: the 
exorphins. J Biol Chem, 254: 2446-2449. 
 
 
Web references 
 
http://ec.europa.eu/food/food/biosafety/animalbyproducts/index_en.print.htm 
http://en.wikipedia.org/wiki/Glycopeptide 
http://en.wikipedia.org/wiki/Vancomycin 
http://www.freepatentsonline.com/y2012/0283174.html 
https://usgene.sequencebase.com/patents/US20060083847 
 122 
 
ACKNOWLEDGMENTS 
Another step of my life has arrived at the end. Such a long way since I arrived at the Food 
Microbiology Lab but it is quite satisfactory to see the outcome of my adventure. I would like to 
acknowledge myself because I reached this result but I have to admit that everything was possible 
just because of the assistance of the following people. 
I am particularly grateful to my supervisor, Prof. Maria Elisabetta Guerzoni, who dared to 
trust in me  and whose incredible creativity and support gave me feedback and inspirations during 
my entire PhD career. Her time and continuous guidance are hugely appreciated.  
I am also thankful to my other supervisor, Dott.ssa Lucia Vannini, who always believed in 
me and gave me complete freedom as well as her support to conduct my research. 
My deep appreciation is for my Canadian supervisor Prof. Mirko Betti, who gave me the 
chance to live the most professional experience of my life. Without his support and his trust in me I 
could not have been able to further my investigation. I will always keep with me all his suggestions. 
A sincere thanks to Dr. Maurice Ndagijimana for all the scientific discussions we had and 
his constant and respectful presence, constantly next to me with precious suggestions.  
Prof. Fausto Gardini and Prof.ssa Rosalba Lanciotti, my gratitude is also extended to you. 
I would like to thank all my friends and colleagues of the Food Microbiology Lab at the 
University of Bologna: Diana Serrazanetti, Chiara Montanari, Giulia Tabanelli, Pamela Vernocchi, 
Francesca Patrignani, Giorgia Gozzi, Lucia Camprini, Lorenzo Siroli, Rodrigo Troncoso, Lucilla 
Dei Più and Danielle Taneyo. We lived, worked and suffered together and we always supported 
each other.  
A personal thanks to "my" technician Luciana Perillo, that followed my "first steps" in the 
microbiology lab and she has always supported me during these years.  
I would also like to show my appreciation to Danka Bukvicki and Amit Kumar Tyagi 
because they became some of my best friends rather than colleagues, and they have continuously 
provided me with their consideration as well as with moral support through the distance. 
Since I spent almost one year in Canada, I have to offer my gratitude for the support and 
friendship received from all my friends and colleagues at the University of Alberta, in Prof. Betti's 
 123 
 
Lab: Pui Khoon (Kimi) Hong, Zied Khiari, Yulija Hrynets, Lihui (Mavis) Do, Henan Wang; and 
those in the Microbiology lab: Alma Fernanda Sanchez Maldonado, Petya Koleva and Xiaoji 
(Christine) Liu. A thanks goes also to all the other people that I met in Edmonton and that made my 
permanence there as familiar as possible in some way: Lynda and Alan Jones, Sam Cheng, Soledad 
Urrutia, Maricruz Ormeño Urrutia, Sahar Navidghasemizad and also all the "Chinese basketball 
players". 
My old friends Andrea Bonora, Luca Vanini, Luca Brochetto, Caterina Villani who have 
always encouraged and granted me with their friendship. 
A special and affectionate thanks to Emma Hernandez Sanabria, because from the beginning 
she has been patient and supportive with me, giving me strength and love.  
I would like to express my sincere admiration to my grandparents, but most importantly to 
my parents, who have been incredibly encouraging along my Ph.D. They all have undoubtedly 
made sacrifices and it is due to them that I have found the motivation and resolution to continue 
straight and committed.  
 
 124 
 
 
 125 
 
 126 
 
 
 
 
 
